var title_f36_28_37312="Aflibercept: Drug information";
var content_f36_28_37312=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Aflibercept: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F14946178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F14946179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?27/18/27939?source=see_link\">",
"       Aflibercept (ophthalmic): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?2/18/2342?source=see_link\">",
"       Aflibercept (ziv-aflibercept) (systemic): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Eylea Intraocular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 mg/0.05 mL (0.05 mL): $2220.00",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 17100 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-3918385851-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37312=[""].join("\n");
var outline_f36_28_37312=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?27/18/27939?source=related_link\">",
"      Aflibercept (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?2/18/2342?source=related_link\">",
"      Aflibercept (ziv-aflibercept) (systemic): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_28_37313="Formestane: International drug information";
var content_f36_28_37313=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Formestane: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4303428\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Lentaron (AR, AT, BE, CH, DE, DK, ES, HU, IT, LU, NL, PT)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1978886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Aromatase Inhibitor",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1978889\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of advanced breast cancer in postmenopausal women",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1978885\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.M.: Adults: 250 mg every 14 days",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1978888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, suspension: 250 mg/2 mL",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10386 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-A7B94B43F3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37313=[""].join("\n");
var outline_f36_28_37313=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303428\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978886\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978889\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978885\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821184\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978888\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10386\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10386|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_28_37314="Vulva trauma";
var content_f36_28_37314=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80199&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Major vuvlar trauma from motor vehicle accident",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 342px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Extensive laceration with abrasion and debris from road.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marc Laufer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37314=[""].join("\n");
var outline_f36_28_37314=null;
var title_f36_28_37315="Peripheral IV placement 7";
var content_f36_28_37315=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F56946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F56946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Peripheral IV placement: Saline flush",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 336px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFQAfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5coxS0VICAUoFFAoAnibZUwmqqnJqbZQBZVwaeCDVLJHenrIRUtAXcjbVG5HWmvM2eKjLlutNKwEGSDS5FOIzTdtMBaSjaaOlMQtRsadTSKAPoH4YeHrbSdBhlwjXlwolldiAeRwB7Cuyd/I/1m4Kf7ikmvP/AIdeItL1PSIrO/vIba4jUKPO+7wOh9q6yaS30tCU1vTmtj0U3QUr7c9RXvU3HkTjsfNV1P2j59y7c3h2DyTtJ/ifnH4Vg6rdhIiZrgSnrkHn8qwfE3jbR7M7YbxLmXuLXLD/AL66V5vr3iy/1UNFETb257L95vqazqYiEVZO5pRwtSo72sj1F9fs32Wdrf2s0+OBHKMv/sn/AGv50yw16O6cQzPtIOFkYfdPoR6V4aVKkMpIYHII612mh6qdUGyXH9qKM+n2kDuP9senf61wc/M9T11S5I6anoVhoAtdfiu7UbIs5aPr5Te3qpr0eKPYq4IKn7uOlea+EtaE8awTvhl4jc9vY+1ehaddbhsdcMPvL/UV2UKltGedi6Tl7yNHylUZUkv3YjP5VG1okpzK0z/VsVdCrs+Q7h7UijIHOK7EzzXFdSpHZ2cZz5C59TzUy+Sn3IVH4VY8nPQZrBvr4vNKI3KW8RwWXqx7/hQ59xcho3VyIbd5HZY0A47Fj6CsK2UzEyS5Z25OaXUwTarKG3JJhSz8lB2+la+h6elyg2nt3puWlxqNmZMyz26s1mSWII8snhuOlSeG4nns0YkhiAGyMHI9RXSXWnJHGylfmHWswAWs6MOkpKuPRh3/ABFTutBvTRk8tkioPWsq4SHTryPJBS6+Vl/ukchs/pW2z5XrWDr0XnRqQTuQhlx1yOlCA5n4l6jPp3hHVWRsQ3Mfkh8cHcfu/WvnJa+ifijfLqXwzvxnYY5IyyY6MGHB/Pg9xXzutebmPxrtY9nK1+6k+txxoxk4op8fXJrgPTJUARaRst0prEseOlIxCDg1AxWBUVASSeakDnvS7lPWnsBFSVZWBZPumleylAyo3CncCtmpYp3Q8HNRvGyHDKR+FJigRqQagnSVauILWflGANYGKVSV6EikM6Pypo+YpMj0NTQ380JxKhx6iufhvZo+jkj0NXotWBwJk/EUAb4v0kj+VsH3rMu7qb5sDcPakjntp/usAam8rj5WyKAOcmmk8wkhlojuXQ5Dmt+SFWGJIwapzabC+ShKmgCvFqUi/fG4VaS9t5eJFH41Rm02ZOU+YVUZJIzh1IoA2za20wzG20+xqtLpUnWOTP1rOSYr0JFWor+ZP4sj3oAieznjYBkP4VJdkiMIByeKvW2p73AdK0Vt47sqcDjnpSbAoaZH5VqQRyTWpCuBkCoGULIUXjBq9bL8uD1rrprQwluW4V3KOnFFFudje1FdCM2cGKCKVkZTgggjsaQHNeadYCnKuTQozUqjAoAEGKfmkNKKljEIoAGKU0CkBG45o2gipGXNMwRVJgM2Um3FSq3PSncEUXEQYpu2rBX0oW3duVUmncCvtprCrDRspwRio3GO1CAh24OQTn1FODyDIDtRS1qiBqpzUwAFNFLniqQMRuTTkyrqysyspyGU4IPqDTB96nCk9mOO56V4E1O31fURHc4XUdp8xQMC4X++vow7jv1HevULeN4CkbPuA/1Unt6GvE/hHZLf+OII5GaMLE7+YD/q8D71e8xoRIYJ1wG5VgOHHqP6jtXbQi5Quzy8XNQq2iXre8JQMMLOnDKejj0rQiuYbmASIfqp6j61hyR7CAT8wHyse4pjCS2kErkh2AKoOuPU10wq8ukjjqUOf3oHQGZksbuVTxHGxB98VgW9uv2a3Z5vLQkEnPByO9F5q+zT5IJQAjfexx+BFSy2yJLaW6MGhf5o8H7oI5H0rRyTV0YKMouzLup2KR6PMkQ3BgCCec5qPS5/sepJASQsi/L/ALwramjEtuUC5XsAKwdct3REnUFXjOVPuK0VrWMm7s664w0APXIya47xK7RIkqf8s3VyPUdD+lbtpqK3enRSRnO9c/SsvVovNiZTg5GKUVZjnK4Rz74gQeMVVuDvO3HWm6Th7VUJyU+Q/UUancQWVrJPPIqJGpYsTjAFVYVzgfi4yWPgm7ExCSXtxGsKZ5cLyTj0GOvvXhKCtzxn4iuvE2uS3dzK7wqSluhPEcY6ADt61igYFeJiqqqzutlofRYOg6NO0t3qFPVCR7UiKSamzge9czOtEbYQVCTk81YPPWgQhunFIZXpMVZaylxlRmoWjdD8ykUwGqzKcqSDV23v5I8bhuFU6XFAG7FeWlwMSqAfcUsmlW04zC4BPoawcYqSKaSI5RytIC5PpM8XKjcKpSROhw6EGtC31eZMCQBxV9L+0uBiZQCfUUAc7ikxXRSaXbTjdCwBPoaoT6TcRElMOKAM3GPap4bqaIjY5x6UySJ4yQ6EfhTKANSHVmHEqZ9xVyK8tph12n3rn6OaQHTiMNzG4IpkkJIw6AiufinliPyORV6DVpU/1gDCgCaaxgcnjafaqcumsvMbZrTTUbeUYcbT71OsazHMOCPY0JgZGm2UjT/MK6yKJYIskdqLS2WJQzAA1n6ve4Ploeahu5aVtSNfnnOPWtCDhs1Qsxlifar6EAdK9CC0OSW5ZkkAQkdaKqMS77QeO9Fa3fQmwt/piydUBHrWNNosmzfHn1wR0r0aS1VlAK7V7etVpoog5jjj3sVzx2r5+NZo+gqYaMjzGSGSE4kRh9aToeDkV6K+lmZT5kQArCvfD0LcwyqjH34NbxrJ7nHPCyjscwTigc1budPuLbO9CVH8S8iq33cVrc57NbiYNKKUnj0oC5FIBpNOFATmlxQAqoDSGOlU0/GRRdjsRgYq1FOEXBU1X20hzn2ouxWHStvOcYqGUACpMEU2UEqaaeoWKZ60ooYc0CuiJmxwpG4paa3pVPYQimnihFpxHFFtNQW51Xwtu/svi6NP+fiJo8/kf6V9HRm2/s4i+cJFxtf+IN22+/tXzB4EBPjTSAM5M+OO/Br6Ks2F1qMrSfOlt8kaDtj7zfn/ACr0MK/dsePmMbVE/InHnzRgRQ5CnIZuCfw7VGt3HHDJHMhE5IPmE4I9V+h9a7D92tlhEGNm7cO1cLqpGoO7wpnym2kjv3xW1WgpK63OehipRlZ7FK6dR/q4ozbtwwxz+J61uadNFdNFICEkUBCoHDYGA3sccH8KxrKCW6JWBS21C7kAttQDJJA5P07mrUjWelrujLMGEUq7kIlUEZZJUbAj4xjGWHeuSFbkep21MN7VXWh1bXz29qRtHHHSue1jUHnhcNnGOgpU16yvoEiiuo3lGSVzz7DiqF+6iDkjJGa9CE4zjzRPJqU5U5csibwjcXEkd3LKyfZ94SJFGCuB8xP1JrZuX+Ug1ieCcSabc4I+W4I/QVb8RX0Gm6dLc3EqxxopJYnpVpq12Zy+KyPHviN4m1Pw944vItMvT5ZjjJQcoG288etcNrXibV9bG3ULx3j/AOea/Kv5CqmuXx1PV7q7OdsjkqD1A7VVAArw61aU5Oz0PpaGHhThG695Iaq06igcVgdQ/dtWo8knrTyMimVIxQxHWnq49cGo8Uu2gC9b3jxnswrSgu7WcbZlAJ9awNp7UoYjg0gOgl0i3nG6BwD7VnXGk3EOdo3D2qtDcvGco5WtK31iVMCQBxRcDIdWQ4dSKaAK6dbuyuxiVVBPrUc2iwSgtbvj6Gi4HObfSkwRWjcaTcw5IXcPaqToyHDqR9RTASOaSI5RytaFvrE8eBJhxWaQKTFIDoo9StLgbZlCn3ok020uBuhYAn0Nc7inxyvGco7D6UAaNxo88eTGQ4qjJDJGcSIRVy31e4j++Q4960I9VtpxidACfUUDOewKQ10r2FldAmJgD7GqFzosqcxsGFFwsZcMTTSBRXYaPp4ijDNxVfRNL2gNIvNa99cJawHoPSok76DS6sq6terBGVX73asS2gactK/TrSxrJfXO5uma15UWC2KjAyMULQHqVbMYUGrMrAKAPrUEAwgqaNDLIor0Y7HKy7p8O87mxRV+CJUUYorZKyM2zpbkb8IoJBOR2wKrTRi05CB5COg6/jWtMu21dyMfwqPesSbcQwY4I79MV8oj6tsz7+WV5PnOQeoB4FZjJGQeeSeM1qMgUYQEjv61VaMA8Rkf3q1TsZtXKJhUEhjuHoD0qnPpsEvQFJD0xW/FbxzEeXETx26/lWjBokhX5kRR1+frn1rooxrVXalFs5q/sqavUkl6nnV1p80CZ27xnGV5NU1B59q9Um8ORS4zMEI/urWdfeDY5wTHcBWPfbivQjgMU1rD8V/meXPF4VP3Z/g/8jz1Tk04jNbuoeEdUtMtDGtzH/0yPzfkawX3RyGOVGSQdVYYIrKpRqUvjVi4VIVPhdwIxRSjkUhGKyLDNHWlzxzS4oAbTGyalI9KaR1oApSDmminzcNTBXTHYxe4vSk6tSnpQgzzViJBxSE0E0xjzVPawlvc6P4chf8AhO9IZmVQkjPk+oU4x717Vpy3SQSvCki31pI0wQfeZSfnQ+pr50s7p7O+t7qPl4JFkAzjODmvoWz8T6df65/aOl3UZtb9vtEak4eCUgb4nHbn8DwRXRhJL4WedmEJXUraWOgm1wTaWJYX3Rsm4Be9R2J+yaQjzYyIpJ3+pBrK1NRaXUnlIRbXJ37FGQj98emetUPHPiCPSPD8j+aizMoWJM8ufTFei5qKbkeUoOTUY9TX8N6rYQabbajsW5gEizZjmIkjdSVGVHDKBuPP8QHFaPjaz0/xTpkLWWpRwX1wha0mBOyYdMPjtnjJ6GvnDw74rv8ASVuIDI0lncktJEegY/xD0Ndt4F8VCyKQXivdafO4DxKfmBxy6e+OCDwfrXhynzO59LCDirDbKfUPD2oNYXi+VfxNs2Dkt9c8A+ldTFrCanpUs8DSNJGu14iuHUjrx3rotZ0m18UQmR2tkvRG5sNQQfKYicCNiew6Z6qeteR3lzqOh6wYJI5LXU7N9jq/yk46Bv6HvV0q0qLutjOvh411Z7lvW/GmpeFdUewsfIdfLR5A4yVkIyf0IrjvEfizV/EWF1G4zCDkRINq5+netLxVpcWoxy63pQYkktfW5OTE/dx32n9Pp05JaKtacm1fQVHDU4JO3vAoxTqBRWB0hSE0E0saF2wKTAdECxxTXXa1aEcSQR5brVSQhnJpDIgKUCnAUtADaXFOxSGgdhpANJgg8Gn4ooFYaHI61PBdyREFHZaiI4ppUUrAbVtrci8SqHHrV1bqxvBiQAE+tcvtOeDTg5HWlZjOgn0SGUZt3xWbcaTcw5wu4eoqGC8liPySMK1bfWnAxKoYeoovYDBZHjOHUg+9HBrqhc2F4MSKoPuKim0O3lBa3fB9qLhY5oL6UhBFadzpFzBkhd6+oqg6Ohw6sD7imAxHdW+RiD7V1WhJcyKPNO5fesvRtOa4kDMOK7KONLWHAwMCokxxVxszpbQknArlrmZ9Qudq52ZqfVr1rqbyojx3xV3TbMQRh3HNJIbd9CS1gS1h5xmsa+vvNvEjXpmrOtagEUohrC03Mt+GY9OauMbsluyOhXhRjrWnpkXG9uKzo1LsB71v2qBYhivRgjlkyYqNoAopDiitjI6m7mBYBFBVRjHqfasqZkI2nJY/eHv71cQhy2/hi2Bz0qu0Q3svzcjPXpXyeyPrFqUmkUttEbKuOwyTVywsZLn5pEENv2BHzH/CrNhbZPmyHjPyqO/ua0wc17+WZR7RKtiNui7+p4WZZv7Jujh9+r7enmRwW8NsuIIwvuOp/GpcE0qjNOYpFGzyMqIvJZjgCvp4xUY8sVZI+YnJzlzSd2xmzigocZxx3NUJNTefIsEAT/ntKMD/AICvf8apXFsZgWu7maVh1Dn5V/AcV5OJznDUXyx95+W33nqYbJsTXXNL3V57/caE93Zw/wCuu4EPu4rF1Z9A1CIpf3NsT2cHDr9Dimi3PlkRQxLH2dFB3Gqc2mKhDFDzwWcYz9K86Weynp7NW89T0Y5Eoa+0d/Q5++8O7W3aReRX8R5CBgJB+HesKWN45SkiMjg4KsMEfhXYS6RE4J8tWbHXG0g+1ZF5aTxj5j9pjBwUl+8Po3UfyrldWlVd0uV/ev8AP8zd4erSWr5vzMXj0px4FPnREO6MsU/uvwyex/xFNpNOLsyU7oYDS45pQKXkCpAoXH3qYKfcfepgrphsYvcDTl4FN70M2BxVrTUQrNUZPNBNIOtQ5DSHMo25qNWeN90bMh9VOKlfpio6zuUaX/CR615Qj/tO62AYA3ms6eea5ffcSySt6uxJ/WkoFW5N7slQjHZCBeKtadeGzuEZstFuyQOo9xVakNIZ674U8Ty2T72Dzabc/wCtVPvKx/jjH94YGVPDY55ArufEeg6d4q0m1aa8gS85Gm6hncJoR0jmPXZn5cn5lY+lfP8A4f1htMm8ufc9k5+dR1U4xuX3r1Hw7rX9mZ2lrnSLglmWPqvbzI89H9VPDdDVK1idUzlDHfaFrTw30T2l/bsY5omA/wC+T2IPY9DWb4g0a2ntG1HR43jKsftFpjIj/wBpfb27duOnuusaFZ+LtPs085ZLtYQdO1XblW5x5Mvcr65GVOe1eRXFtfaDqctrfxvaXkD7WSTuPfsVI5DVL0K3PPgaOtdPr+jxXSvf6VHtOcy269j6r/PH5VzUSlyAKTGIiNI2FFacMIt4tzDmrmmWQGCwrYNhHOmGGKjcDjp5zK2OgptdNdeHcjMf6Vkz6VPCT8pOKewzPNKKe8LqcEGmEEcEUXAKQ0vFBpgJRS0lIANFFLQAlLjNAo70AN20YINOooAQSEdRVmG8liPyOy/jVfFIRS5UBt2+uSKMSqHHrWlbSW2pLjZhvcVytpbSXM4RAT613+i6WLWAO45xUvQpaktlbJaxcCs/XjKsPyd6k1vUBAm1D83as+wmuLs4mB21K7jbtohukWOP3sg5qfVr1beIhTzirV7OlrAegwK4y/umuZjzxVJXJ2K9xK00hZjV3RU/fO3oMVQIwK19ET90zepraC1SIlsb1gmZBkcVtoowKzrBMAHitFTgV6EFocsmO2++KKKKsk13lDSMNpIz2PPSm2w8yccMNo+cnv6CqbMEuQVZssPzNacCiNNo65yT715OV4NYmtea92Or/RHr5njHhqNov3paL9WXlbNTL71ViNPuLlLWBpZATjhVHVmPQCvr3JJc0noj49Rbdlq2SXt7DZQh5TlmOEjX7zn0FZJmlur2P7W4QZ+RCvyKfT0J96t21tvka6u1UzsvGT9weg9B/OpbxYJAoK5QEZOOo6V8fmWazxLdOnpD8/X/ACPsMtyqOGSqVFef5f13K88YEyY+bJ5zxx9e9RmaOHfG8bvHkEKDyPXjuKln3xK8bOt3bgYDIPmUds/4inW0Kt8zJ8uByfm+nJ6V5CVj23sUzeSSnNvHHGo7LwT9R2qrKjhDJM43A4UBiQT7A1uPGgTZ5YRAT8wwSW+veqjwbQmASc53f4VSZk1cxLmCR2DOTErDgL941Ums41fdsYZGB8xLMf6Vvysqv80Pzk8kHO729qo3QV1ZgwUjqoHJ9M1opGcoI5q5sZJBkoMAYycAVi3FnLbkkLuT2PSutlgMzKXVgT2I7/Sq1xZZJV3OR1ycV0QqW0OSpRT1RyideTT+tX7vTWIZ4HAK8YJ61m4IYq2QwOMGtU09jllFx3KlyMNUVTXI55qDtXTB+6YPcTNNpxFNNDYrCU9B3pnU1NtwmahsaGdTTWGDTkHzVOYt65FTew9ypRT2UqcGkI4qkxDaKXFFO4CEVseHNcfSpPKnBlsXYM8fdSP4l9/51kgUjCi4Hs/h3XG0ot5bNd6VeL+8WM4ZsrzJGf4XA4I43DKmuz1rStO8U6Raw3NyjbY8afq2OEXGPLlH9zPUZyh9q+fPDuuPpTtBMDJYy8OndP8AaX0P869V8N64dGuFnjVL/RrlhM8AOFcA4BU9nGOR3xg01IVjlb6xvdD1E2N+jW99C2GQjIA/h5/iVuoIrJ1XSvNZ72yjxKvM8AHJ/wBoe/0617v4gttN8TaB5t/dokarJJZaqoJeJRy3mj+5uIQx9QeRXmem6Y37t0T7i7WaQ8Adev8AnFDQ9zj9Pu42C4YYrdtiGAINWfGXg7bptxrelMitCPMuYV4DL3dfcdx361xNjq0sJG4nFZsDvIwccUSRI4+dQayLDXIpAA5Ga2IZ4pxlWBoAz7nSYZs4ArFvdBZTlAa7Hy/Sk2nHIpMaPOrjT5Ihypqr5Br0iW1ilGGUDNZtzokb8oKVytDhmjYU3B9K6K70iWPO0ZFZ5tihIkUinzBymZRmrksC54qI25Ap8wrMgxS05kYUzBHUUxC0lLn2rS060QsGnwBRcDMwx6KT+FKIZXIARua60f2dEoyQas6YtreTAQoCAaTdgJfCmjCOISSLzWvrNytpbntxWusItLUbl2jFcPrE73995aElAcVnuXsihbxSahdF3ztzW6wjtIPTA6061t0tYBnANc5r+pbiY0NMXmUdZvzPKVU8VmIuKBknJ60vStErEiPW/pMZEEY9awCNzAeprrLGMKiDsBWtJXkRU2Ni0XCDjpVsGq9rgrjpVnH513x2OViE8UU1uD60UxGnbwBp/MJzt/KrgPNCII4go+tIOtduX4b6tQUXu9X/AF5HLmGJ+s13JbLRf15liM9KzTefaL9pIyCkOVjHbP8AE/8AQU++m8qDCnEkh2Lz+f6U/TLMRRYCBN3J9/avNzvFuMVQj11f+R6GR4RTm8RLpt6lpRJvjmnVWjPJCn5gPXFXSUaCdQRgqdh703d5auQ/AAZSOc9j+FQW0TzyTO4VXj42k4C46gV8xY+oTuWJ4DPFGkiKd2B+nX2pGhlljfaVSBQASp/zzSOysAJAyccDHGO1Sq5dVCK2wZAYD7x9MUF7kYCx7JNvl9kDctj1ApPKc5kl3B35wWzgU+6lJcLBEWkcBcnp+NMlE5ZYSwZmGcAYOPX6UgGyWzhA7uvzcGMdAOwHqapTWqL86YG1sAjufYd6uS6eV+Yv+8Xlcc4PoB/WnIIWJJj8yVTjc3C47n60J2Fy3MiUPHC0hSKND1yRzVRhHJGxaJT6sMsa2pjFvJCBJBz5jjj6Be/41Xa2jOS43If9rvVqZEoXOcmtVc/uGyfddo/LrWbfacz7cRHfj72MV1i2YZCzK23dwOnH/wBaoLqD5n3EvIeoHQfWtY1bGE6F9zzu/s5IyVlzu/hbsay3VoydwxjvXo13aoVMVwY2Iz0BOc/WubutJID+UrSJ0255/CuunW6HBVw7WqOaJptWLq3aNyNpUDqCOlVxW17nK1YB1FXCP3NVOlW15iqZFR3IgnHFSwtg4NIjcYpcjNTcdh1wikZFVdvNSufeoyaaB2GkUbaWg1VybB2pDRQaAGkVs+GNefRp9k6GexdgZIu6kfxL7/zrIFNYUxHtGkxS3tisFndNJp148b/K/wAkrj+Jh2Zf89KvvaS3F9DpltFJKN3lQRqcEuT94/WvKvA3imXwzqau6NPYO376AHBHbcvYMP16V6ta/FTwzp2uW2pWcd1JccqwMO1YyRjceT+lDlZDUU2dp4s+Hl7pfgq9it7xH1C5hMOzbiIE9eevTIz05r5huLS4sbqW0vreS3uYTtkikXDKfcV99aJqkF94fh1y7aBYmh85WLDZHHjO7P05JrwX4zar4c8ZCaaWzmtLu2jb7HqePmmOMhGjA5jPYk7hnPqKKNOpXTcVew6ko02k3Y8BWAEZXINTRXNzbH5WJAoib5BuyD3HpTjisirGtY+I3QhZv1rftNXt5wPmANcMYw/UUwRPGcxOVp3FZnpalJOUIIpTH6V5/b6rdWpAYsR7Vuaf4lV8LKfzoA6FlBGGAP1qpNYQyjkAGp7e/t5wNrj6GrG1W5B/KkBzd1oQ5Mf6VkXOnzxE8ZFdyUIpjxq3DqDQM86dCjfMpFN2K3au7uNLhmB+XBrJu9DEIMnRRQBgQ2YH7xhx2qG6dmO2M4x6VZvJsHy46r42Lk07itcoOkpOCT+degeCLHyIVkYZPXmuOikWS4Rcd69I0jEVomPShu4kix4o1MJYlFBDGuM0uZftRLDn1rb1D/TLnaT8orNv4orFSykZpDd7kWv6iIoyiHk1x0jGVyzVYvpXuJixyRUHTqKuInqHag0macPemA60TfdRr75rr7VcMBXM6Om68zjoK6u2U5BxXTQXUxq9i+gIAqQcmoxwOuKkU8V2I5wJOKKRueRRQB0rCmbeapaRdMztY3TZuIxlG/56p6/Ud6sapdLYWUk7csBtQerHoK9WnXhVpKtF6Hl1aE6VT2UlqVHdZb9u6R/u1/3u/wDhWlDICuwn5sfKDxWFpajyYtzknduY471rIS33+c8DFfE4qq69WVR9T7XB0lQpRproaZMckflqCXHOCMcU1jhyFHyyfePr6GqsRZlBd8ORgMO1W4dphDoBKW+XkYBGev4Vz2OtMncebCHZWJOMjAHHcGnLKqsUCSwgYZVZc/gCKhjkMQMLLjPcnIzmrSH5x5m1mz8p5wue4qSkTRLlgZDIk5yirjrQ8QjOUJDD7zNyffNPldyojkQl16Flxz3wRVV/NtyqzyY7g7c7lPUMR396hlrUiYpKw2qQW5IY9x3OP5UfYBuZpVZn44HepYcSM4kCKvIA28sp/iq7p4lksUQcuhwHYH5gf84qG7FpXMdoBC372ZTJ1Chdx/HsKhkVSd5UsM44OAvsa3GslWbCkKB94t3Pf61P9ggmVxuKx9Tk4z9fQVDqGipnOLGdzRCIlGOTnOSfTNTSWRRcGIDHRd2f/wBVbqWioo3OSi8Z28N7Z70lvbb5S0WySMKTgL3z0HvS9qL2aOTNpE8rho8nOGyOM1WudMUnBgPy9NpxXXS28huju3k7ciNQcD2PsKgudLnjBMsSjJwd5Ix9PStY1vMzlRv0PONS0mOUSeWql+pLH+Z71xN9aNFKwPBHY17NdabvkchWJXnAP5c4rlvEOkhxmVfLccggdPx7120cR0Z52IwfVHnHlnHIxVqzwQQamvrYwSlZOvUFTncKqK2xsrn3rv0ktDy2nF6krx7XPpUbjFWVYSD3qOVay2NN9SuabinEHvTTTIG5op6pmmkYNMQ00tLigincQ2lpcUYouOw3bzS+XkU4damQUrgkeg+AviFLo/h2/wDDeuNPPok8ZMGwZaFwdwU8gmNj1Hb862fDt2detUhiRXkchNpOAGPp/X0ryxVBFdj8NbrTobq6tL64mtrq5KrbSAAo2QVZTzw5yCp6cY64rrweNlhrxWz/ADMq+HVaze6Ol1TwnpTCOE2QS4kdo0uLeUkTFSQXQDg4Pr8rY4Oa861TTZdMvXt53WQZOyVPuyAfyPqO1e+m7tTpK2kvlhUGwzBcMgXhYz32L12juSea4zxvNLN4ffRxaSzzzMkloqLnLB+WUjnJHGO9c05e0bkzaK5fdPKhnNSAY571d1TRr3SVga9SMCYHaY5A+1h1VsdGHpVHtWZYhG481G9upPoaep5wKfmgCFTPb/NG5x6Gr9nr88BAkBqtuDDFMaMHqOKCbHVWfiKGXAciteG6hnAKuK84ktwRlCQfanW91dWzZViQPegNT0zauM5rmfEep7QYoz7VQt/EkgjKPnOMc1k3EpuJ2dieaLBcSMZO5u9NvHCrTwMdOlVr0EjNNbib0G2bAXSMa9AtbofZBgjpXnkcZCBs81oW+qNFHtJNVJExdjoReiOVyTXPatftcTFc96hlvt+SD1qoimSXOD9am1tym77F2NAUGRSPAhFO7Y5owcUirFd7cdqheJl+lXgM0jL2p8zQuUm0OPBZsck101sCAKxdMTEefet6AZUcV30F7qOWp8RY6jmhSOmaXkDimMOciugxJGAPPSio2JxRTuBaudK1O5gjnt7WZZ4jvikIxg/j2NZup39xql3DHcW0lstuPnjbjMp6n6eleoQyB155qnqmj22oJ+9Qhx91wcEVtLK5U6Lp0JvXo9v+AZLM41asZ1oLTtv/AME5CDA2gNtwOgq7C/y72OSDjbRd6JeWzbosTIO68N+IqpFIUkZGBDehGDXzVfD1KDtUjY+koYinXV6crmoJ1jhBY7iDhuxq1G4EYZ/uZ6e3+FYtw+6ItGfmXqD6elW7KcSW+QSrKBn3rHludN9C+JsSFCw8th1x/X1q/BJI0CwMAXxhCBkEds/41lpcKrhXACls+x96tWMot7plZiIjyMnp6fhUSiVGRpu0siwvCxCdX45Xjn8Kk05UVTFtV8/c3t1OehNUraZ2jeMHJAZjyQAKt2m2ez2nAAGHxxgkdcehrGRvFjm04yEFi4ljXGA33M+lXNGfyY8ZK5+V1Y/xe3saVJ2ivYxLDsdQYjt/jQ+h7kdea2ZIBgmIsWEeG6BlB/iHp9KwkzWJWkRSPMKthudwU4U/T05qVbfzUZWWJssAUb7273qxaXObJbKb5bhMKkqdJV/H7uaiiiNvGpmdtisACD97Bwc9881jJmsSU6e0luYmZDJJ90AHIyO3pSw2wkWMQOv7pdrOMdc/55rSkt9sKO2fOf8AhbjAHA/GprSzQWKKU8puS5PT8PXtWbmbJJlGx0+O2LYfdI5LM5+8f9o+lRSac8wkAG5VX0xn3966KCHeu9UGO5bv/wDWpktkS+3eMKPugkF/r7VCmU+W9ji7ywVowsZhQ/TkmsHUNBuVTMh2xkk4Zhz7+teoT6XC6bBCGdTuyOue3Peqf2FFKeYFLrjdnBwfQY6CrVVon2cZHimp+F45k3eUuWGTsXk49q47V/Cd1bAiMgoTzkfd+pr6SvLb/SVe0CgKGHKDuP5VlXGll4N0igBRzI/O7t+tdVLGzgclbAQmfMb2EkL4A3D25z71A2SQF55xXvWteE4L2DzI4QSx4eNsFfX61xWteB7iB2KxmSMDgEfN9fWvQp42E/iPLq5fOHw6nmMjZ6UxRmtjU9EvbGVlntnAHOQpxiqCqv8A+uutSTV0cEoOLtIhUYodO9SNjdxQeRRcViAClxT8HNGKYrDAOaCOKcVoxQFhqjmpkGRSKtTRii4JCoCBin+WGU5HFOA5qQrkcUDOs0jx3d2WiLp9zYWt40RJjupXZZAD2YjqB79eK6SwtdRuRb3lxcXAeWP7VFIWPmWa8YZl7Eg8DuCMda8xMQZSCMg8Gt5/EmqXSuj3QhuZESJ5oxtaZFxtRj/wFeOhwPSmnqJom8SHGo3l9FE0tocRXFo/DR44HT3yQR0Jwaw9Sszp+pXNoZBJ5Lbdw78A/mM4PuK6TRo7i5vrURv9mvH3SYPLbR1fb3Ht1P61j+ILFLLUXWAS+QwDB3O75jycMOoz3oYRMlRg0p5pcgdDkUo61NyrDdozmgjNKxxQDkcUXAAABzTcA5pJN1Kp+WmBEYQT0prJjAFWCcCkJGKCbESjaKbOu+M4qQ80h6YouFjMYsqEZqAsTVm74OKgSFm6VqmZMSMZNacIVUGOtQxWhHJFXI48Lz2qJO5cUN9zTsZXig8nilU4GKgsjWlA9aXvTwucUAaunp8gHetWHgDFULIcD1rRX2r1IKyRwy1ZKP1pDnqOtA5B7Ubs4rUgCT6UUjEd6KQHocVvPCv7xOnX2qzG4I65rYQRhJC2AvBzwBjOMgHkmhbO3WJP3Q2t9xehbnsOqn6mtaWaTjpVV15GFXL4SX7t29TKPPFUL+wguVxNGD6MOGH411y6dZyYZYmCAgZ3YA9n9DSv4djl3+RNIjYyFIyPqD1YY/GtnmWGqLlqJ281f/MxWAr03zU3r5Ox5neaXNb5eAmaPGCMfMB/WsaGcx528HlSPUeld94isNU0RGlk0i7vLZfvS2OJSvuU4YVws+qaBrbn7Lei1v8AoPPQx7j6HtXnV8DQqe/hZL0v+R6mGzCvBcmJi7d/8yU3KbYy7DAOVYevvV8XSzRqWCleBkHkCuZuVmt5TDcJskx9VceoPcVLa3ZTcCeQeh7V5FSm07NHsU6yeqZ1UkphK7JP3bgq+Oo44FaFncSRoWX5mwFODkbcc1yovgBzjax5+tWotU8mRlVyoJzzXJOB1xqI7Ga6mktgrRmQquF2cHHcEd+K2LH/AE21TyCqyx45zjGO+P61zemaik/lTArvwFcZ6nsfY+9dBBMqASQR+XKOcgcFT2Ncc1Y64NGk2bR4JZ3ztBy2ein+7+PUVdjRZraRI2ZA67ThepByT/UVTjvUvGLSxuZU+9sbjHp9Kdp86JN5eZI0ZyvTuP0z7+lYM2R0lti4tI7iU7ZVUggjrz1961YoEZdsjFXGNp6isOyBgl8lufnL7VOQVIwGX6EVtWTObfLlflG0nHJx0+tZPcJ3toTC3bzfKRGVD0561ZjsljA8wbgTuOG+b8TS25aQuhJQJgEf57VcVVlyMAAHjHpQkcdSrJaGasSqrqQS+eM9T6CswacxufPyyxnhgB9/HTmuiuIWQYiUHjG4/wANOSAJGquQcd270+XUccTyq66mFd6dGFMjMSRxsxwaoCxlWPaAQ8jliWH3foK6ySDzJBglVHUf1pjRI4YR9RwPQe/vT5Co4x2szjLnT/KGOWYDpgYJ61nXtizpm43OQvyxqAFB+nr713E9lhmIIIGSM9Oepqg8KlmCKrDqeMYz3xRqjpjVjNHmuoaFBc5WaONVZed5PH+Nee+KfAFmzF7VmifH3kI259x6V7/c2UUgKzxvjHbuPwrldW0u0f5fs6IhOQNrFm+o71vSrSi9GRVpRmrNXPmnXvDmo6KolniEtkeFuoPmjJ9G/un2NYyuCMg5FfSSaJDaGR9Pimt3lG1hECgce6n/AArmb/wFpdzctNfWc0Bc8uCqA+5x/hXo08ZF6TPMqZe94M8Tb2pm4dSa9kj+GXh+S4IbULkJ2RWyT+NbOmfDPw9BOpePzIyeWkbcQP6GreNpLQyWAq9TwAyqehB+lAdf7wr66sNO0ex/0PTbOzhUAbljjUE/XIyfrTriztlcYigU/wC4uR+lX9ahsiPqcz5IR4x1dfzqwkkeMh1P419Ux2cEwbZYwXG37zGJcAe5Iqld+GU1WOW2trLSbecj/XSxKiIB1O7FX7aIvqlTrsfNCr5hAjBdv7qDJ/IVLcwXNmsRvLea2Eo3RmaMpvHqM9a+jPB3hO30e+cz+IdIlkuIpDbpajeWAPJU4GQORXReItA0+41eT+0b+OaKO1SSDdB5jCTkZAPQf5xUqum7DnhXF2ufKHmKBywBxnrTHkB5yMH3r6FstB8PLJNp9xHLCYD5qrDYqEldjnCu+W79+MdKq3Hh3w7YS/abyws7aSYeZuv5kjzzjIUDOOPQVrGSauYTpuD5WeDhxJklizd2ySfzq7Y6nc2YVY2DxqeEkG4V7Ff6/wCDLWxntsaa7smG+zzNJu9QMDArz2WPwhfJiza906X0k+ZP1zTbRKT7lFtZsJo1F1o8DMDyY8LmtLTk8EaltS7n1DR5zxuADwr7nP8AjWTfeHL2GBri1xeWqjJeHkqPUr6e4rECg8g8e1WrxJep3Op/Du7W3a68P6jZa7Zgbv8AR22yhfUxnn8s1xM0UkEzRTRvHKpwUcYIp1rPPZziaynlt5gchom2nPr7/jW7L4h/tSIRa9EkrgYFyq4YfX/Gn7r8hao5771IBg4rW1jR59Ojhn4ktJ13xSqc8e9ZJVic1CG0D8Ubc808AnqMinBgowfzoAhIwOKZ1apwAeaZIfypgV57dXOaWOHYeBUpBYcUoyo60XFyoG9KRc0ZLNTyNtIZEQQaaQakP3vakZTnNACA4606LLTKO1CgHrU1qg84VUFeSRMnaLNi3Tbiryr8oxVSDpVxOmD0r1InCxeq4pASKaxwcA0d6okG6UUjHrzRSGeyW6N5w2yfNn7w4z24bqTnPStNYsuyuEKk5+6QD2HA5z+mapWVsGuJpMhnY4zkZI68E8L2474rahTaJXySoAySP/QgeT9a4ZysbxWg+NGBwA+5OM/x/XjjFX7NSIxwNufu4JXI5+q96q2qM5CrlgPurjO0eoxXQW9sIgD1bGQ3cgd1PseoNcspXN4obHEWGW3BPvEgckDocjrgY5HPFcx4y+GmheLRJNqNm1rqLnC3doArlsZw3Z84JGfpkV17MyN8gQPIcIF24LdsAt93BOfelhy8jRhHKMgwzRqcRnvjPXcSOlSrp3THfofOniP4VeLPDMZbTwPEGkKSR5OVkjHrtPIPrtyPWuVuLC8RBJLZXca4+80RG31Bx3r7HgY7QxRRKOdijAUgDcvXpiqeo+GtP1IiTYYJtvEsYAOOxIzzWtTEOorTWvcVOKg/d2Pj2OYEeUzHPpQZGDFuTX0drHgS3diup2FrcKWwJQuB+fUVy2rfCa0ukZ9KlltZcEqjNvQn+YFc7aOqMzyK2v5YWLxkkHqM11egeJ2jAikd1B7E/lWF4g0C/wBBufI1e3a3bnbKB+7f6N/Q81mx4baxAwO9YzhGR0wqyjsz2HStajaZHSJEkbJJjON3qAPWuga6tLqJG2qkZYHeDgAjoPr1rw+K9e1AVJ1KH+FzXa+DIdZ8RS/ZdLtHlD/fnIIiUD+8x4/Ac1xToPodkcQktT0yK5W1KKh3mPo3pn/PatfRrxblWCE70baw/l7V5Z4gHiLwzcfZ7yM7UPyzxtuRuOn1+tWtD8Zx+ZESjxysf3isduD7eorCVGRvGtGSPYo1JLFWIfoc9wOtaVnlV6AensK5nRNVivFYxNkMoDHHfHFdLDkDAPGPqaxirM5sQnaxYcHI2jPuaiaPJKsgbPr61aiO5MnHTH4USKCM9V9v6V0undXOBVHF2KojYfLK5P8AWkKsCfLU59SKlaJQS2CuRkn29KaypyFJ9xntUuJop3IWj3/eBbHGO1QTsgO0xlv93tVmZwgVVIOeBjtUITkndj3zkflWMuxvB9WZTRrMxWFeM4OWPH5cilXTbdXZmiUue55xWhOgKjqHA5KrkVUNrICp+0EKDnAHBrNrU641LrexWm062diZItoI5PQke57VWk0TSJSzPaQux77e1aEigDEh5Xlcnr+FJMcqRGgdj3A5P40+axSbfUy18OaKmAtlb4652/1pt1oWlXUkYNqNiLj5D5eBnpx1+tWlj5Ic4Zj93qBUsiKqkjdk1cW2mynGzMS88MWJhPk27s38Sicxlh6FhmrWnW6WsSWo0+zt7UAuEU72DnuW9atP5iAqhBPUk9AahtNzFgynjjPqa3ozcdETNtIS4twIGVZGCOcuq4ANRaZZ2aXo8yGOSMnJDjcM/Q9a0VhOGPbGTmq9lGqySM33cYx711K5yyqN6NlHU/Mj1m2u4LSFfJXy1HlLhV7gccDJPFJrNzAsCXMQWKQA+azfdUe3+FXpbhXQxNIpKnvwB7ZrIuJokkH2opLHnt0X/PrVKvZcu4nRcnfY8Y+IXxA8QybrPS3u7DTkl3G5IxNK+MA7uqrwOO9ea3iX11M99qKXc00hy9xOrEt9WNe8fEHTYLUwanbLuSCQSOp5DKDn/Gsm38b2NzBsS1d1bqvmADHvmu/DtVI3eh5uKi6U0ktzxroOKdHkmvRb608P6lM3keH7lS4yXgbZg+wHFOXwt4fhiRruy1mAtx8zEj8MCtVC+zMHNLdHE6HrmoaDqEd1pk2xkOTG3KN7EV1fibVfDPjGZbmDTP7A1VlHmiAhoZW9dvA/LB/GrD+A9Nv4WfRdTZJRz5cxDAf1rlNW8LavppJns3lh7TQAup/LkfiKq04ruieaMtnZlG/0250/BnUNExws8Zyjfj2PseaqsuFyKvadrdxZkxswliPysjgEkehB6j2NXms9O1Uf6FL9iuD1jILRfl95f1FTZS2Kvbcy7K+m2JaLulR2CxxYLfMTjAHfJOMe9LrenXujai1lqdlc2NwAH8i4Qq4B/mPcV658AfAEkfis+IPEP2ZLHThmzbzVZJpzxuB9EGeuDlh6V609xo3xK1XVvD+ueG3ksrFRJBeyEYYklfkYco3GRg8jrTUbrUTkfH6MMHNMwWPFdR8StA0zwx42v9I0O9lu7S22gtKQWjc8mMkfexxz747Vz0ShetS1y6FLUYowCDUZUs2KsSYzkVCMh6QxNuyjd1yPxqRwetMK5FIBExg8UOO46UiEKcGnFh0oAjA39KVuBigHBOO9BHOSaYiM5q3YD5yTVYqc+1XtPXnmtaKvNGdV+6a0Qxge1T9qjToKf1r0UcbAcGkJJ6dqfjjBqvM5jbI6U2JDmB60UBg0eRRSA9/jjymQuT344/4EO31q/GpLKOSV6E8kewPeqyLtf5QQwPc5IHoD0Ira0q1CjcRn07cn07Zry5yO2KLmn2gi2s+0k8gcAk9trdj2wasTSABsBCQcZJVcnoG56EcbhmreCF+6hJyHBOMt/tehzg5qKWM7SAXDnIbfnIA65569QfUVimWymG39UZoypXKshwufm9Oc4x7VcgtiZ13RKZTlGARcbgPu9cYxg9+abGrh1bJEhPylgpw4GOcgcAcH8DVyJFRE/dkKAMfKpYL/AA8565HPNU2TYdaqqssYC+WoG3MfUZ+U/U9Dx2rTRucAEEnIzwM9x61WhgAYgpkkkklVHPcfyq5H0yuMexH9KhjJOGXa43LjkEdR9DVaSxi3b41UH0A4z2xU5BDAAck5JAxz+NSA80+RME2jOvNKs9SiMeo2sNxCw5SRc5/Cucm+E/geaUSPoFvnOSFd1B+oBxXakA8/5+lAzS9m0NyZz2k+BvCuk86d4e0yFv7xgVm/M5NdHEixoERQqjsowKb9etPXOPenysTdzyvxLfQxeNtRtbpBNp86RxXMUihlK7ew9s54qHVvAFouPsBF1A3zCKbIk9R5cnUnvg/nWX4wcz+KdUyeBc7MsMcBQPx7167ZWqx6fbwrlkSNRkHGeO3tSr0oyhG61NaNadOT5WeYWejXenPHdaLc+dChJa3kOHJ/iDe9d14d1SLUrXfGGDr8skbD5kb0IqDXNAEzveWc72t+Fx5y/dOOgdehUc8devNedXvi678I+IVPiTTZ4QeGvLb95BMvYHuGHvyK8ipRmn3PUjWhVjZ6M9njYo2M8dBVhSCvBxjvWTpWpWuradb3thPHPazLvjljbIYVoI7L25/nTpT5XZnHUhcJPMA6gjOM9xULRkMNzNwfvjuanZhIuVJHqP4qqNG+fkYgdg3OT6VnUKpfcG0ZAfLLnAY8fnUmw4CoGyO57Gnx7mTEmA/Q4HH1p8ZKJiQjjvjr71MY9ypTZAybVAXOP51BKjMvLBV6cDNXpGU8g81WVlbdhgD39aicUnoVTm7XKRs0jBwAT1Jqsdr/ACowZf8AZ4/WtB443wScjpnNDRYACAgDoO1ZWOqNW25l/dwgRgD37Z9Sakco4KMC3y5DA8VcEG4jc3TtUYtMqwBYDvnvTjdGntIlJ0hRQYowuB3bNVznADtuz0C8VdljhjcCQ5B4Apshhwu1DxyCOtaJu9zRWata5mXDySZQFkUdeaoC3uTJkOdorZ2KwYoxJJzVCS58l2Rxgk1pz3jYUYWlchdZ1Qlo1kHv1rL1G1tb6Flw0EwGMrwR+HeuiSRDGQD0HPvWJqK+a5EYHmAbuf504Jm3MpaM4rV5ZDpVzYXo/eopGezL2NZdvY2Vlawx2lrAqlQVCpx07/8A162PEKG4gEpP7yM+W3uDWNp7q9vYowJZ48EHDcgkY9a+gytp8yPns5g4uJ0OjqpT5mVT6YwAfp2rQIxuA3be4HFYP2vYf3bKwXIwvYd8d/zzT0lv7mRkjwqA/eAx9eO1ejKPU8iMuguo6PZXMjTPEYJhyJIm2N+lQCLWLAlraQX0IUHbL8rj0we9X4LRg5aeXe2doIPAPYD/ADmpXidlQIzMAc5DA8+g/wDr/So5E+pbk10MGf8AsDXwsF5awreAHdFLGEkU9OtYF/8ADCK+vY4tEupoJ5XCRI/7xdxx/F1HHP0rrdSsbS/KLfQeaEBAdTgj6EHnn/Oa7n4O+F5rD7TqtzdzzwNmGximAzGufmbPfJ4HsD61FRKKvJXLg237rsaMug6j4W8BR6T4bmSfVBGtvbyOvMkzcNLIeeF5bvwMelQeKtXh+FnwzmmN017qj/u4ppgA91dP/GVHAUcnA6AYrv41DymUjttXPYdz+NfLnxV1qX4ieOntNP8A3mladuhhb+HP/LST8SMD2HvXNTS6HRJ9zyV5ZJpZJZ5GlmkYvJI3Jdickn6mnb/evQNT+H1slqJLC/aKQD7sw3I/uCOR9KzE8DkOoudQPIz+6i/qTTdGd9hKrDucluwOaaz5Oa9At/BumwgNctcSjGRubaCfoO1SpoumK3y6bEq8qC2WGfxpqhLqJ149DzxC8uBEjyH/AGFJq7Fo2qzgeXYTYPcjFeiQlQnlqkcca/KFUAD6Vq2aAjanBZQGyMgE9foK0WHXVkOu+iPKpvDWtom86bOy5I3JhgcfjWddWN9bttnsrqM/7UTV7kvDcsxBPbpkDsB0qQy4AbcxA4bB5J9OOg/Kq+rRfUj6w+x4WNP1BgxGn3Z2nBPktwfyqKeGeAlbiGaJhwRJGV/nXu7zvnhn3bcgYOR7Yx/n3qFx5oUSKSSTuBPU+2aPqy7j+sPqjwffjkEGtXT+ACa9RvtA0qd1a4sLck/Kdq7ST+FYtx4RtI1drV5Ytpxgncp56DPNVSouDvcmdVTVjnYzxT8jFbDeGrtGAhmikznqCtUptKvInKmNW290bINdKaMioCKinG4EVPNDNAcTwyRn/aXFVXfmhgQRPtbaaKZL9/NFRewz6cs4g8pEYHHTaMj8q6axhyIwpXbjofu5/wDZW7VkaVAWbOC2egPBPrzXSWqAY3Mcj72FwwB/vD39favJkzuSHlAihyMgL/EuSFHQN6jqM496iuN6hflO7+HnPOOB05wOQe4yK0MbclcL1PAzj3HQFe5HvVedQiRlVTfkBTkHPv1/I+2KlAUsIGXbjZt25VgQV745BOfp0+lXEI3xhjllOOQCScYycgdOh9yDVeUKisDGHyRxj5Sew5yMYyfzFS2yMriJenVhnj2GeRz6+wqhF+IhITg9cYwFHGeO/bHNXEB4Hf0zjn8KqIwz5pkViDkN8oGe59vSrUeNowSMjI5/woQD9o9j747U7GR6mmj+XPTvTh2rRIQY9KFyBzS98GlAAFUkITbjp09KeMAe+M4oHSvPfG2o3X9umxSdxbqiP5SjGTzz7jmhrsC1OQ8SX0Opa5qNzaIY0MpTbxksoAJPocg17BoU32nRbKXKlmiXJHTp/nivCoyogZ1BHmMzt0yCSSf1r2zwarp4W04SBg3lA4brinNe6kJbs0pBzzyMYxVaSzS4haG4jSRSM4Yblz24P86vMKYIwGBH41yTp3NYysc/Y+HYNDlmk0SAQQzt5k1ohxHv7si9mPfHBrRtrlLiLcj5Gce4PoR2NaYrm/E2jX5kGpeHJYodUj+/DIP3V2n9x/Q+jdR9OK5K2FfxRN6de/uyNpeuQeQOlNkR/wCBgfmHB4qjpV8t7F+8t5bS6AxLbS43xn8OCPRhwa0CcZJOe1cUl0Zts9AyEYFjlDwW/u07BZyQQccjjB+tNYZXbuGCMAn0pVLKhXAZvrils7dBefUUoQDjB/nUXlFvvLkZ78Z+vrUqkglSMkc5olcLw5G40NJ7gnJOyEZPlyF/oKZIyqhGQOOgpzspYA857HpUFxEHkBHUdKT8ioK7XMQ5dypIBOeo7U2ZXeIhiVJ71cKnHtUM2O+KnlZtGeuhni3XGCOPelZCvG3I9asKQflJwfepHCImSR/jTjA3dV31MmWLZ86D8Ko6lbi6tsYw46EcEVrXD9cD8KzyCr7WOc+lXy2Oqm3JanJW2otFM0Ex+dTtIPFOvJyMvuOcYyO4qh4gtfL1SZ1ynG4VUhuGntiF/hX1rojHqiZ6Mr3Z8y1us8jHA9cd65PT9y3t0nIEYOw7cnBOTj863ryRonlQZCvHge1c/PcJFcruIBmjVkb0I6/X6V6mXvlqep4+arnp37HQWm3fGWU5POBh+eeo6/55rdjOY1jJUKOflO4H6dDXO6cDLdhnyyqo5YZwOO4+tdGoUpknKnns2PwPP+fWvUqs8WkiM434AORwQev69/zqM5UFQuN/bHJPvVgDbG21SD164/Q/5FNWMNgIQF6n5T+oP8hzWSNGVFuIhLHLqCXM1opAkjtwGmcdPlzgZ/pXsXhbWNF1jTli0K5jMVugjMGCkkIHGGRsMvTuOa8pKYDHGFDYc9R17r/QfWoXQfa0vIJZLe/iOIruA4eM44BP8X+4crjqKU6fP1HGfKd98WNWntNCOl6ZIY7/AFAGMun3oYejuPQ4+UH1Oe1eRaJ4bh0i08i0kZVY5LH5ieOm7v8A5NdFd3M13PJc3832i5fAeTohx0Ax07nbTN2xiRjcTjk4z+PQ/Qfyq4QUEl1InJyZQe2SU9XYoMgsemB6dMd+Oe9Rf2bb+azCNlzjI3dPqD+g71pYblSrcDBB42/8B6D14571GxLfJklR3C8jjqFPI+prQgzWsLZCdsbb85I9fc9x9OTR9hi5LKAOoQdVyemOv4DmrrIM/KuQucHO8D3HfP8AtdqaxBA2gbMEj+MDnn39z+lAFSGxtojujRV+uW/HHUfTr604oF4AXd0AwP5Dv+dTMcfdJJIJyvzAjPbuB700AeUg2ZXkYXHftg8qPbqaYiIHazbdo/iZv8f/AK4/KlCqq7QEwTgHPH+foPwFPZcYICkDlcgnHuD1H1P8qTB2lgyndwWHOfbI5b6YH5UxFV4wzkYA2cehJ+pHWgHOShDA8N6fp/8AqHvUkyhAcD93japHOfb5T/L8ahj2eUuBn+I4/wDr/hz+lAx0rfvYwoHTr6e/A5/AfWoepcH5iOvbH1PQVPOJD5YbeHPVR1/I8/r9KJIx87BgRj1Jx7Dufw+lAiuUV5FLYGBjI43Adv8AJFBRcSkZ5wxXGSPcVKqkkjOHU5BPUH8On45x2oQkOSBuJXBUAEL68nj3wtAXKUiuI0bAZR8pBAPX61TutNspnaOa3RQB8pC5OfqK0pAGhk24ZQCSx5H/AH0f54+lRyAJhiw44YnI/DJ/lz9adguc3NoFpIudrxc4wrk8+2aK6EqkjufvKMZZeNv1J4/LiilYfMe3abFiNB/CR052/X2rct1b5CFP3fQZXnnB7jPp2NUNPRuCpG8cDHDLz1x3H+NasQAQEBQmeTjgnPT2OeK8aTPRHIRuwBweRtHf2689RSMoZ84B4+8QcFc9j+XHbmpsE4BGcnDZH6HH5Z9RQwXLOQucjgkde2evP880kIqsu6Qb3YMMgMVx83c/y/n602FBsEqxurjAG7r6CrDxoCuMHdyCMDn0/E8fpUsRyRkjcODt5570wIt+SUYllHODnkdOfr169atRNzyckn1Az/8ArqNg24leeevT6CnRPyRnjOBjIwPT+tUhE4HbqPoTmnimqc8/40vTjH9K1RIfpTgBj9aaKdzj3q0IUHFZeuaHaaqoaVFS5QYScD5lHofUe1aZ/wA807HFDV0CdjwnV9IuNMvXtLuMRleUOeHXswPcfTkV694Rlml8O2TXKsr7AOfQdD9MYrO8SWtnJqFnLqmRDExKY5BGOQR1+pHpXSwmNoEMJUxlQVKYwR6jFJT5kk9xuNncXvRSngUh/lTaQgB/GgHigjmk96nlQ7kNxCspDjAlXgNjn6fSo1+YY9DyKtEdelUrlmhmjc52sdjEjp6ZrgxdBNc63OijUfwsmxlfx5BpMEKWVTvB+YZpV5LYz6/lT0YMmSMdj7V5vKbttAjBhlcAmoZ8GJjjJp5LL0ClPbrQ+SgHQHrUvVWHHR3I4lYorEHBFOcZZfY81KMKMj6/WmO428Vaikg5m2Rueox9DVZ8HIqZiTk5/Gq0hwcjr7VEmb00CqTwelRupySCMD+dS7sIWY4A6mqRvEmkIi5UcEjoTVRdjeEZSeg2XIB9arFdvzMe9XmTzBk9Kq3CFM9vSreup0U5dDjPGpbzo5ERghXZn1rk7G7WJZEY8qp613/iCMXNkU/iHTNeY6tHILpPIUnLeXgDua6KOqsRX0aaNPxDF/o6TJkDAPHfiuS1GMPFpjqQNrMmTx+vavQ9St/O0sKF+6gHP0rzq/by7PY3WKYd8d/WuvDO016nBjI3g/Q6e3UxxRybSoIGSVyO3Rh0/pWtaSl4tjFW28gnDkDHcj/J61hrOI44lOA2Pu/dKjOenTt/jW3psZC+ZIoAJyNvy8fhxXtVbWPnqV7lofdJ/hPGfv49s/rT2yByzDGCAzbl9M7u31NGcNvCqdpIGRjP0x1pZZchifn3DliRzz3A4b9B6VijZjWViY8KTg/Ju6fVW/qarsP3gLYB5wCdp98EcEe9SmQMQVLDPGexPuOh/QVEzIo5z6jt7Zwf8irJGk4ZthyQOhG1sd/w/nRlxKVDYOPmwOfb5T0H069KjkcnaoX5QeM9B+B/x+lMJmYFQQkeTg4yPc/X3zTEOIXgHOE5C9hjqQDyPr1/CmSfM5yNwHsfl/qPXn8KGQjALHeTkZ7+49T+I9jUewcsxJHQgnPPtnr+H6VQhXIYhlIJAJP8QJ+o5/PjtTGIJZs8tyWPIz65HP4HgdaDuD/MFDc9Bhh+HX+eKaF3KV2ncSSTnJH178+hzQIJNg3FsgnndkHJ9cjqffp0pFKvGxcbiM9cPx9ev4n8KPL3uzKFYK2Sc/gSf8/hSPDmL5jhWJ2k8nHv3H4/hTACdyq27IHO5huHsdw5P1PHakwhBwcb8AkD9Mjk/p+VIURVwWZjzt28hj32nv8AU8UsiRB5HIK5ba2ckAj/AGh1+nrTJIblS4BVTzhclVY9OvH9PxqSIIsQjDAkEEY5P4Z+7/velR3CMxBIKgfxMAfp07/5NOECxxNk7hxvON65/Hkt+lIB6yJwqqjL02gEoSP9k/Nn+VQzSDIKArgn+LOPq3VamCAECQAbiMDdkf8AfXUD0HrTXRYzuJ+dDuBYZKjPVR39OetMCHzCCDtAGF2seMn0X1I7BunWkf5ixAJYAkhly2M9Sg4A9x161I+Fl24IJHzA/f6/xntx1P4U1z++KxqwKZzHG2Meh3d/YelMVyN1QKGOd54VMbnz7P0z/snpUMqoyxESKxz1ByE9ix+7+HU1IXWSB0baEcdPuw8evfjue9MkaMeTukwykAiRcKvoNo+97egoAgMQWZjuBdQOAu7B9PQH0A4oomZRI+B8oXhVOEUZ5x/eHqfyooEe92cZaMLhdmO/Kr9T2/wrVRNoGfvAAcjt6H1HbgVQtuCAV44yWXIBPZh+YzV5MLhTkMuTt3Hp3I7kH+leKz1CQjBBZT0/EZ9M9R/hUhYgKBtx1LEkjHbnuP5ZpoyCRyOOSCFz6kd/fFKQWYYwADuGARx+P5GgQEHcSxkKj2PP/wBegIWQ7l5PXPPXr2pWVA235Rz2x9aMIGGwJhV9Rzk+meP8aYCsFX7uCwOVXoBx1pN6KgYsFXoPf0pQzEkKTk8jAP8A9f3pkmHbZtVgvIBPemIsRsHPHI9RTxwOP8KgiZRlQCPQbcYHpUwIz/nitIsljwKXPHt+VIx+TjP86qK8/J2dOQAQW/Enj8Ktuwi4G/z0p34VUhuPMxxznHQkZ+tWVPuM/WnGVwaKeqWEV7BskGWGcHH6fSl0uyh06yjtrYv5adN7ZP51cI9qZ0+nrUtWdxp3Vh3ej3pMe1H9aoQUHqOaXP5UUAJ/WmSRq6kEZp5pCD2NRJXQ0VVYqA2PZvapSokHoT/OmMCrnd0c5GM9aFboOQCcZ9DXh1YcknF7HcnzK6JOGIDHDL1pMjOAR60x5A3zH5WHBqN36HoO3tWbkhqDZIzjqKhdgB1qGWbbVRrtC4BYYJxn0qHM6adBstvIBET6daZEwLfNwMZrL1vU105lM8cnknGXRSwH1xWFfeL9LtbZmkv7dNoIDGQAEdj/APWqUrnXDDSlG66mvcStqt9LBG5Sxt2xKR/y0b+79PWr6RhUCooVR0Fcl8LtestZsLiGKRvtFvKzSq67WcMSQ4Hoa717bzFB6D0qrWdmOvNUpez6IpJLt4P6VVvCX7kVpPa7ao3MLRZOPl7e9aJ6E0pRcro5nUFIYgL+J71ympW5hDTxj95G4kHHUjtXb38ORuY9a52eLJKt0PWt6crF1lfQsWrw3FgxXG103LXkficSW2rqqRlo5JBlOx+teg6ZMbWa4tmOFU7lz6GuL8XqRqcRTaGZhg120FaqmefiXzUH3RY0tnLw8KzEc7jgj612sTkRcRk4XoeM/iOnWue8MWsJuMIfMYfeyc/zrqHSRmQRKqjp83XjPIH+cV69Z+9Y8GktLkefkDLEOMA55xx2I78fhUDzoxJVRgHnv+R6/j3qz9nAbLyNI/6ke6+lI5G3ChRz/CNy9Ow9f9r61CLZTLvk93xk+w/Q4/zzTCJNxCqwHOSP6+n+cVbcgjClck8EHI+oPY+5qEHJByBjhe+Px7/U9KtElfZ8hZQvTIIPGPqOg+tIcgFyxVSPv5+9z3I/mamZd7AkbWz6gEnPbs340gwZCp2hs8leufb1Pv6VSJIGXhgTjPUjgfn0/P8ACmspYY6LnK59/wBD9eB61Mi/KQF4BGSOOPde5/lURJUudirn+EHPP+0PX2HWqsK4xAUMYYkMPujr09P/AK3601wFbaSBs6AcgE/qPwz7VKhAxkYRhk85B/qoHY/WmlyI1b5cdFbH/oHv6U7CuRrvYYBJXHc8r6EHt9W601kLxElV+ZsB+xx0wep9efrUm1vMYAgOP4W+X/vo9GJ9PSmD5gxIdnbAPOxm/wCA9h/QUCuEgdXkDsfMPG5jjPHYjg/So2TDfuwQRzg/K2Md+w/mKkBXcpDDC/Lu2+vYL69/amStshk2ruRedp+4T6sfXuaaEyIISsSxoWcsMbPlYEjsp7+/pTsOFMgJ+X5cqPue2O7e/qaYZZnRSzsWkUbWk6tjnA9P6CmsJpJN7y7FjGN54Kj0X1Pf60JCuLuD4ZsEKdxwchPUt7jpikLeYu4vhiMjI5ZgeBH9KjOFm8hlYMD8iEYdR2J/vHvUjZ+bCn5/lATq3tz936/WmBAzMSVXPyg5Gc4GefMPcDr70MpLFmVWGTtw22MH/ZPc9/0pY9jQR7Tu2LgogwFweOf4h6etOlwcF1VdwIDN0x/u9ue/rQIimb5gx525BkZeo7AJ6+lRzjDxkl4yAAFZtzkY5x/s+p/CpTuTD7plmH4zEd+en4dqgcZdBEygud2E9R2LH7oB/M0DICecH5WG0jK7nx22jsPRaKEztKqXVWILKn3t3u3Zj/KihiPoi2GwqWyox82CRgeoPVhjmrcZY/Jt2n/ZYfmoHPvg9jVaEFBtG/d1KryV9wPTPYmrKBGCKoU7uQoOAfpj8jXinqD4zsAJATOTyNgJzgepB/oanAVVJCkkn064+vf/AApi5U8HjHGSF3eme/8AKpGwRlsjoMkc/iT/AD9qBEZbglnG3u24AH6gf55pAwaPGcsRn5iDz+P+cU5xkBS5OTjAcfj0H6ClbIJ45PJwSee31/GmIam3JPUjnHAJ7ClkPytyzH8cYH51G7HH31G88E7fwIBH1poOyMuV2gNlQB+A6fielUA6JQZCBt2AY4HH+cVcUHHeqtkGB3HjdyehJ9OmOlXQOefyq4ITAcjrz9aULz0peBSjitUSV7u1huE2zDr3Bwfzp8alF2k7lHAJ6ke5rH8S6i1rLZwxhizyBjtGeM/56VujoP0qeW+qEmNU5+tDdP6U3kev408HNNO+jHsN6c0UpHpSY4/wotYBRS0g5/GlpoBCKYT2HWnt0qNjzj8aieg0RzHcuAffOP8AGqNrexzyzQhv30OA64x+Pv8A41cdgBu3HJzzyOK52HSZZ/EhvDI8aJG4UIeGDYOO4PrniuGvS9qtNzppTUXrsdHt3Dd19feoJUwAGHGKktywBjcjcvX39DUjqDkj/wDVXmuN9zdS5WZ9xCJFwc49V61zN94fvLi4ElpfNDIDxxuH4+1duIlkiwOoqHyijnuDUOm1qdVHGOndROEnsNWSRoDftbzt0DIHhf8A3SeR9DXE+LPC107211qMMcghmHCABSDwSRXt01ot4qpcIGj7MTgisDXvDpmhaO0uZhIQQqyHep/rQuaCukd+Hx0JyUZ6f13ObtPBk6yW17YTizv4B+7lA4K90Yd1NbtrrWrzaqdMewW3kijEjzs+UcZx8nf8617HzoreOK6KG5RAJCmdpOOo9qY4eTUY3TGI0Yv9D2pTlzrmIdbnbU4p22/rqW/MlVB5jZJ9OlVrlwy1cDKy5FVZ1U5xyauD6HLC19jntQKLGzOWGT2Nc9eHa6sc9PyrotWQxkOBnnBFcveN85IACmtaZ3Ts1cyL07LqOUcDO1voa4vxlKRdWxXa2ZQvI5zmuzvtzWshYAEdPeuB1Nvt2t2kcg+RCZmGcH0H616eGjzSieNi5ckZHceDV8wXEroWyeSRnJ9c9q6JnLLywKkjoNw49O4Hp61m+GofKswM4ZjkZ46/TtWswII83IbORuO0++COD/nFejUd5s8iCtEgc5GC2Bnq5yP++hzn0FQSANy3zZOMn+WR/LtVpwEOQWBAwDja3Tp6f1NVGLYAUgPjjnt/L+tCBoWVeXyW3d9xwencj730FQF8E98+vBb6jp+VSvECTliwHBVRgjnuP6CmbMbio29m/wBn6j+gq0SyF1BVV2jae2OvsAeg+lNEgYYAYleGAHH0A6gfT8KlIHlsx27RjcByo/3vT6CkK9N4G09PQj+aiqJK0mSdwBwvXByE5/MfWkCFV4VVAJ+YchP6j+fpVlwTgck5+XJ5/wCAmoWPK4XlPwx7j+8ewqhDHzsDEncehYg7vcEfe/Hg0wq2SctluozhvxPT8ue1PDZd8Z3FfmxwR/vDt9B9aQupQEMPLJ+UqPlJ9FHb/CmIiKbcKpwo52hf12np9etO2q6MWwwYdT8y59+5P6GldTvUMpIJztLcex3dz6DsKXc2XJDFt2Qw4c56YHp6elAiBmQOgzulU/eJ5P0Yfdpnysr5Q7PRuMc+n8fv79KlLA5ZyoXcCcD5Rxjkdz/+umFj8u8sWx8me/ptx0x2z1piGZwCFWQ7jgnjefZh/CPX24ppKH5l2BMELxmMd/lHUH39cCllC+YQMYGdyu/837805WDSZUvkj7wX58/T0oBlO32f2rJGUcFhu2FtxPqC3ZqlKq0TfMjpuxuJ2oQOzep9+9V8BNVjCeUFkTayg5UezHue+amDRZcux4OAWXcw9Pk7jPSn1EKqsFj3qzYGMMMH/gH+eKYWIMpUNnucZcjOPm9qlA3BVbcNy9yG+vP8I9aiZY/MZVyQn8PTB+v8R9fakBE7fu/ljBjbIKA4Q+vz/wA6DB5zAA+aWIXJXai8cZHf29qcWJU/NGY+SGbiIn1x/nNDoxIYszOoG0scMPQJ9f0pgVZAoiOfugdzhT9D/F7+1FPlyMsT8xHDMmSee6/wj+ZooA+gYimNkmcqNxC84HqvbHfmrSgkHJyMcjPU92AHfuKqxttKKAAF5KA52/7Sge/BB9asLvAX+EMMqMhc+m3HQjoRXis9IsoWHLkZJwN3y59iPXv608qT1Xdn5Tkfoc+/86giPzZHA+7uPy5A6g57g8cVMp3bsfNgbcsCfwJ+npTAeMF/lJz3Ge/ocd6ZISrbiGPuAeg/HvTlJ3H5jz0y36YH51GSC4URsffZ6deTxmmICrBkxuyuSQMg/Tv601VzHlBhecN17+3NSFGLEZ2jGTtUZP65pBklA2SvVtw4Pf3/AJ0DLEQUAYGAOOev61IKbHyAaePStokMWlJAUk/jQKxvFt+LDRZXBAkkPloPc9+PTrVPYRx2p3p1HXGmVvl80JEMZxg4BGO/evS815LosXm6taRFN4DgZXvj3H+FesZ4zn8zVyXLZGcNbsCP84po47U7j8aQj2/Soa6miF70GkFLVCExS0H3ooAQ4zTHyQQACKeeBTT+IrOexSK5LDD56DpjBOPp60y2i23DNgbj1OBTyAqjB+VmxgcdfTFTIPlHoPWsIq7NG9AdN3IHzjoaYp3HHQ1YqGVduXA+v+NZYyhde0j8yqU/ssYGMTn0/lUhKyYxyO9RO6OvJG4VUaYrxF19PWvN51HTodKpuevUvuwGDRHtcliB7VTt7gSL7elTKe6HFNSu7ilTcdCK8tiW86PO9BggfxCoLJAqNJx+8/lWnGwZOfxqjd2TnL20vlt1KkZUn/PpUTp296JrTq3Xs5uxSuJBbvhv9Wx4PofSmueKzNT1hNPJj1iCSBDwZMb4z/wIf1qO2voZY91ncJdW3UeWwZk/xFZJnpKk0k3/AMOSakFeJgw3KRyO1cnPaqzE7iB0/Cruq6xHuaNX56ZrIa+iVsDc5PXHPNdVOL3HKSSsUNQhJRlZvlFcdolksckt1Id93Lz0ztXnAAPbH86g+JHjP7IjaZpnzalP8gA58oHjJ9/QVZsI5Le1t0dT5ioFIPIHHOe/PtXuZfTteTPnsyqXaijvtDZBa5DhemcenqV7+mO9Ww/yELkegQZ/Q9/5VV0WI22nAOuXbB2kZA9/Wp5Iyyt/EFPXGcH+YrWTTk7HNFPlQwtnJGCAMkLkjH48gfrTHJC8LwOowAB+H8NPlXKAOTnOclsgf8C6jio5QMLtGey9mx/sn09zTQmMLfJuHII4Oc4/EdB/Ooiu372TxkZ4/I9h9adJx93Ppxwc/wBfrTcdTlQc8lecHuCvc1oiGMOdyhgS/UY4P4dj7k/WgN8xOCSSD/kfxcUFRscYCrkE85X8T/QfSmSHlRlw+QVGRk/7voP/ANVWSIX+VhjgnkjlW+v90Ux8kxueV6AnlQfRfSl3bslsAjls9vw7n1qKQnO4FgSMEjkt/vDsPWmSOZMBgeBnhWOACf8Aa7n+lJubaCAWfnOAA59M9gO9IGTcpBXYCQRjKjvx/PNMK5Zo/mJIz5TNzz/eb07kfSmIQSAhm+XHI3D7hz149fWkYHcRhv8AdLfMeP73b3HpTVLl0ZST23hcN7gL+pNJu4lUbRGRjHVT3w/oe/6UwEJJKyBgdmAGxhl/3R3+vpUSLkMEDj5QxC9/dvTPb2pSOVZhtkJ+Vs8t/uemf5VFzkxhflUfMqtg9f4/Un9BTEK+AikmJVBIHH7sD1HqaVAGO1llLEZClsORj+96U1mJUyKyj5iFdV+TgcYHr6Gkj3bVTHynDGNmyGP+929vekBT1FlFxbuxGFfYSFwqg9QB3A71ZkH7zEYY5PAQ8kkdnPTI7dhVPWTnyQ2/Ksp+fgDnov8AnmrMh3wkHYyEhTuyij3bH6n8KOodAikQY27QqkH5B8pP+16+3rSE7tnyBvQudqKfRP6k9agVyNpJYFMbGbA68fIO59AelOZv35ZmChhjdKud2D0K/wAI/rTEPZsDc7nBJPmSLnHodn8qZIFTG7KZXALncX9Qvpnv6UsnD9ZBKc5XrIf8+namyHIbygAQCp2nJx3DHt9R1oAV8lwil1bklU5kPux7jsKKiYbSFBD452IeAOx3evoKKAPfF2iMpJ91T8yD5dp9QByRjnFWg6q/Q45JCfKHx/ED19DgYFUUkEUecbFjI+8duwn17kdvWrSqFj3BOciTbjof4eT1GPx9q8dnpF6DO0tw+Ryw53jvye/6fWpQSycYLE4yfmz7Memf8arRskxZD+83HLAc5x0ZT0z/AIVPH8zMGbcThT33+o9M4/UUgJSygHp0Hyk457A4qEEeY3BweQ5BJwOp+tOZs4yVbnjLYyfTA79DUcpR/lY453tkN26n+hz1oQD1bIbC47Y8rkd8flzT9ok2SbWBB4yp69j1pqogYExgORz8pIB9vw6U+NMqCUIJ4I2EYH59KYiynKjGfWnjr0piDHX8MDFPFax2JY4V5/8AEq8D31jYruPlK08mOQCeFB756n8K9AFeNeM75LjxVqDByUidYWB6LgfpyfzrSC5pJETdomx4Ng8/V4cA7Yvmz6eg/wA+1elHvWB4G077HoyTSAia4G85GCB2H5Vvv1yKJu8rhBWQoOfb8aU4PpTQf/rU7t/9enuMaf8APFO+v60h64FIp44/QVIx/vSc5o/zzS/WqEIef/r0wjj/AB71Ifxpp9+lKSuNELjLKMZA96kTOOaOcZPFKKyirO5Teg40AZ+nSk7c0o6VqSeaeO5fEHh/V7AeGLYatb3hZpNPc4eAKMs8b9cH+6c89PSoLfxnZO6x6vFd6VcdD56EKDjON44/PFdWjJc/EcqG3GzsCMY4Usw7+uK6WaGKZds0aSLjGHUEVyTwdOavsdVLG1Kem5zVlOskMctrIksbDKsh3Kw9QR1q/FPng5BqvJ4T0+KdrjSfM0ud2DMLY4if/ejPy/iAD71n3t5Npe0a1EsUfa8iyYOuAGJ5Q8jrx7159XCTp6rVHbDE06+j0ZvLMqjIODTlnZxjI+tYiTI6o6SKyONwYNkMPUGpftIhj3l+Oorm5mbPDdi3ewRXCFJgHiwcq3INeI/Evw6mhXLXOl3H2YLuaaONypQ4Bzx2wa9P1jXodOt5HmdTNjcVJ4A9z6V4lq95L46vJpLiWUaJvw8gOxr1u4DdkH/j3biuzB0ZVpaImtW+q0/efyPO7nx/qkTH7DeO/vIAw/WqF1448Sagog/tExK5wVtkCE59xzX0Bo3wzsV8N289rbWu9jjy5YgWHJwM9zjv/Ksm+0KHTWmLadFDKVI8wQqDk55DdvTOMeor2KdCEnZNHjVMTNK7ucR4R8KJpoF/eyB9RcZUH5hHn/a7sfevQfD2jNczrLOrCKM5werHthT1/wDrVteHPDMYtYZ79skqGWIAgDIH3vY+1dC0aIiRRoioM7QflVfx/h+nrWrqpLlgYKDb5pFRxkAAgKOOCSq/1FQSFiMjb2+Y8fke3481YkXG3lix4O47WH1/2f1/OqxCDccqASRuC8H/AID/ADNZxRbZC+7JABGcHphv++e/1qBiChJbCDGWHKk+49aklwVIOByOCTj8W9famOVEituYOFIPTd+A9PfvWqRDI3Cj73CkcCQ8cep7fSmfMADk7sYHZxgdvb370mQsTDKKoPpuQfh3P9ajZSAmQw/2GPJ/4F29hVohjC2CzBvlU5LKOB7Adz7+tNztKgpt3HOzOVPuT2+nrUrMPM6Ek8ZVcP8ARR6e9RHGzaf4eTjlR/vDvirJEYFeAzAjuRwP931qM7y0iBWBHJBI3Dv85/X9KkDFemRkYU5yrey+n19aYdpBQqu1TlkZuF/4F357etAhrvucOSAhBG9VzuPpt7f41AdyMF8oAEnKsf3a8dS3r3PvU0r5lY/MrcjI/wBZx6+3r61G33Sx2iNSAzH/AFa8dx3/AMaYhrECXDmTcx43H94fZfbuaYCzM6qyggZOD8q/7/8Ae9afhSyrn04Y5Mh9m/hHc1FIfvBMHZnIP8Hfn+8e5pgRum6JOAVk/vHmT2H93PWkZPnZCu9gCAgP+r/H+In+VI27LcMwfrkfPJ3GR2H9Kb5gMpUbJFXI2g/Kme+fU/ypkibgQWWRnBOC6DnPoq/oDSpjaFIUJgEFTlQf9oetROQw34JI27WYbWPb5f8AZ7URMwYMGVWyMuBnafde5/pSGQayHFsNwO3gHLZ+n0HpU8DFYgxyURcnf/Dz1H96q+osGSNFKqzsBtB6j/a+v6VakxHD8pCMoymfmI/3PXHvQHQrkBTg/KzDqRuZv/iW9/Sl3DzcBX4yWVCGkA9WPcegpNuAc7lydrAcu/fDenufSmuUdjCvJXJ8uPgLnuW7+wpiHRY2Oqjcm7gRn5fxbrn1NRMdyAL8wVc4HyqnPXPcegpyhzvEYV1GEKr8sZH93/E0xyxC5IdEBwScKnuPX2FADGCsVO75WOMsMIT9P738qKJGdmaV1LAnHmMMD6BfX1opDPdkkC7HG2MKdgyoTYT1DE9R6Ec81dilDYIJQDkYBd0OeAT6Z9Kz49gZHURyH7gYoSGOPusT7elWkcsz4LFol4J+Yr7FRxgj8OK8lnoGksmd6H2woO4ZHUgDgYPYVMHDSYYklsBhnIPtgdwapRfKdj/LjG6NuSuOrKBxjHPpTpZCzhZDgN8zYbbvHTcAO/Q81NhlrzlK7/mCEZALBSwHr39fTpQ7HzGKDcDzvG5uf7w7cdwKahAG9EG5xkEAJuA4zk9wf505BuXbuzuxn5i2SO49/X6UASqpWLaFUlsD7pPPp9Pc1KqYZeOBwPlqJVO5QQGJGVwpwAfx6f41MGxkvgDvkjgD/PWgCdfSnDtTFHBz29fWnrWqZLI7uUQWsspIUIpYsQSB9cV8+tIWaSZ3AkndmOXboSTnp0Ir2L4hXf2fw7LGDhpz5eec/h715MyAKijcFC8gSdR39/et6G7ZjV2SPa/DUiSaDYmLJURAdMdulaJ981h+BXMnhm0LZ3AYPz7s89eOK3e/+etQ1qzRbDTx+Jpy8/8A6qQZxTQccHv0NJOwyQim8U4c9v0oPSqYhM/XP5U6mf56Uv1z+NJMBT70hHFKM0Hnj1/GqEM/z60DBPHQ0p6f40dvWoaKFWndByePWmr6VmeKb9dN0O6mJIcrsTAySx4FNvQRzfgCRb7xDr+ogn9864BXkDJA5+gFdwa5D4ZWoh0i4n5zLLjr2UD/ABPPeuvanISEBprqGXBGQeoxnNKetIenb/P86ykUeZ+KvBl6l0s/gzUE0ueR/wB5ZyAy203f7nSM+6kU+PT/ABbNaob/AEW2WdRkrb3ylCfbcAa7O5bGpWiAMxLjvtXGD26mtYtkkA9R09fzrnnThKzaOiniKtPSL0PD77wF4m1+4xqltbW9kWObdrjIf3kI5OP7oyPXNdXpXgWztUH9pz/aZCdpEXyr9Pw44biu5uXY5AxjqTg9PoOT9RWeXXziTnA5C9eAOyjhhjuenStYVJRjyx0XkZVP3kuaerK8kax74I0EaFAVQLnBHbbn9K5SWSB9dWGeEyAg5yisQff/AOv/AErrLp28qOYA7UIwBhgFPT/d9QOvrXCarttPGsO5UGI2Xbt4APIUE96uirtkVHojZtv9Uq5YgZCgnBP+6f8AOKhchWypwcEZ6/mvf3NKuBDsbaGPOGPyn/CmSAmQDLeYvJ7OQOmD/d9u9VFCZXmLBQPk8rJJDHKg+pPc+1Qvuab5Q3m4PfD49/b+dSSFdoYHAzgOF+QH2X196rPkkpsx32g8/Xd/IVsiGQM+1Q2/aucblXI+gX196azAsIyAT97YT19938hSvJlN5Zsn5NwHJ/2VX9AahfAbywFCjkqPuD3J9ewrRGbDzACGRyDnAcDn2Cjv9aikUYT5l2E8jdlM9Mse3+NDHLs2SGbgMR8/0Qenaoj94q0e3b8zKOQAOpcdyB6VaJFypjCNvO88HPzn2U9h2pA5IXG3CcYHG3nqf73tR8qc5GxuAwOd/sB/CKjkY58vYgVAf4sImPQ98dveqEDsV3tgknI3L1f6jsP61HI6g4cRrgkjPMaY/u+p/rRubHzb+Tgr/wAtD/8AWApi7vmYFPLjI+YD93Hx6dyPX1oEKx+ZQUbJ6KSN5x6H0H61FM4AMu4AqRgryEHpt/i+vrSsMgCRMK3zAE/f98/wgdfrTfNViM7SVXAOD8vpj19TVCZBvYEKAFVuqj5t5zn5x/D6mk+bf5hwoB2gt9wHrhT645zShsgqNx6jaPvv3G727/SnBBtMm5GU8Fx/q1z2x6n9KYiMO7YX94Wboh4kcH1P90/pUO7zH5ZWQnBYLhAfTHqfWptisHBYsrYPJ/1nvn+EH+QprIvmqwc7xwHIwAOny+uf5UAyGQ7fURuMZc5MvP8AD/d9KaTt2EsAVPYYMfP8J/i9KlmACs3KBsgNjJk+g/hX0qsvybFzn5sgduvRTSArz7PtUbqxKA47ZyT/ABfWtCfaoBA2A5yc5/759MfrWbMw+2IyBlIJBwOR9fX3rQnlUZYMiIy43KM7j6L6Y/nQNkROWZdsgByNgOXPs38yaYw+7F8pAywROFHvu9fSllV8mMhtxGREp+fHu36momkaQqgZHCndheIx7k/ypkiyAyM2VVwhAJHCJ/s/T1NNPKl/lkIJO88IP9pfX2FG1wHJAbaMlmOFT2Pr71Hu/dbwxYBiQ8vEf+8B29qAA4LF1LBdwHmv1+mP50UpLEK54c8F2HzfQDvRSA9vRiyAR4LYwWIyJO+DnjIPFWYHxIhLlc4A3ZYr6BgOOuRzWZHmZghP7w5GASfM55I7DHFWjLJHA8jMpwCAD8gbnGCBzkGvLaPQNORgpKbmgVGHyyPgp3BwOcdqmiLeU8gRo3z5mAgTaOxBPtms21YFIxG2w48sNt2YyeQxPPX8aso6cSDajRElDgvsbptbPQZz71Nhl4SLHNsLgEfMwUeYQAOWB7Z496tQl9rCXKuBl8vj/gQA/A1mwtKyqOURD8pdggU9WBHYHpk1Zt5Tg7QxVfmOwfcY+57Y70mMuo+8q6qDzn5Rt+hGf1p5cBlBcA/w7TkkdSRgdPUVEq/MVYA/xMPvEepH14p+7O7rv4Ppyf4gBSAsQfdHb09h7Z6ip16cdvSq8OD0G3PIGMc+o9/apmcKhY8KByTxj6mncTPP/iTcCS8ggII2LuPBBGffv2ri2VmGCS46jgH9P8a1vEMpl1C4lV1Idy3Dkgc9MnpWWoMvyurNg9cAiuujpExqas9S8BZHh6AEsQMhQQBj24rofyP4Vy/gMuNMCsMgcZCEZx7nuOPwrqO/P61k37zLWwv15pKX+VIfbimwDgU7PFMPAyaVWGfcckURl0YNCn/PNJjpjj8KdSdKpoEFH6/pSc+/8qARzjGR19aVwFP8/SmckDPX65px9+lB5FJjHLXEfEQS3t9o2lwqGaaQv06EDg/hyePSu2HTj9K495jN8UYIiQRb2LADuCTkn6YIoTuxM6jTLOPTtPgtYuViXGT3Pc/nVjOaU/pTc0mxoO9Nc4X9OP8APFLnBOf0/wAKr3DfIQOeeRnAHqSfSs5MaMy6kC63EuGLHBJC7z9M/wAIrVY/NIBnaPxA+orFU79UjfduRW+YqNq9TgEnk1qs3zuOj7s9drGs5bIaGTEgdB35JyM98kc/h3rPlH75os/eyxB6/UKv/oX6Zq3cNjG3hgO52tj1z6frWZcOxfgkoCzHI2r1HYcg+/QURKY27X/RpCTnaBgnnH5f15rh/HAz9gvkLHbIsbDG1VUnH1znNdncu2zazYJ7d8fhx+B571yvi+2Fz4duIvlZkBdCz5CsO+fXjgVvR0kjOprEuFljjcFs7SBuPb/fHr6VFJIqzJEYyVK58uRup9SR09h9ahs7z7ZZW9wpKyGME7+x9T/e6Z+mKieQqrYzsJ3fPyGx/E4/h69PerUbaE3vqNlct8wLbsYDAfOe2APTsKikOWAEaKp6opOwduSe9K5yASWVjxuBG5h/dTHQVVkbCsD1U5Pon1H8XpWqRmxZclsnJJ6MPv8AoQp9O1QSDCbcL8vOF+6PdvUj+dEkihs7gA3Abru9l/ujH50xmBYRqoDp/BnAiHqT/F/jWiIYJITnYeM43sOT/u+gFQvyQrOuVJITsmO5PfH86lkIL7wHLHuBhz+HoKh2qUK7RgH7vWND6H3HU1QhH5Y53sWHL4w7H02+gqLnkZQBcE7jmFD/AIj9TTim9Vx5gLYxuP7x/TDdhUagsv7tUJTG75cCM57g/e9TVCGyDaiEs3OFw74Z/o3Yd6JCQ2ExlFB5wPK9iP4vU0Z3Aj52D9SRkyHryv8ACP6VHIiuAMR7V+6rNmMZ77uu40xEaYZcqSwc9l+eX3Ydgev0pGJ2K6tG8a9M8ogPTb33H1NSOFcEtvYsMEkYeQeg/wBk1ErNt+YozqRllGAnbO3ox7CmIVAu7Y3mbm6KT88uevzdgfShyAVkO19owD90L67T0J7ZpeA21txRgeVGWbH94dh2pokOV2M2FJ/1YBTOPuhf0zQCI3ykreYdhb+F+M+mex+lR3MxTKsCZG45+/8AQDotLGd0m5BhlPKpycf7pqnqJCqqqQVJwAhwmM9Aev1NC3Blm4kDxgsuCQSccuw7ZHYVAMkKwxyMZU/K3P6U+4bZEACpABLFfvD/AHm7+n0qFXMe5yrScZB7df4h6UMERSDNzGCpYbTkM2APoe9XCzR5cOBuyPM2/e9tvb6+tUMM0wxswRlVZsDP17Y9O9XmyACWO4YGSP3nTpj0FICrLlQECMFPHlKcsc/7Xqe49KJHDCPcyEKdx4xGD0+b6dMUuB5zR4ZVyMRqeuR3PZjUQXzYVVQG287R91SO59QP1qiSV3JJG1X/AIVB4UDrhT39TTWkGCR97gm4k4X/AL59B2pA6yKQQsoU8DdiMH0HoxpJNzKZ95crgNK/8OPQegpDGOcqDlkGMbn++cnovuaKY0g8lXA2Lj7zHJYZ7ehNFAHsytIsjxsA74+4D146jHqO1SqW+0/Od5dQxG/YJAB2Hrj+VVbdsbFjmYhSfLKjaqkc8k9eO9PtZAqtlV+c7iqjcykcghj2P5V5p3mixEyDDebJ93eFJ3+oJPfGOR6damR8hGJJVsjaZAuQOxx0PfNUyxZ2EwbzDhWTO7f3BAHGQPwqcMwkQpukV+QSRGHVR0x1zjtUgaNuABubYhYbR8uQp6kMT3zxmrEcnmCMMVO3lA7ZYN2UgceoyazYEaWEqSsgYbM4LeYO/PZgMflV1ZBEPmxgqRgsBkDjaQOh71LKLqs45xIqoQE8whdh9ceh6ZqxGRtywKrtycfIBn9apQSBZVUKEdflDFMMCeqnPbuDU6tlFYgRk9ATuZOf5frUtpbjSb2RoQdCSFyT26N71X1i7W0spHYuMcfKRnJ7ZPrT4nHd4wcDIHIP0rzf4pT6temG00nTry4Duf3kfKgDgZHbvzRGUW90Pkl2Mu5v4r+6k8lpSo+VGlA3AD37/jVOSMLJyq5GDn7uP6Unhzwp4hRw13pzxoMHmVVOfzNdJJ4T1J5Ny+WikgtmTr7dK6PrFGGnOvvM3RqS+ydL4IZTZYZlySODIxPPqPbpXW9//rfpXOeHrWXToVS4kDkd19zz+gFbf2pMH5WP1rneJo3b5jT2FS2xZFA+tVxdxZOdwx6ipkkRxlHDfjWkK0J/C7kypzjuhT/9aq07mPe6clRuPv7VZPv/APrqvcrujK4J3cdcfjRNkonhdZIlZehGcU/61n2E2C6MMbSFAJ59qvdP/rVpGVxNAR6UhHBBHt1xTj7mkoaATPOB0+lH8/eg/X86QZwO/rjipGOY4XLdBzz6V5/4PmbVPH+rXzL8kSFUbHByQAR3zgEGu11e4S1065mlcIqRnLdT07e9ch8Kbd2s7/UJSxNxJhWJ5bHXjt1x+FVB6NkS3SO7c8Uw8Z7Y6/8A16CTuPT2Hc/4VHk4xxx+Q+vrWTZaQFuuATjHA4A/HvVec7oCrAMOckjCfgO/071I2WBBAGPfgfT+tV7n+Hze5IGRljkjovY1AyhCx/tUF2BIzliOevRVq/csBK46KTk/xDpzkdqzYiE1TADKzOThTudjk5z6e1XZSTcdScdujD6eppyHEhdgFjYFghJ5HzLn0H+1VSb5ZcSfJJ1z5mP/AB/v7A/jUs8pUkqTnGCV4Jz2AP5Z+tZ1xII2O0x+Xg7js3R89iD3J6+mKIoGJJk/MxO7BOB8mfoO49WrLv1eW0nSQK7lSwBTGR6n14/OrEs4UEZCFsMd53gejMex74qjMQ6n5cqw+UMTs/3j6egHqa2itSGznfCj+Zpr23y7YJDgMf3ag88H+8fT8KvTPkthHDFt2H+8fdvX1/Ss7w44h1S+hc4DZO4pnn02/wA2+lasy7iVIUBcthjkL35bufauip8RjD4Sqd3O0gK3UgZLewH8OPX1NQvgjawTahyqlvkj/wCB9yPT1q0xLMWzIQRjOP3hGPT09+9QEgAqhQbTg4/1aj0PqaaBkLo+/JBXj7xH7xu/T071CWOwhVUFSDsP3B7sex7mrMnzMuWJY8DPJP0PYVWKqcgKW6khhwvPf+8atEjSwJXaTlxhc8O3sD2HfNM2kFyF3NEMljwIx7j+L1NG3bGOZCW4Jxktzk5H8I702QKCARuxgDcTtQ/7Pr6mqRLEDDK4yVcc9y3fkfw+pqMnLqSBhRhd33U78HuT1qSQMTtCsWbt0kf3bsBTGIDbwQVGRuC5VM9Rt659fSmAoBAXIk+YH5c4lbPqfQ/pUZY/M/B28lh9xPqO5PT6UrID8p5DHIUn7x927f4VExB2tIA+37vOMHtt/vfXtQIAM7dxZVkHUcl/p/dHYU2RhgKqx+WrbQQcop/2fU9vzpMYLH5ySckfdkb1J9vao2ZVb5cE4P3fkOPZTwB79aYD5dsZPmZVcZZS2Gx0Hzjt6VVdjLlcfMcYYjt6Ajp9O9Lv2PhgD7L8v4kHiosGRlGMc8EL/h/Ki4WFTksWbMZ+8H+YZHuOf8KztVIN5Dx8xbl5Tj8No7elamAPutucjgg8Y9m7H2/OsOUpJri+WsQVc5ABfn3z+tVEmRrXSCWFAd7BQMBxs79VHcfzqrJjLbQdqdWHVT/tepqe+VlIVw24FSBI2Wx9eg+lQ7kATBI2rwVHzLx0A7/X0pANtziPOUAJy25coDjqff2qbJ2HarAnGAfvn6f7I61AjBEDRkBQeTtymcd/cUpbcBgSDcAdpOS3uD2HtQDIpAS4ixlByUU8cn+I+p/SpCrPtX7+z5hzhV989wOwprnnleAOVTpyejn1Pr2odlbIKLIBng8IvuD3A7CmIVXZg7EqVbrJjEY9j7moRl2PcqAdzcKuOyjuB1NPkc/K2S4Rh8zDAX6juaZKQARhTtBGW4THov8AOgCNn2spSRQWz++kHX6L2J7UUjneC5ZlOCTKwy7duF7e1FIZ/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Once appropriate IV tubing is attached and the catheter is secured, flush it with isotonic saline.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Frank, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37315=[""].join("\n");
var outline_f36_28_37315=null;
var title_f36_28_37316="Meningococcal serogroup C conjugate vaccine: Drug information";
var content_f36_28_37316=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Meningococcal serogroup C conjugate vaccine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/5/35923?source=see_link\">",
"    see \"Meningococcal serogroup C conjugate vaccine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5222824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Menjugate&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F5222828\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vaccine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F5256491\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Immunization: I.M.: 0.5 mL as a single dose",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F5256490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Immunization: I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Infants:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &ge;2-12 months: 0.5 mL as a single dose for a total of 3 doses administered at least 4 weeks apart",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &ge;4-11 months without prior vaccination: 0.5 mL as a single dose for a total of 2 doses administered at least 4 weeks apart",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Note:",
"     </b>",
"     The NACI recommends at least 1 of the 3 sequential doses for  infants &ge;2-12 months be administered beyond 5 months of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &ge;1 year: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F5256492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F5950130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Menjugate&reg;: 10 mcg of oligosaccharide antigen group [conjugated to  diphtheria toxin protein carrier CRM 197; packaged with of diluent containing aluminum hydroxide]",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11234054\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F5256495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer by deep intramuscular injection only; do not administer via I.V., SubQ, or I.D. routes. Administer into the anterolateral thigh in infants and the deltoid area in older children, adolescents, and adults. Use separate injection sites if administering multiple vaccinations on the same day.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Acetaminophen may be used when needed to provide comfort; however, routine prophylactic administration of acetaminophen to prevent fever due to vaccine use is not recommended. There is evidence of a decreased immune response to some vaccines associated with acetaminophen administration; the clinical significance of this reduction in immune response has not been established.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F5256487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not mix with other vaccines in the same syringe.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F5222829\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     To provide active immunization against invasive meningococcal disease caused by",
"     <i>",
"      N. meningitidis",
"     </i>",
"     serogroup C, in children &ge;2 months and adults",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     The National Advisory Committee on Immunization (NACI) recommendations for persons considered at an increased risk for meningococcal disease:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Chemoprophylaxis and immunoprophylaxis:",
"     </i>",
"     Selection of meningococcal vaccination to be based upon serogroup(s):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     Individuals living in the same household or with close contact (eg, kissing, shared cigarettes, shared eating or drinking utensils) of infected patient",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:4em;margin-top:0em;\">",
"     Employees and children of nursery schools or day care",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">",
"     <i>",
"      Immunoprophylaxis:",
"     </i>",
"     Selection of meningococcal vaccination to be based upon serogroup(s):",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:4em;margin-top:0em;\">",
"     Adolescents and young adults",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     Laboratory workers routinely exposed to isolates of",
"     <i>",
"      N. meningitidis",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Military recruits",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Persons traveling to or who reside in countries where",
"     <i>",
"      N. meningitidis",
"     </i>",
"     is hyperendemic or epidemic, particularly if contact with local population will be prolonged",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Persons with terminal complement component deficiencies",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:4em;margin-top:0em;\">",
"     Persons with anatomic or functional asplenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Use is also recommended during meningococcal outbreaks caused by serogroup C.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;margin-top:0em;\">",
"     <i>",
"      Chemoprophylaxis:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:4em;margin-top:0em;\">",
"     Healthcare workers with intensive unprotected contact with infected patients",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:4em;margin-top:0em;\">",
"     Airline passengers sitting directly next to an infected patient for duration of at least 8 hours",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;margin-top:2em;\">",
"     See NACI guidelines for specific drug treatment at file://www.phac-aspc.gc.ca/naci-ccni",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F5222837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Temperature &lt;38&deg;C (5% to 47%), headache (34%), irritability (10% to 30%), malaise (25% adults), sleepiness (9% to 19% children), chills (13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Diarrhea (8% to 18%), appetite changes (6% to 16%), nausea (16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Local: Injection site: Pain (22% to 81%; severe &le;2%), erythema (16% to 28%), induration (7% to 24%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Myalgia (29%), arthralgia (16%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Fever &ge;38&deg;C (2% to 9%), crying (unusual/persistent; up to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Rash (4% to 9%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Vomiting (5% to 9%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Agitation, anaphylaxis, angioedema, bronchospasm, dizziness, facial edema, hypersensitivity reactions, hypoesthesia, hypotonia, lymphadenopathy, maculopapular rash, paresthesia, pruritus, seizure, syncope, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F5222832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to meningococcal group C-CRM197 conjugate vaccine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F5222833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &bull; Anaphylactoid/hypersensitivity reactions: Immediate treatment (including epinephrine 1:1000) for anaphylactoid and/or hypersensitivity reactions should be available during vaccine use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Syncope: Syncope has been reported with use of injectable vaccines and may be accompanied by transient visual disturbances, weakness, or tonic-clonic movements. Procedures should be in place to avoid injuries from falling and to restore cerebral perfusion if syncope occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Acute illness: May consider deferring administration in patients with moderate or severe acute illness (with or without fever); may administer to patients with mild acute illness without fever.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Bleeding disorders: Use with caution in patients with a history of bleeding disorders (including thrombocytopenia) and/or patients on anticoagulant therapy; bleeding/hematoma may occur from I.M. administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Diphtheria infection: Vaccine is not intended for immunization against diphtheria. Vaccinations with diphtheria toxoid should still be administered as regularly scheduled.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Meningococcal infections: Not to be used to treat meningococcal infections or to provide immunity against",
"     <i>",
"      N. meningitidis",
"     </i>",
"     serogroups A, B, 29-E, H, I, K, L, W-135, X, Y, or Z. Vaccination against other serogroups if needed should be administered at least 2 weeks after the administration of Menjugate&reg;.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Altered immunocompetence: Use with caution in severely immunocompromised patients (eg, HIV, patients receiving chemo/radiation therapy or other immunosuppressive therapy); safety and efficacy have not been established.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Effective immunity: Vaccination may not result in effective immunity in all patients. Response depends upon multiple factors (eg, type of vaccine, age of patient) and may be improved by administering the vaccine at the recommended dose, route, and interval. Vaccines may not be effective if administered during periods of altered immune competence (CDC, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299662\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F5256481\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cytarabine (Liposomal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5222830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have not demonstrated risks to the fetus. Reproductive studies in humans have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F5222831\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F13908742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Menjugate (AR, AU, BE, CH, CZ, DE, FI, GB, IE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F5256493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Induces immunity against meningococcal disease via the formation of bactericidal antibodies directed toward the polysaccharide capsular components of",
"     <i>",
"      Neisseria meningitidis",
"     </i>",
"     serogroup C.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Canadian Immunization Guide, Seventh Edition, 2006,&rdquo; Ottawa, ONT: Minister of Public Works and Government Services Canada, Public Health Agency of Canada, National Advisory Committee on Immunization, 2006. Available at file://www.phac-aspc.gc.ca/publicat/cig-gci/index.html",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2011, 60(2):1-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/28/37316/abstract-text/21293327/pubmed\" id=\"21293327\" target=\"_blank\">",
"        21293327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      MacDonald NE, Halperin SA, Law BJ, et al, &ldquo;Induction of Immunologic Memory by Conjugated vs Plain Meningococcal C Polysaccharide Vaccine in Toddlers: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1998, 280(19):1685-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/28/37316/abstract-text/9832000/pubmed\" id=\"9832000\" target=\"_blank\">",
"        9832000",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      MacLennan JM, Shackley F, Heath PT, et al, &ldquo;Safety, Immunogenicity, and Induction of Immunologic Memory by a Serogroup C Meningococcal Conjugate Vaccine in Infants: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 2000, 283(21):2795-280.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/28/37316/abstract-text/10838647/pubmed\" id=\"10838647\" target=\"_blank\">",
"        10838647",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Prymula R, Siegrist CA, Chlibek R, et al, &ldquo;Effect of Prophylactic Paracetamol Administration at Time of Vaccination on Febrile Reactions and Antibody Responses in Children: Two Open-Label, Randomised Controlled Trials,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2009, 374(9698):1339-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/28/37316/abstract-text/19837254/pubmed\" id=\"19837254\" target=\"_blank\">",
"        19837254",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics, &ldquo;Febrile seizures: Clinical Practice Guideline for the Long-Term Management of the Child With Simple Febrile Seizures,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008,  121(6):1281-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/28/37316/abstract-text/18519501/pubmed\" id=\"18519501\" target=\"_blank\">",
"        18519501",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trotter CL, Andrews NJ, Kaczmarski EB, et al, &ldquo;Effectiveness of Meningococcal Serogroup C Conjugate Vaccine 4 Years After Introduction,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2004, 364(9431):365-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?36/28/37316/abstract-text/5276396/pubmed\" id=\"5276396\" target=\"_blank\">",
"        5276396",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9446 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-1D72A0B336-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37316=[""].join("\n");
var outline_f36_28_37316=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5222824\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5222828\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5256491\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5256490\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5256492\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5950130\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11234054\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5256495\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5256487\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5222829\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5222837\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5222832\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5222833\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299662\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5256481\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5222830\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5222831\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13908742\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038899\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5256493\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9446\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9446|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?35/5/35923?source=related_link\">",
"      Meningococcal serogroup C conjugate vaccine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_28_37317="Inspissated stool";
var content_f36_28_37317=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78827%7EPULM%2F57853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78827%7EPULM%2F57853&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Plain abdominal radiograph showing inspissated stool which might be mistaken for drug packets",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 525px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Stool predominantly in upper left quadrant of radiograph. Body packing was not suspected. Pellets of stool lack the geometric appearance of drug packets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen Traub, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 473px\">",
"   <div class=\"ttl\">",
"    Plain abdominal radiograph showing inspissated stool",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 453px; height: 392px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pellets of stool, which lack the geometric appearance of drug packets, are predominantly present in rectum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen Traub, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37317=[""].join("\n");
var outline_f36_28_37317=null;
var title_f36_28_37318="Approach to the patient with a scalp eruption";
var content_f36_28_37318=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the patient with a scalp eruption",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/28/37318/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37318/contributors\">",
"     Beth G Goldstein, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37318/contributors\">",
"     Adam O Goldstein, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/28/37318/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37318/contributors\">",
"     Robert P Dellavalle, MD, PhD, MSPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37318/contributors\">",
"     Moise L Levy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/28/37318/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37318/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/28/37318/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of scalp eruptions is broad. A good history and physical examination can narrow the diagnostic possibilities, although the diagnosis may be challenging because of the hair covering the scalp area [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37318/abstract/1\">",
"     1",
"    </a>",
"    ]. It is important to remember in evaluating these lesions that many of these disorders are not confined to the scalp.",
"   </p>",
"   <p>",
"    A number of scalp eruptions influence hair growth, resulting in temporary or permanent hair loss. This review focuses upon common benign scalp eruptions seen in children and adults. Hair loss is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13846?source=see_link\">",
"     \"Nonscarring hair loss\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/29/9690?source=see_link\">",
"     \"Evaluation and diagnosis of hair loss\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CHILDREN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Tinea capitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tinea capitis is a dermatophyte infection that is a common and underdiagnosed cause of scaling scalp eruptions in children. Sources of this fungal infection include other children and animals, particularly cats.",
"   </p>",
"   <p>",
"    Dermatophyte infections of the scalp can present as mild scaling alone; inflammatory, scaly patches or plaques; or with scale and deep-seated boggy nodules with extensive exudate (kerion) (",
"    <a class=\"graphic graphic_picture graphicRef86628 graphicRef86686 graphicRef86627 \" href=\"mobipreview.htm?41/59/42938\">",
"     picture 1A-C",
"    </a>",
"    ). Circular areas of alopecia are common. In addition, there may be posterior cervical adenopathy in patients with a significant inflammatory response.",
"   </p>",
"   <p>",
"    The clinical diagnosis is fairly straightforward. The majority of tinea capitis in the United States is due to",
"    <em>",
"     Trichophyton tonsurans",
"    </em>",
"    ; this form most frequently occurs in African-American patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37318/abstract/2\">",
"     2",
"    </a>",
"    ]. Unlike tinea capitis due to",
"    <em>",
"     Microsporum canis",
"    </em>",
"    infection, tinea capitis due to",
"    <em>",
"     T. tonsurans",
"    </em>",
"    does not fluoresce upon exposure to a Wood's lamp. A potassium hydroxide preparation (KOH) or fungal culture from the associated scale or a hair shaft in an involved area is necessary to confirm the diagnosis (",
"    <a class=\"graphic graphic_picture graphicRef62438 \" href=\"mobipreview.htm?5/56/6023\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/58/7082?source=see_link\">",
"     \"Dermatophyte (tinea) infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/51/31543?source=see_link&amp;anchor=H4044416#H4044416\">",
"     \"Dermatologic procedures\", section on 'Potassium hydroxide (KOH) prep'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/51/31543?source=see_link&amp;anchor=H9#H9\">",
"     \"Dermatologic procedures\", section on 'Fungal culture'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pediculosis capitis (head lice)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediculosis capitis (head lice) frequently occurs in children, often presenting as pruritus of the scalp without an identifiable eruption. Head lice are often found on the posterior scalp, postauricular region, and neck (",
"    <a class=\"graphic graphic_picture graphicRef80788 \" href=\"mobipreview.htm?41/18/42274\">",
"     picture 3",
"    </a>",
"    ). Nits (lice eggs cemented to the hair shaft), are typically found close to the base of the hair shaft in patients with active infestations (",
"    <a class=\"graphic graphic_picture graphicRef65846 graphicRef74790 \" href=\"mobipreview.htm?26/18/26921\">",
"     picture 4A-B",
"    </a>",
"    ). Nits are not easily dislodged from the hair shaft, a feature that distinguishes them from the scale seen in seborrheic dermatitis. Excoriations are often evident, as well as cervical adenopathy in longer standing infestations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/15/25849?source=see_link\">",
"     \"Pediculosis capitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Scabies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Scabies can involve the scalp in very young children and immunocompromised patients of any age. Other frequent sites of involvement include the palms and soles in infants (",
"    <a class=\"graphic graphic_picture graphicRef60206 graphicRef56862 \" href=\"mobipreview.htm?41/48/42758\">",
"     picture 5A-B",
"    </a>",
"    ), interdigital web spaces (",
"    <a class=\"graphic graphic_picture graphicRef72616 graphicRef51161 \" href=\"mobipreview.htm?37/3/37941\">",
"     picture 6A-B",
"    </a>",
"    ), wrists, axillae, breasts, and umbilicus. The scraping procedure, dermoscopy, or the adhesive tape test can be used to confirm the presence of scabies, mites, ova, or feces [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37318/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/2/28712?source=see_link\">",
"     \"Scabies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Atopic dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atopic dermatitis may involve the posterior scalp. A positive personal or family history of asthma, hay fever, or seasonal rhinitis, as well as other signs of atopic dermatitis such as pruritic, erythematous scaling plaques in the flexural areas of older children and adults, can assist with making the clinical diagnosis (",
"    <a class=\"graphic graphic_picture graphicRef64525 \" href=\"mobipreview.htm?23/31/24051\">",
"     picture 7",
"    </a>",
"    ). The face and extensor surfaces are common additional sites of skin involvement in infants (",
"    <a class=\"graphic graphic_picture graphicRef77457 \" href=\"mobipreview.htm?22/55/23408\">",
"     picture 8",
"    </a>",
"    ). In children, one must always maintain a high suspicion for a dermatophyte infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/40/42631?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H3\">",
"     'Tinea capitis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Cradle cap",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seborrheic dermatitis (cradle cap) in infants is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/14/2278?source=see_link&amp;anchor=H608072814#H608072814\">",
"     \"Cradle cap and seborrheic dermatitis in infants\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A seborrheic-like eruption occurs in Langerhans cell histiocytosis (Letterer-Siwe disease), a rare disorder of histiocytes that may affect the scalp, groin, trunk, and face (",
"    <a class=\"graphic graphic_picture graphicRef68224 graphicRef57722 graphicRef69504 \" href=\"mobipreview.htm?26/16/26890\">",
"     picture 9A-C",
"    </a>",
"    ). Petechiae are often present within the areas of the skin eruption. These patients are ill with fever, lymphadenopathy, and hepatosplenomegaly. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21338?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     ADULTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Folliculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Folliculitis is an inflammatory process of the hair follicles that most frequently occurs as a result of the invasion of microorganisms into the follicle (",
"    <a class=\"graphic graphic_picture graphicRef62916 \" href=\"mobipreview.htm?11/25/11667\">",
"     picture 10",
"    </a>",
"    ). Bacterial culture of the hair-based pustules often reveals a",
"    <em>",
"     Staphylococcus aureus",
"    </em>",
"    infection. If the culture reveals only normal flora, acne of the scalp is another possibility. Fungal and viral forms of folliculitis may also occur. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/55/22387?source=see_link\">",
"     \"Folliculitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/20/6474?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/58/7082?source=see_link&amp;anchor=H31#H31\">",
"     \"Dermatophyte (tinea) infections\", section on 'Majocchi's granuloma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Dissecting scalp cellulitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dissecting cellulitis of the scalp presents as deep-seated nodules, pustules, and cysts in adults (",
"    <a class=\"graphic graphic_picture graphicRef75929 \" href=\"mobipreview.htm?20/38/21094\">",
"     picture 11",
"    </a>",
"    ). These can heal with scarring, sinus tract formation, and significant, often permanent, alopecia. The culture is frequently negative or grows normal skin flora. There is vigorous granulomatous inflammation in this condition, which is typically managed with chronic oral antibiotics or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dermatomyositis and dermatitis herpetiformis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uncommon diseases such as dermatomyositis and dermatitis herpetiformis of the scalp may present with intense itching in the presence or absence of clinically evident inflammatory lesions (",
"    <a class=\"graphic graphic_picture graphicRef64903 \" href=\"mobipreview.htm?4/5/4181\">",
"     picture 12",
"    </a>",
"    ). In dermatomyositis, a photosensitive eruption along with symptoms of large group muscle weakness and fatigue are often present. Additional cutaneous signs of dermatomyositis include periorbital edema with a violaceous hue and scaling erythematous papules overlying the joints on the fingers and hands (",
"    <a class=\"graphic graphic_picture graphicRef56879 graphicRef68649 graphicRef54230 graphicRef77822 graphicRef63383 graphicRef75246 \" href=\"mobipreview.htm?41/45/42714\">",
"     picture 13A-F",
"    </a>",
"    ). In addition to the scalp, dermatitis herpetiformis frequently involves the elbows, knees, and sacral area (",
"    <a class=\"graphic graphic_picture graphicRef78315 \" href=\"mobipreview.htm?23/38/24163\">",
"     picture 14",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/4/27722?source=see_link\">",
"     \"Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35369?source=see_link\">",
"     \"Dermatitis herpetiformis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Seborrheic dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seborrheic dermatitis is common in babies and also affects adults of all ages [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37318/abstract/5\">",
"     5",
"    </a>",
"    ]. Cradle cap is a form of seborrheic dermatitis that occurs in infants and presents with yellowish, greasy scales on the scalp. Both infants and adults may exhibit the classic presentation of seborrheic dermatitis, which is characterized by the presence of erythematous patches with fine, greasy scale on the scalp, ears, central face, eyebrows, trunk, and occasionally in the pubic region (",
"    <a class=\"graphic graphic_picture graphicRef59104 graphicRef82073 graphicRef54173 graphicRef52803 \" href=\"mobipreview.htm?36/61/37850\">",
"     picture 15A-D",
"    </a>",
"    ). When lesions consistent with seborrheic dermatitis are present in areas other than the scalp, the recognition of these lesions can assist with diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3721?source=see_link\">",
"     \"Overview of dermatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Another scaling eruption of the scalp, with some clinical similarities to seborrheic dermatitis or psoriasis, is described as",
"    <strong>",
"     tinea amiantacea",
"    </strong>",
"    . These patients produce thick, scaling eruptions on the scalp with significant adherent scale involving the hair shafts. Use of salicylic acid liquid 2% overnight along with low to medium potency topical corticosteroid lotions assists in management of this disorder. Secondary infection should be addressed with anti-staphylococcal antibiotics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Psoriasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psoriasis of the scalp tends to appear as thick, silvery, scaling plaques with erythema (",
"    <a class=\"graphic graphic_picture graphicRef87343 \" href=\"mobipreview.htm?39/15/40183\">",
"     picture 16",
"    </a>",
"    ). Any area of the scalp may be involved. Pruritus may be nonexistent to severe. Other signs of psoriasis may be present elsewhere, such as on extensor surfaces, elbows, knees, sacrum, or nails (eg, pitting, onycholysis, oil spots) (",
"    <a class=\"graphic graphic_picture graphicRef54581 graphicRef78531 graphicRef70962 graphicRef66374 graphicRef53509 \" href=\"mobipreview.htm?40/21/41306\">",
"     picture 17A-E",
"    </a>",
"    ). A family history of psoriasis is present in 30 to 40 percent of patients. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of psoriasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A variant between seborrheic dermatitis and psoriasis is called sebopsoriasis. This diagnosis is typically made when the scale of the scalp eruption is thicker than that seen in seborrheic dermatitis, but not quite as thick as that of psoriasis and there are not other sites involved to help determine which diagnosis best describes the eruption [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37318/abstract/6\">",
"     6",
"    </a>",
"    ]. Treatment is similar to psoriasis therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Allergic or irritant contact dermatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Allergic or irritant contact dermatitis can occur after exposure to hair care products such as coloring agents, permanents, relaxers, or even shampoos. These products contain a variety of potentially sensitizing or irritating ingredients that may cause eruptions in susceptible individuals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37318/abstract/7\">",
"     7",
"    </a>",
"    ]. Sensitization can occur after multiple uneventful uses of a given product. Allergic reactions are characterized by marked pruritus with associated weeping, erythematous areas on the scalp, and often involvement of the forehead and eyelids. Irritant reactions are frequently mild in the scalp, but often are accentuated on the thin skin of the eyelids. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3721?source=see_link\">",
"     \"Overview of dermatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Herpes zoster",
"    </span>",
"    &nbsp;&mdash;&nbsp;Herpes zoster can occur on the scalp. Patients tend to be far more symptomatic than the eruption appears. Grouped vesicles on an erythematous base typically evolve over a few days in the area of the affected dermatome. Only erythematous wheals may be evident early in the presentation, while crusted erosions can be the only cutaneous sign after several days (",
"    <a class=\"graphic graphic_picture graphicRef74420 \" href=\"mobipreview.htm?27/50/28453\">",
"     picture 18",
"    </a>",
"    ). Patients usually complain of unilateral symptoms of burning, aching, stinging, or throbbing. The extent of the symptoms varies considerably from one patient to the next and tends to be more severe in mature adults and when the V1 dermatome is involved. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23688?source=see_link\">",
"     \"Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Discoid lupus erythematosus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discoid lupus erythematosus can involve the scalp with erythematous scaling plaques that evolve to demonstrate prominent follicular keratin plugs, atrophy, and alopecia (",
"    <a class=\"graphic graphic_picture graphicRef53535 \" href=\"mobipreview.htm?39/14/40166\">",
"     picture 19",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37318/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. The scale is thick and adherent; it appears tacked down when attempts are made to remove the scale, as the scale penetrates into the follicular openings. Hyperpigmentation and hypopigmentation can be striking in darkly pigmented patients. Persistent lesions heal with scar formation. Involvement of the external auditory canal, face, V of the neck, and forearms are also seen (",
"    <a class=\"graphic graphic_picture graphicRef75833 graphicRef64844 \" href=\"mobipreview.htm?17/32/17929\">",
"     picture 20A-B",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/33/36378?source=see_link\">",
"     \"Mucocutaneous manifestations of systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with discoid lupus erythematosus rarely develop systemic involvement; however, a diffuse nonscarring alopecia may be seen in those with significant systemic lupus erythematosus. The diagnosis of discoid lupus erythematosus is most commonly made by routine histopathological evaluation of a skin biopsy. The tissue for the biopsy should be obtained from a new, inflamed site to obtain the highest yield.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Lichen planopilaris",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lichen planopilaris is an inflammatory eruption involving the follicles, particularly of the scalp. This eruption of unknown etiology may occur as an isolated phenomenon or in conjunction with more typical lichen planus. The scalp is involved with erythematous and scaly perifollicular lesions (",
"    <a class=\"graphic graphic_picture graphicRef52848 \" href=\"mobipreview.htm?9/34/9767\">",
"     picture 21",
"    </a>",
"    ). Persistent inflammation eventually results in permanent scarring alopecia. A punch biopsy is typically performed in the newest areas of involvement for diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37318/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=see_link&amp;anchor=H13#H13\">",
"     \"Lichen planus\", section on 'Scalp lesions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Bullous diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pemphigus vulgaris is a mucocutaneous blistering disorder that may present as crusted, weeping, diffuse lesions in multiple skin sites, including the scalp (",
"    <a class=\"graphic graphic_picture graphicRef63170 graphicRef53425 graphicRef57924 graphicRef77462 \" href=\"mobipreview.htm?41/0/41994\">",
"     picture 22A-D",
"    </a>",
"    ). Erosions in the mouth are also typically present in pemphigus vulgaris.",
"   </p>",
"   <p>",
"    Mucous membrane pemphigoid (cicatricial pemphigoid) is a blistering disorder that primarily involves mucosal surfaces, but may also present with erosive, bullous, and scarring lesions on the head, neck, and upper body (",
"    <a class=\"graphic graphic_picture graphicRef54769 graphicRef73874 graphicRef63997 graphicRef54207 \" href=\"mobipreview.htm?31/27/32186\">",
"     picture 23A-D",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22714?source=see_link&amp;anchor=H53290512#H53290512\">",
"     \"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid\", section on 'Mucous membrane pemphigoid'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19146?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and diagnosis of pemphigus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H561873\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A wide variety of disorders of childhood and adulthood may present with lesions on the scalp. Examples include infections, parasitic infestations, autoimmune disorders, and primary inflammatory skin diseases. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Children'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Adults'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the diagnosis of a scalp eruption is uncertain, examination of other skin sites may offer clues that aid in narrowing the differential diagnosis. Depending on the clinical scenario, select laboratory studies may also be of value. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Children'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Adults'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37318/abstract/1\">",
"      McDonald LL, Smith ML. Diagnostic dilemmas in pediatric/adolescent dermatology: scaly scalp. J Pediatr Health Care 1998; 12:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37318/abstract/2\">",
"      Abdel-Rahman SM, Farrand N, Schuenemann E, et al. The prevalence of infections with Trichophyton tonsurans in schoolchildren: the CAPITIS study. Pediatrics 2010; 125:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37318/abstract/3\">",
"      Walter B, Heukelbach J, Fengler G, et al. Comparison of dermoscopy, skin scraping, and the adhesive tape test for the diagnosis of scabies in a resource-poor setting. Arch Dermatol 2011; 147:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37318/abstract/4\">",
"      Dupuy A, Dehen L, Bourrat E, et al. Accuracy of standard dermoscopy for diagnosing scabies. J Am Acad Dermatol 2007; 56:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37318/abstract/5\">",
"      Pi&eacute;rard-Franchimont C, Hermanns JF, Degreef H, Pi&eacute;rard GE. From axioms to new insights into dandruff. Dermatology 2000; 200:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37318/abstract/6\">",
"      van de Kerkhof PC, de Hoop D, de Korte J, Kuipers MV. Scalp psoriasis, clinical presentations and therapeutic management. Dermatology 1998; 197:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37318/abstract/7\">",
"      Tosti A, Piraccini BM, van Neste DJ. Telogen effluvium after allergic contact dermatitis of the scalp. Arch Dermatol 2001; 137:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37318/abstract/8\">",
"      Nielson TA, Reichel M. Alopecia: diagnosis and management. Am Fam Physician 1995; 51:1513.",
"     </a>",
"    </li>",
"    <li>",
"     McCauliffe DP, Sontheimer RD. Cutaneous Lupus Erythematosus. In: The Clinical Management of Systemic Lupus Erythematosus, Second Edition, Schur PH (Ed), Lippincott, Philadelphia 1996.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37318/abstract/10\">",
"      Tandon YK, Somani N, Cevasco NC, Bergfeld WF. A histologic review of 27 patients with lichen planopilaris. J Am Acad Dermatol 2008; 59:91.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1734 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-06EB330AA9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37318=[""].join("\n");
var outline_f36_28_37318=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H561873\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CHILDREN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Tinea capitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pediculosis capitis (head lice)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Scabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Atopic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Cradle cap",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      ADULTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Folliculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Dissecting scalp cellulitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dermatomyositis and dermatitis herpetiformis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Seborrheic dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Psoriasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Allergic or irritant contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Discoid lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Lichen planopilaris",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Bullous diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H561873\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/1734\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/1734|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/47/9976\" title=\"picture 1A\">",
"      Tinea capitis - black dot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/35/26167\" title=\"picture 1B\">",
"      Tinea capitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?42/62/44007\" title=\"picture 1C\">",
"      Kerion in tinea capitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/56/6023\" title=\"picture 2\">",
"      Tinea capitis KOH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?41/18/42274\" title=\"picture 3\">",
"      Pediculosis capitis louse",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/26/34212\" title=\"picture 4A\">",
"      Pediculosis capitis nits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/27/22965\" title=\"picture 4B\">",
"      Head lice nits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/31/9713\" title=\"picture 5A\">",
"      Scabies infant foot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?2/39/2674\" title=\"picture 5B\">",
"      Scabies infant foot 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?19/5/19537\" title=\"picture 6A\">",
"      Scabies infant scalp",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/4/4160\" title=\"picture 6B\">",
"      Interdigital scabies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/31/24051\" title=\"picture 7\">",
"      Adult atopic dermatitis 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/55/23408\" title=\"picture 8\">",
"      Atopic dermatitis infantile I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/49/40724\" title=\"picture 9A\">",
"      Langerhans cell histiocytosis scalp lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/62/34786\" title=\"picture 9B\">",
"      Langerhans histiocytosis skin 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/56/4997\" title=\"picture 9C\">",
"      Langerhans histiocytosis skin 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?11/25/11667\" title=\"picture 10\">",
"      Scalp folliculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?20/38/21094\" title=\"picture 11\">",
"      Dissecting cellulitis of the scalp",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?4/5/4181\" title=\"picture 12\">",
"      Dermatomyositis scalp",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/6/29793\" title=\"picture 13A\">",
"      Dermatomyositis - heliotrope eruption",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/10/29860\" title=\"picture 13B\">",
"      Dermatomyositis - heliotrope eruption on eyelid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?12/58/13217\" title=\"picture 13C\">",
"      Dermatomyositis - neck and chest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?13/41/13969\" title=\"picture 13D\">",
"      Dermatomyositis - upper back",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?43/45/44754\" title=\"picture 13E\">",
"      Gottron papules",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?6/48/6915\" title=\"picture 13F\">",
"      Gottron sign",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?23/38/24163\" title=\"picture 14\">",
"      Dermatitis herpetiformis elbows",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/42/28320\" title=\"picture 15A\">",
"      Seborrheic dermatitis face 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?3/14/3301\" title=\"picture 15B\">",
"      Seborrheic dermatitis ear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/51/32566\" title=\"picture 15C\">",
"      Seborrheic dermatitis scalp",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/14/15585\" title=\"picture 15D\">",
"      Infantile seborrheic dermatitis multiple sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/15/40183\" title=\"picture 16\">",
"      Scalp psoriasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/28/33219\" title=\"picture 17A\">",
"      Psoriasis plaque",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/48/31492\" title=\"picture 17B\">",
"      Inverse psoriasis chest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/7/15474\" title=\"picture 17C\">",
"      Nail psoriasis pits",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?32/51/33585\" title=\"picture 17D\">",
"      Nail psoriasis oil drop",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/29/29138\" title=\"picture 17E\">",
"      Nail psoriasis hyperkeratosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?27/50/28453\" title=\"picture 18\">",
"      Herpes zoster ophthalmicus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/14/40166\" title=\"picture 19\">",
"      Discoid LE of the scalp",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?8/11/8372\" title=\"picture 20A\">",
"      Discoid lupus - left ear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/56/16261\" title=\"picture 20B\">",
"      Discoid lupus - right cheek",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/34/9767\" title=\"picture 21\">",
"      Lichen planopilaris",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/35/40502\" title=\"picture 22A\">",
"      Pemphigus vulgaris large erosions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?26/56/27526\" title=\"picture 22B\">",
"      Pemphigus vulgaris bullae and erosions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/48/769\" title=\"picture 22C\">",
"      Pemphigus vulgaris - oral",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/38/26213\" title=\"picture 22D\">",
"      Pemphigus vulgaris oral lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/47/5876\" title=\"picture 23A\">",
"      Brunsting-Perry pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?33/7/33905\" title=\"picture 23B\">",
"      Mucous membrane pemphigoid gingivitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?37/49/38674\" title=\"picture 23C\">",
"      Mucous membrane pemphigoid palate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/12/31937\" title=\"picture 23D\">",
"      Ocular cicatricial pemphigoid stage 3",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/11/22714?source=related_link\">",
"      Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/4/27722?source=related_link\">",
"      Clinical manifestations and diagnosis of adult dermatomyositis and polymyositis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/53/21338?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of Langerhans cell histiocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/14/2278?source=related_link\">",
"      Cradle cap and seborrheic dermatitis in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/34/35369?source=related_link\">",
"      Dermatitis herpetiformis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/51/31543?source=related_link\">",
"      Dermatologic procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/58/7082?source=related_link\">",
"      Dermatophyte (tinea) infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/8/23688?source=related_link\">",
"      Epidemiology and pathogenesis of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/62/27625?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of psoriasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/29/9690?source=related_link\">",
"      Evaluation and diagnosis of hair loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/55/22387?source=related_link\">",
"      Folliculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/27/9656?source=related_link\">",
"      Lichen planus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/33/36378?source=related_link\">",
"      Mucocutaneous manifestations of systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13846?source=related_link\">",
"      Nonscarring hair loss",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/40/3721?source=related_link\">",
"      Overview of dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/20/6474?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/44/19146?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of pemphigus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/15/25849?source=related_link\">",
"      Pediculosis capitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/2/28712?source=related_link\">",
"      Scabies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_28_37319="Diagnosis of acute cellular rejection in liver transplantation";
var content_f36_28_37319=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis of acute cellular rejection in liver transplantation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/28/37319/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37319/contributors\">",
"     K Rajender Reddy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/28/37319/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37319/contributors\">",
"     Robert S Brown, Jr, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/28/37319/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37319/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/28/37319/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite improvements in immunosuppressive therapy, hepatic allograft rejection remains an important cause of morbidity and late graft loss in patients undergoing liver transplantation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/1-6\">",
"     1-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At one end of the spectrum, graft function may remain stable in many patients found to have focal or mild histologic features of rejection on a protocol liver biopsy, even when no treatment is provided [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/7\">",
"     7",
"    </a>",
"    ]. Such lymphocyte trafficking through the allograft has been hypothesized to contribute to the development of a degree of immunological tolerance. On the other hand, approximately 5 to 10 percent of liver transplant recipients who develop acute cellular rejection progress to severe ductopenic rejection despite antirejection therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/8\">",
"     8",
"    </a>",
"    ]. These patients may require retransplantation.",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of acute cellular liver transplant rejection are described below. The treatment of this complication and a review of transplantation immunobiology are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41718?source=see_link\">",
"     \"Treatment of acute cellular rejection in liver transplantation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/27/10682?source=see_link\">",
"     \"Transplantation immunobiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TIMING AND RISK FACTORS FOR REJECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early acute cellular rejection mostly occurs within 90 days of the liver transplantation. Early acute rejection episodes do not adversely affect graft or patient outcomes, except in patients transplanted for hepatitis C virus, who have worse outcomes in the setting of bolus glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Late cellular rejection episodes are often associated with low blood",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    concentrations and have been associated with reduced graft survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/2,12-14\">",
"     2,12-14",
"    </a>",
"    ]. The following examples illustrate the range of findings in the largest series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a cohort of 762 consecutive adult liver transplant recipients, 490 (64 percent) developed at least one episode of rejection, most occurring during the first six weeks after transplantation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/15\">",
"       15",
"      </a>",
"      ]. Approximately 20 percent of these patients developed a second rejection episode within one year of transplantation.",
"     </li>",
"     <li>",
"      In another report, late acute rejection (after more than 180 days) occurred in 97 of 415 patients (23 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/16\">",
"       16",
"      </a>",
"      ]. Most (73 percent) responded to pulse intravenous steroids, while 5 percent were steroid-resistant. Late rejection appeared to be less likely in those who underwent transplantation for a viral etiology.",
"     </li>",
"     <li>",
"      In another series of 717 liver transplant recipients, 7.5 percent had at least one episode of late acute rejection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/8\">",
"       8",
"      </a>",
"      ]. Most occurred within the first year, but some were seen as late as one to six years. Thus, the term \"acute\" seems inappropriate for describing this type of rejection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to low blood levels of immunosuppressive therapy, several other risk factors for acute cellular rejection have been identified. In the study discussed above, independent variables associated with acute cellular rejection within 42 days of transplantation included lower recipient age, fewer HLA-DR matches, cold ischemia time of at least 15 hours, and donor age of at least 30 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/15\">",
"     15",
"    </a>",
"    ]. Some variables associated with early allograft dysfunction have been described as indicators of poor long-term graft and patient survival; these include donors older than 50 years, cold ischemia time greater than 15 hours, donor pre-procurement acidosis, and recipient prothrombin time or bilirubin that remains steadily elevated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A low rate of cellular rejection was observed in patients transplanted for alcoholic liver disease, while patients transplanted for autoimmune diseases had higher rates of rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/9\">",
"     9",
"    </a>",
"    ]. Nutritional status may have a role in the development of acute cellular rejection. In a multivariate analysis of pretransplant patient characteristics, depleted mid-arm muscle circumference was associated with the absence of acute rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/18\">",
"     18",
"    </a>",
"    ]. Cytomegalovirus genotype gB1 infection was associated with an increased rate of acute rejection in another report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/19\">",
"     19",
"    </a>",
"    ]. The identification of additional clinical risk factors may permit a more individualized approach to immunosuppressive therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of clinical signs and symptoms may be observed in patients with rejection, and include fever, malaise, abdominal pain, hepatosplenomegaly, and rarely, increasing ascites. However, none of these is specific for rejection.",
"   </p>",
"   <p>",
"    Acute cellular rejection is generally suspected based upon the development of hepatic biochemical test abnormalities, which may include elevations of some or all of the following: serum aminotransferases, alkaline phosphatase, gamma-glutamyl transpeptidase (GGT), and bilirubin levels. However, these abnormalities are neither sensitive nor specific for distinguishing acute cellular rejection from other causes of hepatic allograft dysfunction and do not correlate with the severity of the rejection episode [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/20-22\">",
"     20-22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Abnormalities in the hepatic biochemical tests in the short-term post-transplant period are frequently a manifestation of preservation injury or acute cellular rejection. Preservation injury usually manifests with elevation of the alkaline phosphatase and GGT, without a significant increase in total bilirubin. By contrast, elevation of transaminases (alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) together with rising bilirubin level",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    GGT should raise concern for acute cellular rejection.",
"   </p>",
"   <p>",
"    Because of the limitations of hepatic biochemical tests alone as indicators of acute cellular rejection, other biochemical tests have been evaluated in an attempt to diagnose liver allograft rejection without the need for liver biopsy. Serum concentrations of soluble interleukin-2 receptor, soluble CD8, and soluble intercellular adhesion molecules have been suggested as indicators of hepatic allograft rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. However, there appears to be considerable overlap in the results of these tests with post-transplant CMV hepatitis. Other markers that have been studied to diagnose rejection include beta-2-microglobulin in serum and bile, tumor necrosis factor-alpha in serum, tissue and blood eosinophilia, and interleukin-6 in bile [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/26-29\">",
"     26-29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    More recent novel approaches to the non-histologic diagnosis of acute cellular rejection have included measurement of alanine aminopeptidase N (APN) in bile [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/30\">",
"     30",
"    </a>",
"    ], specific transcriptome patterns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/31\">",
"     31",
"    </a>",
"    ], and pattern of serum proteomic profile wherein complement component 4 (C4) and ALT were highly predictive of acute cellular rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/32\">",
"     32",
"    </a>",
"    ]. In addition, hepatocyte derived microRNAs (HDmiRs, mir-122, miR-148a) have been evaluated as markers of acute cellular rejection. HDmiRs were elevated up to 20-fold during an episode of acute cellular rejection compared with levels six months after resolution of the episode. Further, miR-122 levels rose earlier than aminotransferases during the event of rejection, suggesting a role for such biomarkers in the earlier diagnosis of rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/33\">",
"     33",
"    </a>",
"    ]. However, it must be emphasized that these markers are still investigational, are not widely available, and are nonspecific, so liver histology is still required to establish the diagnosis of acute cellular rejection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     LIVER BIOPSY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver histology remains the gold standard for the diagnosis of acute cellular rejection. Despite its utility, liver biopsy carries a small risk of complications in liver transplant recipients. One study found a 1.8 percent rate of significant complications after each biopsy in this setting, including an increased rate of sepsis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/34\">",
"     34",
"    </a>",
"    ]. In another report, infectious complications of liver biopsy were associated with the presence of biliary strictures and biliary anastomosis by choledochojejunostomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are three major histologic features associated with cellular rejection (",
"    <a class=\"graphic graphic_picture graphicRef80063 graphicRef60368 graphicRef79840 \" href=\"mobipreview.htm?40/24/41354\">",
"     picture 1A-C",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A mixed inflammatory infiltrate in the portal triad",
"     </li>",
"     <li>",
"      Destructive or nondestructive nonsuppurative cholangitis involving interlobular bile duct epithelium",
"     </li>",
"     <li>",
"      Endotheliitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The adequacy of any particular biopsy is ultimately left to the judgment of the pathologist. An international consensus document recommended examination of at least two hematoxylin and eosin stained sections from at least two different levels of a core needle biopsy containing at least five portal triads [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The portal tract infiltrate is predominantly mononuclear but may also contain neutrophils and eosinophils. Some investigators have stressed the relative importance of eosinophils [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/39,40\">",
"       39,40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nonsuppurative cholangitis may be destructive or nondestructive, and this feature is important for the prognosis of rejection. The affected ducts are surrounded by immunocytes, which may also be found between epithelial cells, inside the basement membrane, or even in the lumen. Neutrophils may be part of the rejection process but have to be distinguished from the suppurative cholangitis seen in ascending infections. The clinical and radiologic features should distinguish nonsuppurative from suppurative cholangitis.",
"     </li>",
"     <li>",
"      Endotheliitis or phlebitis (venulitis) is diagnostically the",
"      <strong>",
"       most reliable",
"      </strong>",
"      sign of rejection in the appropriate clinical setting. However, it can be fleeting, particularly after the administration of steroid boluses. This lesion is characterized by the attachment of lymphocytes and other immunocytes to the luminal surface of the endothelium. The inflammatory process may affect only a small segment of the cross-section of the vessel. Lymphocytes also aggregate under the damaged endothelium, which is then lifted from the basement membrane.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Acute cellular rejection may also be associated with inflammatory infiltrates (mostly T-cells) in sinusoids, hepatocanalicular cholestasis, and apoptosis. Centrilobular necrosis is considered a marker of severe rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/41\">",
"     41",
"    </a>",
"    ]. More recent immunohistochemical observations suggest that antibody-mediated rejection is associated with positive C4d staining in those with acute cellular rejection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/42,43\">",
"     42,43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a conference held in Banff, Canada in the summer of 1995, a panel of experts in liver transplantation convened for the purpose of developing a consensus system for the grading of acute liver allograft rejection that was scientifically correct, simple, reproducible, and clinically useful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/36\">",
"     36",
"    </a>",
"    ]. The panel agreed on a common nomenclature, a set of histopathologic criteria for grading acute rejection, and a preferred method of reporting. After the global assessment of rejection, three specific features (portal inflammation, bile duct inflammation, and venular inflammation) are more critically evaluated and scored on a scale of 0 to 3.",
"   </p>",
"   <p>",
"    The three scores are added to arrive at a final rejection activity index (RAI) (",
"    <a class=\"graphic graphic_table graphicRef74243 \" href=\"mobipreview.htm?17/43/18108\">",
"     table 1",
"    </a>",
"    ), similar to the scoring system developed for chronic hepatitis. Although there is no clear-cut consensus, an RAI of &le;4 is considered mild acute rejection. While the Banff schema provides an indicator of the presence and severity of acute cellular rejection, a large retrospective analysis found that the RAI score did not correlate with response to corticosteroids or graft survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of liver transplant dysfunction depends in part upon the time at which it occurs. Within the first few days after transplantation, abnormal liver tests may reflect technical or functional problems, such as hepatic artery thrombosis, preservation injury, biliary anastomosis leakage or stenosis, primary graft nonfunction, or even consequences of shock and septicemia. Although many of these problems may be evident clinically or on studies such as Doppler ultrasonography, the biopsy findings may sometimes be the first evidence of a problem.",
"   </p>",
"   <p>",
"    We routinely obtain both a Doppler ultrasound and a liver biopsy on the same day when a transplant recipient presents with hepatic dysfunction. There are no universal data on the relative frequency of the different causes of hepatic dysfunction at different times and there may be an important center-specific component. As an example, centers that routinely accept older donor organs tend to see an increased incidence of functional cholestasis.",
"   </p>",
"   <p>",
"    Other causes of liver allograft dysfunction include cytomegalovirus (CMV) and Epstein-Barr virus infections, recurrent hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, drug-induced liver injury, functional cholestasis, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    toxicity (",
"    <a class=\"graphic graphic_figure graphicRef83412 \" href=\"mobipreview.htm?12/37/12894\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Recurrent hepatitis C virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;HCV infection almost always recurs in the graft [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16474?source=see_link\">",
"     \"Liver transplantation for hepatitis C virus infection\"",
"    </a>",
"    .) Acute cellular rejection can be difficult to distinguish from recurrent HCV due to overlapping histologic features [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. Both conditions are associated with bile duct injury and portal lymphocytic infiltration. The finding of endotheliitis is more consistent with cellular rejection, whereas lobular hepatitis suggests recurrent HCV. The input of an experienced pathologist is critical in order to avoid an unnecessary increase in immunosuppression. In a small study of HCV infected transplant recipients, intrahepatic gene expression determined by microarray differed between patients with histologic evidence of cellular rejection and those with recurrent HCV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Functional cholestasis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Functional cholestasis is a unique entity that typically occurs in the early post-transplant period. This form of cholestasis is independent of rejection, parenteral nutrition, or the use of specific drugs. Subcellular organelle damage produced by cold ischemia may play an etiologic role, leading to bile flow dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/50\">",
"     50",
"    </a>",
"    ]. Liver histology shows cholestasis in zones 2 and 3 and may be associated with ballooning of the hepatocytes in these areas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Cyclosporine toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     Cyclosporine",
"    </a>",
"    toxicity is an occasional cause of hepatic allograft dysfunction. It should be suspected when abnormal liver tests are seen in conjunction with otherwise unexplained elevations in serum creatinine. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=see_link\">",
"     \"Cyclosporine and tacrolimus nephrotoxicity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Massive hemorrhagic necrosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;A rare complication after liver transplantation is acute graft necrosis and failure in the absence of vascular obstruction. Histologic features include widespread hemorrhage and infarction. This syndrome has been described as massive hemorrhagic necrosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Alloimmune hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another immunologic event that can occur after liver transplantation is massive hemolysis with a graft that is ABO-compatible but nonidentical. In this situation, the recipient might be blood group A, B, or AB. Implantation of a blood group O liver in blood group A or B recipients or a blood group A, B, or even O liver in blood group AB recipients leads to antibody production against the A",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    B antigens on the host red cells. This is followed by massive hemolysis with a rapid fall in hemoglobin and a rapid rise in serum bilirubin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37319/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. This phenomenon occurs around the 7th to the 10th postoperative day and is usually self-limited. Knowledge about the graft and recipient blood groups should enable a correct and early diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     APPROACH TO THE PATIENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient with hepatic allograft dysfunction often presents with liver test abnormalities. In this setting, ultrasonography should be performed to assess hepatic artery and portal vein blood flow, and to detect biliary tract abnormalities. Blood tests for CMV antigen, hepatitis B surface antigen, HBV DNA, HCV RNA, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    concentration should be obtained. If biliary tract abnormalities are found or suspected because of a history of biliary tract problems, magnetic resonance cholangiopancreatography, endoscopic retrograde cholangiopancreatography, or percutaneous transhepatic cholangiography should be performed; otherwise, one should proceed to a liver biopsy to assess graft abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/51/826?source=see_link\">",
"     \"The role of endoscopy in biliary complications after liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are limited data to support screening liver biopsies in patients who have normal liver tests. However, protocol biopsies are performed at arbitrary intervals at some centers.",
"   </p>",
"   <p>",
"    A final caveat is that most of the disorders post-transplant patients are susceptible to are not mutually exclusive. The liver biopsy, for example, may show evidence of coexisting disorders; furthermore, treatments for these disorders may be directly contradictory. In this setting, treatment is usually aimed at the disorder thought to be most important; the patient is then carefully monitored to assess the response.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H65599053\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Despite improvements in immunosuppressive therapy, hepatic allograft rejection remains an important cause of morbidity and late graft loss in patients undergoing liver transplantation. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early acute cellular rejection mostly occurs within 90 days of the liver transplantation. Early acute rejection episodes do not adversely affect graft or patient outcomes, except in patients transplanted for hepatitis C virus, who have worse outcomes in the setting of bolus glucocorticoid therapy. Late cellular rejection episodes are often associated with low blood",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      concentrations and have been associated with reduced graft survival. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Timing and risk factors for rejection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Acute cellular rejection is generally suspected based upon the development of hepatic biochemical test abnormalities, which may include elevations of some or all of the following: serum aminotransferases, alkaline phosphatase, gamma-glutamyl transpeptidase, and bilirubin levels. However, liver histology is required to establish the diagnosis of acute cellular rejection. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are three major histologic features associated with cellular rejection (",
"      <a class=\"graphic graphic_picture graphicRef80063 graphicRef60368 graphicRef79840 \" href=\"mobipreview.htm?40/24/41354\">",
"       picture 1A-C",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Liver biopsy'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      A mixed inflammatory infiltrate in the portal triad",
"     </li>",
"     <li>",
"      Destructive or nondestructive nonsuppurative cholangitis involving interlobular bile duct epithelium",
"     </li>",
"     <li>",
"      Endotheliitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The differential diagnosis of liver transplant dysfunction depends in part upon the time at which it occurs. Within the first few days after transplantation, abnormal liver tests may reflect technical or functional problems, such as hepatic artery thrombosis, preservation injury, biliary anastomosis leakage or stenosis, primary graft nonfunction, or even consequences of shock and septicemia. Other causes of liver allograft dysfunction that may be seen later include cytomegalovirus and Epstein-Barr virus infections, recurrent hepatitis B virus or hepatitis C virus infection, functional cholestasis, and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      toxicity (",
"      <a class=\"graphic graphic_figure graphicRef83412 \" href=\"mobipreview.htm?12/37/12894\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of acute cellular rejection in liver transplantation is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41718?source=see_link\">",
"       \"Treatment of acute cellular rejection in liver transplantation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H560146094\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and UpToDate would like to thank Dr. Scott Cotler, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/1\">",
"      Wiesner RH, Ludwig J, van Hoek B, Krom RA. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure. Hepatology 1991; 14:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/2\">",
"      Klintmalm GB, Nery JR, Husberg BS, et al. Rejection in liver transplantation. Hepatology 1989; 10:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/3\">",
"      Emond JC, Thistlethwaite JR, Baker AL. Rejection in liver allograft recipients: Clinical characterization and management. Clin Transpl 1987; 1:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/4\">",
"      Ascher NL, Stock PG, Bumgardner GL, et al. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet 1988; 167:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/5\">",
"      Oguma S, Belle S, Starzl TE, Demetris AJ. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology 1989; 9:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/6\">",
"      Krom RA, Wiesner RH, Rettke SR, et al. The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc 1989; 64:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/7\">",
"      McVicar JP, Kowdley KV, Bacchi CE, et al. The natural history of untreated focal allograft rejection in liver transplant recipients. Liver Transpl Surg 1996; 2:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/8\">",
"      Soin AS, Rasmussen A, Jamieson NV, et al. CsA levels in the early posttransplant period--predictive of chronic rejection in liver transplantation? Transplantation 1995; 59:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/9\">",
"      Neuberger J, Adams DH. What is the significance of acute liver allograft rejection? J Hepatol 1998; 29:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/10\">",
"      Dousset B, Conti F, Cherruau B, et al. Is acute rejection deleterious to long-term liver allograft function? J Hepatol 1998; 29:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/11\">",
"      Samonakis DN, Germani G, Burroughs AK. Immunosuppression and HCV recurrence after liver transplantation. J Hepatol 2012; 56:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/12\">",
"      Adams DH, Neuberger JM. Patterns of graft rejection following liver transplantation. J Hepatol 1990; 10:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/13\">",
"      Mor E, Gonwa TA, Husberg BS, et al. Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. Transplantation 1992; 54:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/14\">",
"      Anand AC, Hubscher SG, Gunson BK, et al. Timing, significance, and prognosis of late acute liver allograft rejection. Transplantation 1995; 60:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/15\">",
"      Wiesner RH, Demetris AJ, Belle SH, et al. Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome. Hepatology 1998; 28:638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/16\">",
"      Ramji A, Yoshida EM, Bain VG, et al. Late acute rejection after liver transplantation: the Western Canada experience. Liver Transpl 2002; 8:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/17\">",
"      Bennett-Guerrero E, Feierman DE, Barclay GR, et al. Preoperative and intraoperative predictors of postoperative morbidity, poor graft function, and early rejection in 190 patients undergoing liver transplantation. Arch Surg 2001; 136:1177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/18\">",
"      Bathgate AJ, Hynd P, Sommerville D, Hayes PC. The prediction of acute cellular rejection in orthotopic liver transplantation. Liver Transpl Surg 1999; 5:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/19\">",
"      Rosen HR, Corless CL, Rabkin J, Chou S. Association of cytomegalovirus genotype with graft rejection after liver transplantation. Transplantation 1998; 66:1627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/20\">",
"      Abraham SC, Furth EE. Receiver operating characteristic analysis of serum chemical parameters as tests of liver transplant rejection and correlation with histology. Transplantation 1995; 59:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/21\">",
"      Williams JW, Peters TG, Vera SR, et al. Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation 1985; 39:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/22\">",
"      Henley KS, Lucey MR, Appelman HD, et al. Biochemical and histopathological correlation in liver transplant: the first 180 days. Hepatology 1992; 16:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/23\">",
"      Adams DH, Wang L, Hubscher SG, et al. Soluble interleukin-2 receptors in serum and bile of liver transplant recipients. Lancet 1989; 1:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/24\">",
"      Perkins JD, Nelson DL, Rakela J, et al. Soluble interleukin-2 receptor level as an indicator of liver allograft rejection. Transplantation 1989; 47:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/25\">",
"      Adams DH, Mainolfi E, Elias E, et al. Detection of circulating intercellular adhesion molecule-1 after liver transplantation--evidence of local release within the liver during graft rejection. Transplantation 1993; 55:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/26\">",
"      Adams DH, Burnett D, Stockley RA, et al. Biliary beta 2-microglobulin in liver allograft rejection. Hepatology 1988; 8:1565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/27\">",
"      Foster PF, Sankary HN, Hart M, et al. Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation 1989; 47:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/28\">",
"      Hoffmann MW, Wonigeit K, Steinhoff G, et al. Tumor necrosis factor alpha and interleukin-1 beta in rejecting human liver grafts. Transplant Proc 1991; 23:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/29\">",
"      Umeshita K, Monden M, Tono T, et al. Determination of the presence of interleukin-6 in bile after orthotopic liver transplantation. Its role in the diagnosis of acute rejection. Ann Surg 1996; 223:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/30\">",
"      Kim C, Aono S, Marubashi S, et al. Significance of Alanine Aminopeptidase N (APN) in Bile in the Diagnosis of Acute Cellular Rejection After Liver Transplantation. J Surg Res 2011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/31\">",
"      Asaoka T, Kato T, Marubashi S, et al. Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation. Liver Transpl 2009; 15:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/32\">",
"      Massoud O, Heimbach J, Viker K, et al. Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay. Liver Transpl 2011; 17:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/33\">",
"      Farid WR, Pan Q, van der Meer AJ, et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation. Liver Transpl 2012; 18:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/34\">",
"      Bubak ME, Porayko MK, Krom RA, Wiesner RH. Complications of liver biopsy in liver transplant patients: increased sepsis associated with choledochojejunostomy. Hepatology 1991; 14:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/35\">",
"      Larson AM, Chan GC, Wartelle CF, et al. Infection complicating percutaneous liver biopsy in liver transplant recipients. Hepatology 1997; 26:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/36\">",
"      Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/37\">",
"      Snover DC, Freese DK, Sharp HL, et al. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol 1987; 11:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/38\">",
"      Demetris AJ, Qian SG, Sun H, Fung JJ. Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol 1990; 14 Suppl 1:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/39\">",
"      Foster PF, Sankary HN, Williams JW, et al. Morphometric inflammatory cell analysis of human liver allograft biopsies. Transplantation 1991; 51:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/40\">",
"      Foster PF, Bhattacharyya A, Sankary HN, et al. Eosinophil cationic protein's role in human hepatic allograft rejection. Hepatology 1991; 13:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/41\">",
"      Ludwig J, Gross JB Jr, Perkins JD, Moore SB. Persistent centrilobular necroses in hepatic allografts. Hum Pathol 1990; 21:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/42\">",
"      Bellamy CO, Herriot MM, Harrison DJ, Bathgate AJ. C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology 2007; 50:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/43\">",
"      Wilson CH, Agarwal K, Carter V, et al. Late humoral rejection in a compliant ABO-compatible liver transplant recipient. Transplantation 2006; 82:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/44\">",
"      H&ouml;roldt BS, Burattin M, Gunson BK, et al. Does the Banff rejection activity index predict outcome in patients with early acute cellular rejection following liver transplantation? Liver Transpl 2006; 12:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/45\">",
"      Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/46\">",
"      Ferrell LD, Wright TL, Roberts J, et al. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992; 16:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/47\">",
"      Petrovic LM, Villamil FG, Vierling JM, et al. Comparison of histopathology in acute allograft rejection and recurrent hepatitis C infection after liver transplantation. Liver Transpl Surg 1997; 3:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/48\">",
"      Regev A, Molina E, Moura R, et al. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl 2004; 10:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/49\">",
"      Sreekumar R, Rasmussen DL, Wiesner RH, Charlton MR. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation. Liver Transpl 2002; 8:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/50\">",
"      Williams JW, Vera S, Peters TG, et al. Cholestatic jaundice after hepatic transplantation. A nonimmunologically mediated event. Am J Surg 1986; 151:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/51\">",
"      Goldstein NS, Hart J, Lewin KJ. Diffuse hepatocyte ballooning in liver biopsies from orthotopic liver transplant patients. Histopathology 1991; 18:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/52\">",
"      H&uuml;bscher SG, Adams DH, Buckels JA, et al. Massive haemorrhagic necrosis of the liver after liver transplantation. J Clin Pathol 1989; 42:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/53\">",
"      Oda T, Yamashi S, Ohoka H, et al. A case of hemolytic anemia resulting from autoantibody in renal transplantation &mdash; study of autoanti-A or autoanti-B. Transplant Proc 1985; 17:2294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37319/abstract/54\">",
"      Jenkins RL, Georgi BA, Gallik-Karlson CA, et al. ABO mismatch and liver transplantation. Transplant Proc 1987; 19:4580.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4587 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-E2FE460E4C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37319=[""].join("\n");
var outline_f36_28_37319=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H65599053\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TIMING AND RISK FACTORS FOR REJECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      LIVER BIOPSY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Recurrent hepatitis C virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Functional cholestasis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Cyclosporine toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Massive hemorrhagic necrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Alloimmune hemolysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      APPROACH TO THE PATIENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H65599053\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H560146094\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4587\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4587|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/37/12894\" title=\"figure 1\">",
"      Causes of liver allograft dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4587|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?10/60/11206\" title=\"picture 1A\">",
"      Acute liver TPL rejection I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?9/38/9831\" title=\"picture 1B\">",
"      Acute liver TPL rejection II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/27/30135\" title=\"picture 1C\">",
"      Endotheliitis liver TPL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4587|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/43/18108\" title=\"table 1\">",
"      Liver transplant RAI",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/5/16474?source=related_link\">",
"      Liver transplantation for hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/51/826?source=related_link\">",
"      The role of endoscopy in biliary complications after liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/27/10682?source=related_link\">",
"      Transplantation immunobiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/47/41718?source=related_link\">",
"      Treatment of acute cellular rejection in liver transplantation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_28_37320="Summary of the healing process";
var content_f36_28_37320=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F53467&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F53467&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Summary of the healing process",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 318px; height: 656px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Summary of the healing process. Intermediate phase of the repair reaction.",
"    <br>",
"     (A) As a new extracellular matrix is deposited at the wound site, the initial fibrin clot is lysed by a combination of extracellular proteolytic enzymes and phagocytosis.",
"     <br>",
"      (B) Concurrent with fibrin removal, there is deposition of a temporary matrix formed by proteoglycans, glycoproteins, and type III collagen.",
"      <br>",
"       (C) Final phase of the repair reaction. Eventually the temporary matrix is removed by a combination of extracellular and intracellular digestion, and the definitive matrix, rich in type I collagen, is deposited.",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"        Reproduced with permission from: Rubin E, Farber JL. Pathology, 3rd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 1999. Copyright &copy; 1999 Lippincott Williams &amp; Wilkins.",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37320=[""].join("\n");
var outline_f36_28_37320=null;
var title_f36_28_37321="Management of diabetic foot lesions";
var content_f36_28_37321=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of diabetic foot lesions",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/28/37321/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37321/contributors\">",
"     David K McCulloch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37321/contributors\">",
"     Richard J de Asla, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/28/37321/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37321/contributors\">",
"     John F Eidt, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37321/contributors\">",
"     Joseph L Mills, Sr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37321/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?36/28/37321/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?36/28/37321/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?36/28/37321/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 27, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lifetime risk of a foot ulcer for patients with diabetes (type 1 or 2) may be as high as 25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Diabetic foot ulcers are a major cause of morbidity and mortality, accounting for approximately two-thirds of all nontraumatic amputations performed in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. This observation illustrates the importance of prompt treatment of foot ulcers in patients with diabetes. The management of diabetic foot lesions is provided here. Evaluation and prevention of foot ulcers and the treatment of diabetes-related foot infections (cellulitis and osteomyelitis) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11464?source=see_link\">",
"     \"Evaluation of the diabetic foot\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/33/538?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     WOUND CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in managing diabetic foot ulcers is classifying the wound. Classification is based upon clinical evaluation of the extent of the lesion and, in some classification systems, an assessment of the vascular status of the foot. The intensity and duration of treatment can be determined after clinical evaluation of the ulcer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11464?source=see_link&amp;anchor=H13#H13\">",
"     \"Evaluation of the diabetic foot\", section on 'Wound evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A widely used classification of diabetic foot ulcers is that proposed by Wagner [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Grade 0 &ndash; No ulcer in a high-risk foot",
"     </li>",
"     <li>",
"      Grade 1 &ndash; Superficial ulcer involving the full skin thickness but not underlying tissues (",
"      <a class=\"graphic graphic_picture graphicRef70998 \" href=\"mobipreview.htm?25/57/26512\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Grade 2 &ndash; Deep ulcer, penetrating down to ligaments and muscle, but no bone involvement or abscess formation (",
"      <a class=\"graphic graphic_picture graphicRef51991 \" href=\"mobipreview.htm?36/47/37631\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Grade 3 &ndash; Deep ulcer with cellulitis or abscess formation, often with osteomyelitis (",
"      <a class=\"graphic graphic_picture graphicRef71315 \" href=\"mobipreview.htm?29/9/29842\">",
"       picture 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Grade 4 &ndash; Localized gangrene (",
"      <a class=\"graphic graphic_picture graphicRef63780 \" href=\"mobipreview.htm?22/42/23200\">",
"       picture 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Grade 5 &ndash; Extensive gangrene involving the whole foot",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Wagner classification is based upon clinical evaluation (depth of ulcer and presence of necrosis) alone and does not account for the vascular status of the foot. A modified system that is frequently used by orthopedic surgeons individually scores the components of wound depth and ischemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/7\">",
"     7",
"    </a>",
"    ]. Other ulcer classification systems have also been published [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/8-11\">",
"     8-11",
"    </a>",
"    ]. The International Working Group on the Diabetic Foot proposed classifying all ulcers according to the following categories: perfusion, extent, depth, infection, and sensation (PEDIS) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/12\">",
"     12",
"    </a>",
"    ]. The PEDIS system is primarily used for research purposes.",
"   </p>",
"   <p>",
"    The usual approach to the management of lesions of each Wagner grade is given below, followed by a discussion of some newer approaches.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     GRADE 0 LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Counseling regarding preventive foot care should be given to any patient whose feet are at high risk, particularly patients with existing neuropathy. There are several measures that can markedly diminish ulcer formation, such as avoiding poorly fitting shoes, walking barefoot, and smoking. This topic is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11464?source=see_link&amp;anchor=H18#H18\">",
"     \"Evaluation of the diabetic foot\", section on 'Preventive foot care'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     GRADE 1 AND 2 LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extensive debridement, good local wound care, relief of pressure on the ulcer, and control of infection (when present) are believed to be important components of therapy for grade 1 and 2 foot ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/9,13,14\">",
"     9,13,14",
"    </a>",
"    ]. There are limited data evaluating the efficacy of this standard approach, particularly the benefits of debridement and local wound care. In a meta-analysis of the control groups from 10 trials (622 patients) evaluating standard treatment (debridement and local wound care) versus various new therapies, 24 and 31 percent of ulcers healed after 12 and 20 weeks, respectively, of standard treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In clinical practice, measurements of a patient's ulcer size should be taken at every office visit so that comparisons can be made and progress documented. The surface area of a healthy diabetic foot ulcer should decrease in size at a rate of approximately one percent a day. Ulcers that do not improve should be evaluated for ongoing soft tissue infection or osteomyelitis requiring antibiotics, insufficient vascular flow, or most commonly, the need for more effective off-loading. (See",
"    <a class=\"local\" href=\"#H13\">",
"     'Assessment for peripheral artery disease'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H14\">",
"     'Assess for osteomyelitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Method of debridement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Debridement of necrotic tissue is important for ulcer healing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/16\">",
"     16",
"    </a>",
"    ], although there are few trials comparing the different methods of debridement (sharp, enzymatic, autolytic, mechanical, and biological). The types of debridement are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37064?source=see_link&amp;anchor=H17#H17\">",
"     \"Treatment of pressure ulcers\", section on 'Debridement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sharp debridement involves the use of a scalpel or scissors to remove necrotic tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/17\">",
"     17",
"    </a>",
"    ]. It is the most widely used method except in certain settings, such as highly vascular ulcers or when there is significant vascular compromise such that concerns exist as to the patient's ability to heal any new wounds created by sharp debridement. In such settings, enzymatic debridement (topical application of proteolytic enzymes such as collagenase) may be preferable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/8\">",
"     8",
"    </a>",
"    ]. Autolytic debridement, using a semiocclusive or occlusive (hydrogel) dressing to cover a wound so that necrotic tissue is digested by enzymes normally present in wound tissue, may be a good option in patients with painful ulcers.",
"   </p>",
"   <p>",
"    In a systematic review of six small randomized trials, hydrogels were significantly more effective than wet to moist saline or dry gauze in healing foot ulcers in diabetic patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/18\">",
"     18",
"    </a>",
"    ]. However, a hydrogel combined with good wound care (defined as sharp debridement, saline dressings, pressure relief, and control of infection) was not significantly better than good wound care alone. Larval therapy (a form of biological debridement) showed no significant benefit in small studies. Overall, the review was limited by the small number of trials and poor methodological quality.",
"   </p>",
"   <p>",
"    Thus, there are few data to guide choice of debridement. When surgeons with expertise in sharp debridement are available, we prefer this method. As an alternative, we suggest application of a hydrogel since limited data support its efficacy in promoting ulcer healing. For patients with evidence of arterial insufficiency, we suggest referral to a vascular specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Infection control",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of infection is clinical and is likely to be present if the ulcer contains obvious purulent material or there is redness, swelling or warmth around the ulcer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/19\">",
"     19",
"    </a>",
"    ]. Cultures of the ulcer base are taken after debridement and prior to initiation of empiric antibiotic therapy. Tissue samples taken by curettage, rather than wound swab or irrigation, are preferable because they provide more accurate results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/20\">",
"     20",
"    </a>",
"    ]. The most common infecting organisms are aerobic gram-positive cocci. Other frequent pathogens are aerobic gram-negative bacilli and anaerobes, usually as a second organism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, the limited data on antibiotic therapy of diabetic foot infections lack standardization to allow comparison of outcomes of different regimens. On the basis of the available studies, no single drug or combination appears to be superior to others. Empiric antibiotic therapy should cover gram-positive cocci (",
"    <a class=\"graphic graphic_table graphicRef69671 \" href=\"mobipreview.htm?17/35/17981\">",
"     table 1",
"    </a>",
"    ). Subsequent antibiotic therapy should be tailored to culture and susceptibility results. It is not always necessary to cover all microorganisms isolated from cultures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/33/538?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities\", section on 'Antimicrobial therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Local wound care",
"    </span>",
"    &nbsp;&mdash;&nbsp;After debridement, ulcers should be kept clean and moist but free of excess fluids. Moisture accelerates tissue healing. Dressings should be selected based upon wound characteristics, such as the extent of exudate, desiccation, or necrotic tissue. &nbsp;",
"   </p>",
"   <p>",
"    Some dressings simply provide protection, whereas others promote wound hydration or prevent excessive moisture. Wet-to-dry saline dressings are frequently used, but some ulcers may require a moister environment. In addition, wet-to-dry dressings will remove both nonviable and viable tissues. Thus, caution is required to avoid damaging healthy tissue.",
"   </p>",
"   <p>",
"    Some dressings are impregnated with antimicrobial agents to prevent infection and enhance ulcer healing. However, there are no clinical trial data to support their effectiveness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37064?source=see_link&amp;anchor=H14#H14\">",
"     \"Treatment of pressure ulcers\", section on 'Dressing choices'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mechanical off-loading",
"    </span>",
"    &nbsp;&mdash;&nbsp;Off-loading devices, including total contact casts, cast walkers, shoe modifications and other devices to assist in ambulation are available to reduce or eliminate pressure in the region of the ulcer, which is important for healing. The evidence supports the use of total contact casts and nonremovable cast walkers for relief of pressure associated with diabetic ulcer healing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/23\">",
"     23",
"    </a>",
"    ]. A 2000 Cochrane database review updated in 2013 evaluated 14 trials comparing various forms of pressure-relieving treatments (nonremovable, removable) and dressings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. In five trials, the likelihood of wound healing was significantly better at 12 weeks for nonremovable, pressure-relieving casts compared with removable devices or dressings (relative risk [RR] 1.17, 95% CI 1.01-1.36). In one trial, no significant differences were found between different types of nonremovable pressure-relieving treatments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Total contact cast",
"    </span>",
"    &nbsp;&mdash;&nbsp;A total contact cast is a padded fiberglass shell designed to take pressure off the heel or elsewhere on the foot by averaging the pressure across the sole of the foot (ie, eliminates high and low pressure regions by providing contact at all points) or to generally un-weight the entire foot through a total contact fit at the calf. The most aggressive unloading is achieved by making the patient non-weight-bearing. Disadvantages of total contact casting include expertise needed in applying the cast, inability to inspect the wound frequently, inconvenience in activities of daily living (eg, bathing), and the risk of developing a secondary ulcer in an ill-fitting cast (particularly in patients with neuropathy) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/9\">",
"     9",
"    </a>",
"    ]. Frequent cast changes may be needed to avoid complications.",
"   </p>",
"   <p>",
"    Based upon randomized trials, total contact casting enhances diabetic ulcer healing and is the standard for relieving pressure from the forefoot [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/24-32\">",
"     24-32",
"    </a>",
"    ]. As an example, in a trial of off-loading modalities in 63 diabetic patients with superficial, noninfected, nonischemic plantar ulcers, the proportion of ulcers that were healed at 12 weeks was significantly higher in those randomly assigned to a total contact cast compared with a half-shoe or removable cast walker (90 versus 58 and 65 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/29\">",
"     29",
"    </a>",
"    ]. Patients with a total contact cast also had faster wound healing. Another small trial found that a casting combined with Achilles tendon lengthening resulted in significantly fewer ulcer recurrences at seven months (15 verus 59 percent) and two years (38 versus 81 percent) compared with the casting alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Total contact casts should",
"    <strong>",
"     not",
"    </strong>",
"    be used in patients with infected wounds, osteomyelitis, peripheral ischemia, bilateral ulceration, lower extremity amputation or heel ulceration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1273196\">",
"    <span class=\"h3\">",
"     Cast walkers",
"    </span>",
"    &nbsp;&mdash;&nbsp;An alternative to total contact casting is a prefabricated brace called a cast walker that is designed to maintain a total contact fit (",
"    <a class=\"graphic graphic_figure graphicRef64409 \" href=\"mobipreview.htm?39/47/40688\">",
"     figure 1",
"    </a>",
"    ). Several cast walkers (non-removable, removable) are commercially available and provide capability to off-load the foot similar to contact casts. Cast walkers also appear to facilitate wound healing, but a significant disadvantage is poor patient compliance if the cast walker is removed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cast walkers appear to have a similar ability to off-load the foot compared with total contact casting.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study compared plantar foot pressure metrics in a standard shoe, total contact cast and prefabricated pneumatic walking brace [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/36\">",
"       36",
"      </a>",
"      ]. Five plantar foot sensors were placed at the first, third, and fifth metatarsal heads, fifth metatarsal base, and mid-plantar heel of 10 healthy male subjects who walked at a constant speed over a distance of 280 meters. Peak pressures were significantly reduced in the pneumatic walking brace compared with the standard shoe for all sensor locations to an equal or greater degree compared with the total contact cast in all sensor locations.",
"     </li>",
"     <li>",
"      Another study measured foot pressures using an in-shoe pressure measurement system (Novel Pedar&reg;) in 18 healthy subjects while wearing a cast walker or total contact cast [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/37\">",
"       37",
"      </a>",
"      ]. Peak foot pressures using the cast walker were significantly reduced in the forefoot (12 versus 18",
"      <span class=\"nowrap\">",
"       N/cm",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      and foot as a whole (14 versus 19",
"      <span class=\"nowrap\">",
"       N/cm",
"       <sup>",
"        2",
"       </sup>",
"       )",
"      </span>",
"      compared with a fiberglass total contact cast, but no differences were found for the heel or midfoot.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These studies suggest these prefabricated products are at least as good as total contact casting for off-loading the foot and equalizing foot pressures when the foot anatomy is normal, but data are not available demonstrating these effects for patients with diabetic foot deformities.",
"   </p>",
"   <p>",
"    Cast walkers have been used for the treatment of neuropathic plantar ulcers but these devices, thus far, have not been found to be superior to total contact casting in randomized trials. In one trial, the rate of ulcer healing was significantly higher in those randomly assigned to total contact casting compared with a half-shoe or removable cast walker [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/29\">",
"     29",
"    </a>",
"    ]. Another trial that randomly assigned 48 patients to total contact casting or a removable cast walker (ie, Stabil-D&reg;), found no difference in the number of days to achieve healing (35 versus 39 days) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1140745573\">",
"    <span class=\"h3\">",
"     Therapeutic shoes",
"    </span>",
"    &nbsp;&mdash;&nbsp;After healing of the ulcer is achieved, extra-depth and -width shoes with orthotic inserts are often prescribed to prevent recurrent ulceration [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/24\">",
"     24",
"    </a>",
"    ]. However, in one trial, 400 diabetic patients with a history of foot ulcer were randomly assigned to wear therapeutic shoes or their usual footwear for two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/39\">",
"     39",
"    </a>",
"    ]. The risk of re-ulceration was not found to be different between the groups. Non-prescription rocker sole shoes (",
"    <a class=\"graphic graphic_figure graphicRef86276 \" href=\"mobipreview.htm?41/15/42238\">",
"     figure 2",
"    </a>",
"    ) may also offload the foot [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. In a non-randomized prospective study of 92 patients with healed diabetic foot ulcers, the first-year annual rate of foot ulcer relapse was significantly lower in patients who used stock diabetic shoes (rocker sole) compared with those who wore their usual footwear (15 versus 60 versus percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/41\">",
"     41",
"    </a>",
"    ]. In the United States, reimbursement from insurance carriers can be expected for at least one pair of shoes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    shoe inserts, provided the design of the",
"    <span class=\"nowrap\">",
"     shoe/insert",
"    </span>",
"    meets qualifying guidelines.",
"   </p>",
"   <p>",
"    Wedge shoes (eg, Darco International), also called half shoes, are available as a forefoot wedge and heel wedge shoes to off-load the forefoot and heel, respectively (",
"    <a class=\"graphic graphic_figure graphicRef53678 \" href=\"mobipreview.htm?40/18/41248\">",
"     figure 3",
"    </a>",
"    ). These shoes may be useful under certain circumstances. For example, plantar heel ulcers are particularly difficult to heel because of an inability to adequately off-load this region; the heel wedge shoe can be useful to achieve this goal.",
"   </p>",
"   <p>",
"    The disadvantage of wedge shoes is that most patients, especially elderly patients or those with proprioception abnormalities may not be able to maintain their balance, and some patients find walking in them difficult, if not impossible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43837846\">",
"    <span class=\"h3\">",
"     Knee walkers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Knee walkers are ambulatory assist devices that may be indicated for anyone with a lower extremity issue where weight bearing needs to be avoided (",
"    <a class=\"graphic graphic_figure graphicRef73730 \" href=\"mobipreview.htm?0/58/930\">",
"     figure 4",
"    </a>",
"    ). These devices are becoming more popular in the treatment of diabetic ulcer as a means to off-load the foot. There are no trials evaluating the effectiveness of these devices in healing diabetic foot ulcers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Debridement, good local wound care, and relief of pressure on the ulcer are believed to be important components of therapy for grade 1 and 2 foot ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/9\">",
"     9",
"    </a>",
"    ]. This treatment program does not require hospitalization. Close monitoring is required, and hospitalization for bed rest and intravenous antibiotic therapy is advisable if the ulcer does not improve. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/33/538?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     GRADE 3 LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Before deciding upon appropriate management of deep ulcers, it is important to evaluate for substantial peripheral vascular disease or bony involvement. A brief review is found here. These topics are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11464?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation of the diabetic foot\", section on 'Physical signs of peripheral artery disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11464?source=see_link&amp;anchor=H14#H14\">",
"     \"Evaluation of the diabetic foot\", section on 'Signs of infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Assessment for peripheral artery disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of the adequacy of the circulation is an important component of the evaluation of all wounds, and particularly wounds found in patients with diabetes. Symptoms of claudication or extremity pain at rest, and physical findings of diminished or absent pulses, cool temperature, pallor on elevation, or dependent rubor should raise suspicion about the presence of peripheral artery disease. Noninvasive vascular studies including ankle-brachial index, pulse volume recordings and duplex ultrasonography should be obtained to confirm the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11464?source=see_link&amp;anchor=H11#H11\">",
"     \"Evaluation of the diabetic foot\", section on 'Physical signs of peripheral artery disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ankle-brachial index is a measurement of the ratio of blood pressure at the ankle to that in the brachial artery that correlates with the presence and severity of arterial occlusive disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/42\">",
"     42",
"    </a>",
"    ]. In patients with diabetes, the blood vessels may be incompressible and ankle-brachial index values misleading. Segmental volume plethysmography and toe-brachial index values are more reliable for determining the severity of disease. The noninvasive diagnosis of lower extremity peripheral artery disease is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/16/10506?source=see_link\">",
"     \"Noninvasive diagnosis of arterial disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Assess for osteomyelitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osteomyelitis is likely to be present if bone can be seen at the floor of a deep ulcer, or if it can be easily detected by probing the ulcer with a sterile, blunt stainless steel probe. Other signs that suggest osteomyelitis are an ulcer size larger than 2 x 2 cm and an otherwise unexplained elevation in the erythrocyte sedimentation rate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/33/538?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities\", section on 'Diagnosis of underlying osteomyelitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Radiologic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiologic tests may be useful if the diagnosis of osteomyelitis remains uncertain. The diagnosis is clear if osteomyelitis is visible on plain radiographs. However, radiologic changes occur late in the course of osteomyelitis and negative radiographs do not exclude it. Other imaging techniques that may be useful in selective cases include radionuclide bone imaging, magnetic resonance imaging and imaging with indium-labeled leukocytes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H407278409\">",
"    <span class=\"h3\">",
"     Bone biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If clinical and radiographic assessments fail to provide a diagnosis, then bone biopsy can be considered. Bone biopsy does carry the risk of inoculating an otherwise uninfected bone if the biopsy is obtained through an infected soft tissue bed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/50/12071?source=see_link\">",
"     \"Approach to imaging modalities in the setting of suspected osteomyelitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of grade 3 lesions includes debridement, infection control, local wound care, and relief of pressure. The presence of osteomyelitis or peripheral artery disease warrants additional therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/43\">",
"     43",
"    </a>",
"    ]. Coordination of care among providers is important for keeping rates of amputation as low as possible. This was illustrated in a study of 10 Department of Veterans Affairs (VA) medical centers in which increased rates of amputation were seen in programs with the lowest scores for availability of clinical protocols, educational seminars, discharge planning and quality of care meetings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Antimicrobial therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether it is important to make a definitive diagnosis of osteomyelitis and whether patients with osteomyelitis should always be treated by hospitalization, intravenous antimicrobial drug therapy, and surgical debridement of bone are debated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/45\">",
"     45",
"    </a>",
"    ]. Some authors have suggested that osteomyelitis is present in as many as two-thirds of diabetic patients who have foot ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/46\">",
"     46",
"    </a>",
"    ], but this figure is much higher than is generally believed and may reflect bias in the severity of the cases studied.",
"   </p>",
"   <p>",
"    Surgical removal of infected bone may be necessary if the ulcer is not healing. A short period of hospitalization, with surgical debridement, including culture of material obtained from deep in the ulcer and bone biopsy, is often helpful in choosing antibiotic therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/47\">",
"     47",
"    </a>",
"    ]. Parenteral antibiotic therapy based upon the culture results has traditionally been given for four to six weeks in patients with osteomyelitis. The optimal regimen and when to transition to oral therapy are dependent upon the clinical features of each case. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/33/538?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities\", section on 'Antimicrobial therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Mechanical off-loading",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical off-loading relieves pressure on the ulcer and enhances healing. Total contact casting and cast walkers are alternatives to prolonged bed rest for the relief of pressure and allow for continued ambulation. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Mechanical off-loading'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Revascularization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Revascularization plays an important role in the management of diabetic foot ulcers in patients with documented peripheral artery disease (to avoid the need for amputation) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/9\">",
"     9",
"    </a>",
"    ]. In patients with diabetes, foot ulcers, and critical limb ischemia, revascularization, when possible, is associated with a lower incidence of amputation. As an example, in a longitudinal study of 564 patients with diabetes, foot ulcers (in 85 percent of subjects), and critical limb ischemia (defined as ankle-pressure &lt;70 mmHg), angioplasty (PTA) or bypass grafting (BPG) was performed in 74.5 and 20.6 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/48\">",
"     48",
"    </a>",
"    ]. Neither procedure was possible in the remaining 4.9 percent. Among patients who received PTA, BPG, or no revascularization, amputations were ultimately performed in 8.2, 21.2, and 59.2 percent, respectively. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/9/14486?source=see_link\">",
"     \"Clinical manifestations and evaluation of chronic critical limb ischemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/58/19370?source=see_link\">",
"     \"Treatment of chronic lower extremity critical limb ischemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     GRADE 4 AND 5 LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with these more advanced lesions require urgent hospital admission and surgical consultation, and amputation may sometimes be required. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/33/538?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     ADVANCED THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several approaches have been reported that may improve ulcer healing, such as vacuum-assisted wound closure, the use of custom-fit semipermeable polymeric membrane dressings, cultured human dermis, and application of products such as platelet-derived growth factors and platelet releasate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/49-51\">",
"     49-51",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Negative pressure wound therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Negative pressure wound therapy (NPWT), also called vacuum-assisted closure (VAC), involves the application of controlled subatmospheric pressure to the surface of the wound. NPWT enhances wound healing by increasing wound perfusion, reducing edema, reducing the local bacterial burden and increasing the formation of granulation tissue. The indications, contraindications, and uses of negative pressure wound therapy systems are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/41/26264?source=see_link\">",
"     \"Negative pressure wound therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Randomized trials have found that NPWT reduces time to closure of diabetic foot ulcers, and wounds following diabetic foot surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/52-57\">",
"     52-57",
"    </a>",
"    ]. In this patient population, NPWT also decreases length of hospitalization, complication rates, and cost [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/58-60\">",
"     58-60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One multicenter trial randomized 342 patients with diabetic foot ulcers (stage 2 or 3 Wagner ulcers, and adequate vascular perfusion) to negative pressure wound therapy or moist wound therapy (ie, hydrogel, alginate) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/53\">",
"       53",
"      </a>",
"      ]. All ulcers were debrided (as needed) within two days of randomization, and the majority of the patients also received off-loading therapy. The primary endpoint was wound closure. A significantly greater percentage of patients treated with negative pressure wound therapy achieved wound closure within the 16 week timeframe of the study compared with alternative medical therapy (43 versus 29 percent). The negative pressure wound therapy group also demonstrated significantly fewer amputations compared with the alternate medical therapy group (4 versus 10 percent).",
"     </li>",
"     <li>",
"      Another multicenter trial followed 162 diabetic patients for 16 weeks following partial foot amputation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/52\">",
"       52",
"      </a>",
"      ]. The percentage of patients with healed wounds (56 versus 39 percent) and time to complete closure (42 versus 84 days) were significantly improved in patients randomized to vacuum-assisted wound closure group compared with the control group.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Skin substitutes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human skin equivalents have been studied in diabetic patients with noninfected, nonischemic chronic plantar ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/50,61-64\">",
"     50,61-64",
"    </a>",
"    ]. In one study of 208 patients, weekly application of the cultured skin equivalent (Graftskin) for four weeks improved the healing rate compared with usual care (complete wound healing in 56 and 38 percent of patients, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/61\">",
"     61",
"    </a>",
"    ]. Bioengineered skin substitutes (Dermagraft, Apligraf) are also available for the treatment of nonhealing diabetic foot ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/62,63\">",
"     62,63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Growth factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A platelet-derived growth factor gel preparation (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?29/61/30675?source=see_link\">",
"     becaplermin",
"    </a>",
"    ) is approved by the US Food and Drug Administration as an adjuvant therapy for diabetic foot ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/65\">",
"     65",
"    </a>",
"    ]. It promotes cellular proliferation and angiogenesis and thereby improves wound healing. However, its use has been limited by high cost and by post-marketing reports of an increased rate of mortality secondary to malignancy in patients treated with three or more tubes of becaplermin (3.9 versus 0.9 in controls per 1000 person years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/66\">",
"     66",
"    </a>",
"    ]. In another trial, local application of human epidermal growth factor was shown to promote healing of diabetic foot ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Hyperbaric oxygen therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperbaric oxygen therapy, as a component of diabetic ulcer management, may be associated with improved healing but the indications for hyperbaric oxygen in the treatment of nonhealing diabetic foot ulcers remain uncertain. Several metaanalyses of these trials have concluded that hyperbaric oxygen therapy in the treatment of diabetic foot ulcers may offer a benefit; however, each noted that the methodologic quality of the included studies was poor and there was a potential for bias [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/68-72\">",
"     68-72",
"    </a>",
"    ] The available trials are limited by small sample size and heterogeneity of the wounds being treated (eg, ulcer size, ulcer depth, microbial environment, presence of ischemia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/73-82\">",
"     73-82",
"    </a>",
"    ]. No conclusions could be drawn regarding specific indications for or timing of therapy.",
"   </p>",
"   <p>",
"    A pooled analysis found significantly improved wound healing (OR 9.99, 95% CI 3.97-25.1), and decreased risk of amputation (OR 0.24, 95% CI 0.14-0.43) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/68-71\">",
"     68-71",
"    </a>",
"    ]. A later metaanalysis found similar results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/72\">",
"     72",
"    </a>",
"    ]. As an example of these effects, in one of the larger trials that included 70 patients with severely ischemic foot ulcers (Wagner grades 3 and 4), the amputation rate was 9 percent in the treatment group and 33 percent in the control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/73\">",
"     73",
"    </a>",
"    ]. In another trial that included 94 patients, a significantly increased incidence of complete healing (Wagner 2 though 4 ulcers) was achieved in the hyperbaric oxygen therapy group (52 versus 29 percent) compared with a placebo group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Therapies that combine hyperbaric oxygen therapy with known mediators of wound healing may augment the effects of hyperbaric oxygen. Activation and mobilization of endothelial progenitor cells (EPCs) are impaired in patients with diabetes. These cells are known to play an important role in wound healing by participating in the formation of new blood vessels in areas of hypoxia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/83-86\">",
"     83-86",
"    </a>",
"    ]. Hyperoxia effectively improves EPC mobilization, but does not specifically target to a specific site which may, in part, explain the nonuniform improvement in diabetic foot wounds with hyperbaric oxygen therapy alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/87\">",
"     87",
"    </a>",
"    ]. However, in a murine model of diabetes, coadministration of the chemokine stromal cell-derived factor-1 alpha (SDF-1 alpha) resulted in homing of activated EPCs into the wound site [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/88\">",
"     88",
"    </a>",
"    ]. These data suggest that combining hyperbaric oxygen therapy with administration of SDF-1 alpha may be synergistic. Other combination therapies (eg, fibroblast growth factor) are also being studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/89,90\">",
"     89,90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H369378086\">",
"    <span class=\"h2\">",
"     Other agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Small trials have shown some promise for other topical agents. In a randomized study, application of .05 percent tretinoin solution for 10 minutes a day followed by iodine gel for four weeks resulted in complete resolution of 46 percent of the ulcers in the treatment group (n = 13) compared with 18 percent in the control group (n = 11) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/91\">",
"     91",
"    </a>",
"    ]. In addition, electrical stimulation near the ulcer may also help slowly healing ulcers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?36/28/37321/abstract/92,93\">",
"     92,93",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/26/36259?source=see_link\">",
"       \"Patient information: Diabetes mellitus type 1: Overview (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/22/9572?source=see_link\">",
"       \"Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?42/38/43618?source=see_link\">",
"       \"Patient information: Foot care in diabetes mellitus (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The treatment of diabetic foot ulcers begins with a comprehensive assessment of the ulcer and the patient's overall medical condition. Evidence of underlying neuropathy, bony deformity, and peripheral artery disease should be actively sought. The wound is classified upon initial presentation and with each follow-up visit using a standardized system to document the examination, plan treatment, and follow the progress of healing. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Wound classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adequate debridement, proper local wound care, relief of pressure on the ulcer by mechanical off-loading, and control of infection (when present) are important components of therapy. Dressings are selected based upon wound characteristics. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Local wound care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several methods are available to achieve mechanical off-loading and include total contact casts, cast walkers, wedge shoes, and bedrest. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Mechanical off-loading'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Few data are available comparing methods of debridement (sharp, enzymatic, autolytic, mechanical, and biological). In the absence of such data, we suggest surgical (sharp) debridement rather than another method (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If a surgeon with clinical expertise in sharp debridement is not available, we suggest autolytic debridement with hydrogels (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Method of debridement'",
"      </a>",
"      above.) Alternatively, the patient can be referred to a facility with appropriate surgical expertise in the management of diabetic foot problems.",
"     </li>",
"     <li>",
"      For managing extensive open wounds following debridement for infection or necrosis, or partial foot amputation, we suggest negative pressure wound therapy (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). All necrotic tissue or infected bone (osteomyelitis) must be removed from the wound prior to using this device. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Negative pressure wound therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/41/26264?source=see_link&amp;anchor=H12#H12\">",
"       \"Negative pressure wound therapy\", section on 'Contraindications'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with Wagner grade 3 and higher ulcers with critical limb ischemia, we recommend revascularization (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Revascularization should also be performed in patients with any degree of limb ischemia and a nonhealing ulcer. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Grade 3 lesions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with Wagner grade 4 and 5 ulcers require immediate surgical consultation. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Grade 4 and 5 lesions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/1\">",
"      Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 2008; 31:1679.",
"     </a>",
"    </li>",
"    <li>",
"     National Diabetes Data Group. Diabetes in America, 2nd Edition, National Institutes of Health, Washington, D.C  p.409.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/3\">",
"      American Diabetes Association. Clinical Practice Recommendations: foot care in patients with diabetes mellitus. Diabetes Care 1996; 19:S23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/4\">",
"      Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999; 22:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/5\">",
"      Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population &gt;=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 2004; 27:1591.",
"     </a>",
"    </li>",
"    <li>",
"     O'Neal, LW, Wagner, FW. The Diabetic Foot, Mosby, St Louis 1983. p.274.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/7\">",
"      Brodsky JW. Outpatient diagnosis and care of the diabetic foot. Instr Course Lect 1993; 42:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/8\">",
"      Frykberg RG, Zgonis T, Armstrong DG, et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg 2006; 45:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/9\">",
"      Khanolkar MP, Bain SC, Stephens JW. The diabetic foot. QJM 2008; 101:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/10\">",
"      Oyibo SO, Jude EB, Tarawneh I, et al. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care 2001; 24:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/11\">",
"      Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg 1996; 35:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/12\">",
"      Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20 Suppl 1:S90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/13\">",
"      Cardinal M, Eisenbud DE, Armstrong DG, et al. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen 2009; 17:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/14\">",
"      Armstrong DG, Lavery LA, Nixon BP, Boulton AJ. It's not what you put on, but what you take off: techniques for debriding and off-loading the diabetic foot wound. Clin Infect Dis 2004; 39 Suppl 2:S92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/15\">",
"      Margolis DJ, Kantor J, Berlin JA. Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis. Diabetes Care 1999; 22:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/16\">",
"      Lebrun E, Tomic-Canic M, Kirsner RS. The role of surgical debridement in healing of diabetic foot ulcers. Wound Repair Regen 2010; 18:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/17\">",
"      Steed DL, Donohoe D, Webster MW, Lindsley L. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. J Am Coll Surg 1996; 183:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/18\">",
"      Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2010; :CD003556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/19\">",
"      Joseph WS, Lipsky BA. Medical therapy of diabetic foot infections. J Vasc Surg 2010; 52:67S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/20\">",
"      Lipsky BA. Medical treatment of diabetic foot infections. Clin Infect Dis 2004; 39 Suppl 2:S104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/21\">",
"      Lipsky BA, Pecoraro RE, Larson SA, et al. Outpatient management of uncomplicated lower-extremity infections in diabetic patients. Arch Intern Med 1990; 150:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/22\">",
"      Bergin SM, Wraight P. Silver based wound dressings and topical agents for treating diabetic foot ulcers. Cochrane Database Syst Rev 2006; :CD005082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/23\">",
"      Cavanagh PR, Bus SA. Off-loading the diabetic foot for ulcer prevention and healing. J Vasc Surg 2010; 52:37S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/24\">",
"      Spencer S. Pressure relieving interventions for preventing and treating diabetic foot ulcers. Cochrane Database Syst Rev 2000; :CD002302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/25\">",
"      Lewis J, Lipp A. Pressure-relieving interventions for treating diabetic foot ulcers. Cochrane Database Syst Rev 2013; :CD002302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/26\">",
"      Katz IA, Harlan A, Miranda-Palma B, et al. A randomized trial of two irremovable off-loading devices in the management of plantar neuropathic diabetic foot ulcers. Diabetes Care 2005; 28:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/27\">",
"      Mueller, MJ, Diamond, JE, Sinacore, DR, et al. Total contact casting in treatment of diabetic plantar ulcers: controlled clinical trial. Diabetes Care 1989; 12:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/28\">",
"      Caravaggi C, Faglia E, De Giglio R, et al. Effectiveness and safety of a nonremovable fiberglass off-bearing cast versus a therapeutic shoe in the treatment of neuropathic foot ulcers: a randomized study. Diabetes Care 2000; 23:1746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/29\">",
"      Armstrong DG, Nguyen HC, Lavery LA, et al. Off-loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001; 24:1019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/30\">",
"      Nabuurs-Franssen MH, Huijberts MS, Sleegers R, Schaper NC. Casting of recurrent diabetic foot ulcers: effective and safe? Diabetes Care 2005; 28:1493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/31\">",
"      Piaggesi A, Macchiarini S, Rizzo L, et al. An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a randomized prospective trial versus traditional fiberglass cast. Diabetes Care 2007; 30:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/32\">",
"      Piaggesi A, Viacava P, Rizzo L, et al. Semiquantitative analysis of the histopathological features of the neuropathic foot ulcer: effects of pressure relief. Diabetes Care 2003; 26:3123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/33\">",
"      Mueller MJ, Sinacore DR, Hastings MK, et al. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial. J Bone Joint Surg Am 2003; 85-A:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/34\">",
"      Lavery LA, Vela SA, Lavery DC, Quebedeaux TL. Total contact casts: pressure reduction at ulcer sites and the effect on the contralateral foot. Arch Phys Med Rehabil 1997; 78:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/35\">",
"      Armstrong DG, Lavery LA, Kimbriel HR, et al. Activity patterns of patients with diabetic foot ulceration: patients with active ulceration may not adhere to a standard pressure off-loading regimen. Diabetes Care 2003; 26:2595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/36\">",
"      Baumhauer JF, Wervey R, McWilliams J, et al. A comparison study of plantar foot pressure in a standardized shoe, total contact cast, and prefabricated pneumatic walking brace. Foot Ankle Int 1997; 18:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/37\">",
"      Pollo FE, Brodsky JW, Crenshaw SJ, Kirksey C. Plantar pressures in fiberglass total contact casts vs. a new diabetic walking boot. Foot Ankle Int 2003; 24:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/38\">",
"      Faglia E, Caravaggi C, Clerici G, et al. Effectiveness of removable walker cast versus nonremovable fiberglass off-bearing cast in the healing of diabetic plantar foot ulcer: a randomized controlled trial. Diabetes Care 2010; 33:1419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/39\">",
"      Reiber GE, Smith DG, Wallace C, et al. Effect of therapeutic footwear on foot reulceration in patients with diabetes: a randomized controlled trial. JAMA 2002; 287:2552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/40\">",
"      Brown D, Wertsch JJ, Harris GF, et al. Effect of rocker soles on plantar pressures. Arch Phys Med Rehabil 2004; 85:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/41\">",
"      Busch K, Chantelau E. Effectiveness of a new brand of stock 'diabetic' shoes to protect against diabetic foot ulcer relapse. A prospective cohort study. Diabet Med 2003; 20:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/42\">",
"      Fowkes FG. The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 1988; 17:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/43\">",
"      Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care 1990; 13:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/44\">",
"      Wrobel JS, Charns MP, Diehr P, et al. The relationship between provider coordination and diabetes-related foot outcomes. Diabetes Care 2003; 26:3042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/45\">",
"      Eckman MH, Greenfield S, Mackey WC, et al. Foot infections in diabetic patients. Decision and cost-effectiveness analyses. JAMA 1995; 273:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/46\">",
"      Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers. Diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA 1991; 266:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/47\">",
"      Mushlin AI, Littenberg B. Diagnosing pedal osteomyelitis: testing choices and their consequences. J Gen Intern Med 1994; 9:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/48\">",
"      Faglia E, Clerici G, Clerissi J, et al. Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care 2009; 32:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/49\">",
"      Blackman JD, Senseng D, Quinn L, Mazzone T. Clinical evaluation of a semipermeable polymeric membrane dressing for the treatment of chronic diabetic foot ulcers. Diabetes Care 1994; 17:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/50\">",
"      Marston WA, Hanft J, Norwood P, et al. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 2003; 26:1701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/51\">",
"      Margolis DJ, Kantor J, Santanna J, et al. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001; 24:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/52\">",
"      Armstrong DG, Lavery LA, Diabetic Foot Study Consortium. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet 2005; 366:1704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/53\">",
"      Blume PA, Walters J, Payne W, et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes Care 2008; 31:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/54\">",
"      McCallon SK, Knight CA, Valiulus JP, et al. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage 2000; 46:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/55\">",
"      Eginton MT, Brown KR, Seabrook GR, et al. A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds. Ann Vasc Surg 2003; 17:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/56\">",
"      Ford CN, Reinhard ER, Yeh D, et al. Interim analysis of a prospective, randomized trial of vacuum-assisted closure versus the healthpoint system in the management of pressure ulcers. Ann Plast Surg 2002; 49:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/57\">",
"      Etoz, A, Ozgenel, Y, Ozcan, M. The use of negative pressure wound therapy on diabetic foot ulcers. Wounds 2004; 16:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/58\">",
"      Philbeck, TE, Schroeder, WJ, Whittington, KT. Vacuum-assisted closure therapy for diabetic foot ulcers: clinical and cost analysis. Home Health Consultant 2001; 8:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/59\">",
"      Armstrong DG, Lavery LA, Abu-Rumman P, et al. Outcomes of subatmospheric pressure dressing therapy on wounds of the diabetic foot. Ostomy Wound Manage 2002; 48:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/60\">",
"      Andros G, Armstrong DG, Attinger CE, et al. Consensus statement on negative pressure wound therapy (V.A.C. Therapy) for the management of diabetic foot wounds. Ostomy Wound Manage 2006; Suppl:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/61\">",
"      Veves A, Falanga V, Armstrong DG, et al. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001; 24:290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/62\">",
"      Edmonds M, Bates M, Doxford M, et al. New treatments in ulcer healing and wound infection. Diabetes Metab Res Rev 2000; 16 Suppl 1:S51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/63\">",
"      Barber C, Watt A, Pham C, et al. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes. J Wound Care 2008; 17:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/64\">",
"      Kirsner RS, Warriner R, Michela M, et al. Advanced biological therapies for diabetic foot ulcers. Arch Dermatol 2010; 146:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/65\">",
"      Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998; 21:822.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.regranex.com/ (Accessed on October 07, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/67\">",
"      Tsang MW, Wong WK, Hung CS, et al. Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care 2003; 26:1856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/68\">",
"      Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2004; :CD004123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/69\">",
"      Goldman RJ. Hyperbaric oxygen therapy for wound healing and limb salvage: a systematic review. PM R 2009; 1:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/70\">",
"      Roeckl-Wiedmann I, Bennett M, Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg 2005; 92:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/71\">",
"      Wang C, Schwaitzberg S, Berliner E, et al. Hyperbaric oxygen for treating wounds: a systematic review of the literature. Arch Surg 2003; 138:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/72\">",
"      Liu R, Li L, Yang M, et al. Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clin Proc 2013; 88:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/73\">",
"      Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 1996; 19:1338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/74\">",
"      Duzgun AP, Satir HZ, Ozozan O, et al. Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. J Foot Ankle Surg 2008; 47:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/75\">",
"      Kessler L, Bilbault P, Ort&eacute;ga F, et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers: a prospective randomized study. Diabetes Care 2003; 26:2378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/76\">",
"      Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg 2003; 25:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/77\">",
"      Doctor N, Pandya S, Supe A. Hyperbaric oxygen therapy in diabetic foot. J Postgrad Med 1992; 38:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/78\">",
"      Lin, TF, Chen, et al. The vascular effects of hyperbaric oxygen therapy in treatment of early diabetic foot. Undersea Hyperb Med 2001; 28(suppl):63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/79\">",
"      Hammarlund C, Sundberg T. Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plast Reconstr Surg 1994; 93:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/80\">",
"      L&ouml;ndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010; 33:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/81\">",
"      Zamboni WA, Wong HP, Stephenson LL, Pfeifer MA. Evaluation of hyperbaric oxygen for diabetic wounds: a prospective study. Undersea Hyperb Med 1997; 24:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/82\">",
"      Baroni G, Porro T, Faglia E, et al. Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care 1987; 10:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/83\">",
"      Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117:1219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/84\">",
"      Silvestre JS, L&eacute;vy BI. [Diabetes and peripheral arterial occlusive disease: therapeutic potential and pro-angiogenic strategies]. Ann Cardiol Angeiol (Paris) 2006; 55:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/85\">",
"      Capoccia BJ, Robson DL, Levac KD, et al. Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood 2009; 113:5340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/86\">",
"      Hung SC, Pochampally RR, Chen SC, et al. Angiogenic effects of human multipotent stromal cell conditioned medium activate the PI3K-Akt pathway in hypoxic endothelial cells to inhibit apoptosis, increase survival, and stimulate angiogenesis. Stem Cells 2007; 25:2363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/87\">",
"      Berendt AR. Counterpoint: hyperbaric oxygen for diabetic foot wounds is not effective. Clin Infect Dis 2006; 43:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/88\">",
"      Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007; 117:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/89\">",
"      Efrati S, Gall N, Bergan J, et al. Hyperbaric oxygen, oxidative stress, NO bioavailability and ulcer oxygenation in diabetic patients. Undersea Hyperb Med 2009; 36:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/90\">",
"      Nakada T, Saito Y, Chikenji M, et al. Therapeutic outcome of hyperbaric oxygen and basic fibroblast growth factor on intractable skin ulcer in legs: preliminary report. Plast Reconstr Surg 2006; 117:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/91\">",
"      Tom WL, Peng DH, Allaei A, et al. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes. Arch Dermatol 2005; 141:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/92\">",
"      Baker LL, Chambers R, DeMuth SK, Villar F. Effects of electrical stimulation on wound healing in patients with diabetic ulcers. Diabetes Care 1997; 20:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?36/28/37321/abstract/93\">",
"      Peters EJ, Lavery LA, Armstrong DG, Fleischli JG. Electric stimulation as an adjunct to heal diabetic foot ulcers: a randomized clinical trial. Arch Phys Med Rehabil 2001; 82:721.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8175 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-64F316EBC0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37321=[""].join("\n");
var outline_f36_28_37321=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H28\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      WOUND CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      GRADE 0 LESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      GRADE 1 AND 2 LESIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Method of debridement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Infection control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Local wound care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mechanical off-loading",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Total contact cast",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1273196\">",
"      - Cast walkers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1140745573\">",
"      - Therapeutic shoes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H43837846\">",
"      - Knee walkers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      GRADE 3 LESIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Assessment for peripheral artery disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Assess for osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Radiologic tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H407278409\">",
"      - Bone biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Antimicrobial therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Mechanical off-loading",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Revascularization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      GRADE 4 AND 5 LESIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      ADVANCED THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Negative pressure wound therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Skin substitutes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Growth factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Hyperbaric oxygen therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H369378086\">",
"      Other agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/8175\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8175|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?39/47/40688\" title=\"figure 1\">",
"      Removable cast walker",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/15/42238\" title=\"figure 2\">",
"      Rocker sole shoe",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/18/41248\" title=\"figure 3\">",
"      Wedge shoes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?0/58/930\" title=\"figure 4\">",
"      Knee walker",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8175|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/57/26512\" title=\"picture 1\">",
"      Wagner 1 foot ulcer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?36/47/37631\" title=\"picture 2\">",
"      Wagner grade 2 ulcer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?29/9/29842\" title=\"picture 3\">",
"      Wagner 3 foot ulcer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?22/42/23200\" title=\"picture 4\">",
"      Wagner 4 foot ulcer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8175|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/35/17981\" title=\"table 1\">",
"      Oral agents for mild to moderate diabetic foot infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/50/12071?source=related_link\">",
"      Approach to imaging modalities in the setting of suspected osteomyelitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/9/14486?source=related_link\">",
"      Clinical manifestations and evaluation of chronic critical limb ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/33/538?source=related_link\">",
"      Clinical manifestations, diagnosis, and management of diabetic infections of the lower extremities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/12/11464?source=related_link\">",
"      Evaluation of the diabetic foot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/41/26264?source=related_link\">",
"      Negative pressure wound therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/16/10506?source=related_link\">",
"      Noninvasive diagnosis of arterial disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?35/26/36259?source=related_link\">",
"      Patient information: Diabetes mellitus type 1: Overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?9/22/9572?source=related_link\">",
"      Patient information: Diabetes mellitus type 2: Overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?42/38/43618?source=related_link\">",
"      Patient information: Foot care in diabetes mellitus (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/58/19370?source=related_link\">",
"      Treatment of chronic lower extremity critical limb ischemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37064?source=related_link\">",
"      Treatment of pressure ulcers",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f36_28_37322="Folliculitis decalvans";
var content_f36_28_37322=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87488%7EDERM%2F87489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87488%7EDERM%2F87489&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Folliculitis decalvans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous inflammatory papules and pustules are present on the crown of the scalp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Folliculitis decalvans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 433px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tufted folliculitis (multiple hairs emerging from a single inflamed follicular orifice) is evident at the periphery of scarring in this patient with folliculitis decalvans.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37322=[""].join("\n");
var outline_f36_28_37322=null;
var title_f36_28_37323="Clinical characteristics basilar-type migraine";
var content_f36_28_37323=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F73674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F73674&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical characteristics of basilar-type migraine",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Always present:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two or more basilar-type aura symptoms (ie, vertigo, dysarthria, tinnitus, diplopia, bilateral visual symptoms, bilateral paresthesia, decreased level of consciousness, hypacusis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Visual aura characterized by positive features (ie, zigzag lines, flickering light) or negative features (ie, scotoma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        May be present:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sensory aura characterized by positive features (ie, pins and needles) or negative features (ie, numbness)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aphasic aura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Temporal characteristics of aura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aura symptoms almost always develop gradually over &ge;5 minutes and/or aura symptoms occur in succession over &ge;5 minutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Duration 5 to 120 minutes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A headache with migraine features begins after the onset of aura",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Patient characteristics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Basilar-type migraine onset occurs before age 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Most patients with basilar-type migraine also have attacks of migraine with typical aura and without basilar-type aura",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Kirchmann M, Thomsen LL, Olesen J. Basilar-type migraine: clinical, epidemiologic, and genetic features. Neurology 2006; 66:880.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37323=[""].join("\n");
var outline_f36_28_37323=null;
var title_f36_28_37324="Television guidelines";
var content_f36_28_37324=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65107&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65107&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Parental guidelines for television",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Rating",
"       </td>",
"       <td class=\"subtitle1\">",
"        Explanation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"2\">",
"        TV-Y",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        All children",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The program is designed to be appropriate for all children. Whether animated or live-action, the themes and elements of the program are specifically designed for a very young audience, including children from ages&nbsp;two to six&nbsp;years. The program is not expected to frighten younger children.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"2\">",
"        TV-Y7",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Dir",
"        <span>",
"         e",
"        </span>",
"        cted to older children",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The program is designed for children older than&nbsp;seven years. It may be more appropriate for children who have the developmental skills to distinguish fantasy from reality. Themes and elements in the program may include mild fantasy or comedic violence, or may frighten children younger than seven.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        TV-Y7-FV",
"       </td>",
"       <td>",
"        As above, but fantasy violence may be more intense or more combative than other programs in TV-Y7.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"2\">",
"        TV-G",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        General audience",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Most parents would find the program suitable to all ages. Although the rating does not signify a program designed specifically for children, most parents may let younger children watch the program unattended. It contains little or no violence, no strong language, and little or no sexual dialogue or situations.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"2\">",
"        TV-PG",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Parental guidance suggested",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The program contains material that parents may find unsuitable for younger children. Many parents may want to watch it with their younger children. The theme itself may call for parental guidance and/or the program contains one or more of the following: moderate violence (V), some sexual situations (S), infrequent coarse language (L), or some suggestive dialogue (D).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"2\">",
"        TV-14",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Parents strongly cautioned",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The program contains some material that many parents would find unsuitable for children younger than 14. Parents are strongly urged to exercise greater care in monitoring the program and are cautioned against letting children younger than 14 watch unattended. The program contains one or more of the following: intense violence (V), intense sexual situations (S), strong coarse language (L), or intensely suggestive dialogue (D).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"2\">",
"        TV-MA",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Mature audience only",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The program is specifically designed to be viewed by adults and therefore may be unsuitable for children younger than 17. The program contains one of more of the following: graphic violence (V), explicit sexual activity (S), or crude indecent language (L).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from",
"     <a href=\"file://transition.fcc.gov/vchip/#guidelines\">",
"      file://transition.fcc.gov/vchip/#guidelines",
"     </a>",
"     . Accessed on June 19, 2012.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37324=[""].join("\n");
var outline_f36_28_37324=null;
var title_f36_28_37325="Grading system for systemic reactions to immunotherapy";
var content_f36_28_37325=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F54901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F54901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Grade 1",
"       </td>",
"       <td class=\"subtitle1\">",
"        Grade 2",
"       </td>",
"       <td class=\"subtitle1\">",
"        Grade 3",
"       </td>",
"       <td class=\"subtitle1\">",
"        Grade 4",
"       </td>",
"       <td class=\"subtitle1\">",
"        Grade&nbsp;5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          <em>",
"           Symptom(s)/sign(s) of&nbsp;one organ system present*",
"          </em>",
"         </strong>",
"        </p>",
"        <hr/>",
"        <p>",
"         <strong>",
"          Cutaneous",
"         </strong>",
"         <br/>",
"         Generalized pruritus, urticaria, flushing, or sensation of heat or warmth&bull;",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <p>",
"         Angioedema (not laryngeal, tongue or uvular)",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <hr/>",
"        <p>",
"         <strong>",
"          Upper respiratory",
"         </strong>",
"         <br/>",
"         Rhinitis: (eg, sneezing, rhinorrhea, nasal pruritus, and/or nasal congestion)",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <p>",
"         Throat-clearing (itchy throat)",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <p>",
"         Cough perceived to originate in the upper airway, not the lung, larynx, or trachea",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <hr/>",
"        <p>",
"         <strong>",
"          Conjunctival",
"         </strong>",
"         <br/>",
"         Erythema, pruritus, or tearing",
"        </p>",
"        <hr/>",
"        <p>",
"         <strong>",
"          Other",
"         </strong>",
"         <br/>",
"         Nausea, metallic taste, or headache",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          <em>",
"           Symptom(s)/sign(s) of more than&nbsp;one organ system present",
"          </em>",
"         </strong>",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <hr/>",
"        <p>",
"         <strong>",
"          Lower respiratory",
"         </strong>",
"         <br/>",
"         Asthma: cough, wheezing, shortness of breath (eg, less than 40 percent PEF or FEV",
"         <sub>",
"          1",
"         </sub>",
"         drop, responding to an inhaled bronchodilator)",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <hr/>",
"        <p>",
"         <strong>",
"          Gastrointestinal",
"         </strong>",
"         <br/>",
"         Abdominal cramps, vomiting, or diarrhea",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <hr/>",
"        <p>",
"         <strong>",
"          Other",
"         </strong>",
"         <br/>",
"         Uterine cramps",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Lower respiratory",
"         </strong>",
"         <br/>",
"         Asthma (eg, 40 percent PEF or FEV",
"         <sub>",
"          1",
"         </sub>",
"         drop NOT responding to an inhaled bronchodilator)",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <hr/>",
"        <p>",
"         <strong>",
"          Upper respiratory",
"         </strong>",
"         <br/>",
"         Laryngeal, uvula, or tongue edema with or without stridor",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Lower or upper respiratory",
"         </strong>",
"         <br/>",
"         Respiratory failure with or without loss of consciousness",
"        </p>",
"        <p>",
"         or",
"        </p>",
"        <hr/>",
"        <p>",
"         <strong>",
"          Cardiovascular",
"         </strong>",
"         <br/>",
"         Hypotension with or without loss of consciousness",
"        </p>",
"       </td>",
"       <td>",
"        Death",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td colspan=\"5\">",
"        Patients may also have a feeling of impending doom, especially in grades 2, 3, or 4.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"5\">",
"        <strong>",
"         Note:",
"        </strong>",
"        Children with anaphylaxis seldom convey a sense of impending doom and their behavior changes may be a sign of anaphylaxis; eg, becoming very quiet or irritable and cranky.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"5\">",
"        <strong>",
"         Scoring includes a suffix that denotes if and when epinephrine is or is not administered in relationship to onset of symptom(s)/sign(s) of the SR: a, &le;5 minutes; b, &gt;5 minutes to &le;10 minutes; c, &gt;10 to &le;20 minutes; d, &gt;20 minutes; z, epinephrine not administered.",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"5\">",
"        The final grade of the reaction will not be determined until the event is over, regardless of the medication administered. The final report should include the first symptom(s)/sign(s) and the time of onset after the subcutaneous allergen immunotherapy injection",
"        <sup>",
"         &Delta;",
"        </sup>",
"        and a suffix reflecting if and when epinephrine was or was not administered,",
"        <strong>",
"         eg, Grade 2a; rhinitis: 10 minutes",
"        </strong>",
"        .",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td colspan=\"5\">",
"        <strong>",
"         Final report: Grade a to d, or z __________ First symptom(s)/sign(s) __________ Time of onset of first symptom __________",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td colspan=\"5\">",
"        <strong>",
"         Comments",
"         <sup>",
"          &loz;",
"         </sup>",
"         :",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Each grade is based on organ system involved and severity. Organ systems are defined as cutaneous, conjunctival, upper respiratory, lower respiratory, gastrointestinal, cardiovascular, and other. A reaction from a single organ system, such as cutaneous, conjunctival, or upper respiratory, but not asthma, gastrointestinal, or cardiovascular, is classified as a grade 1. Symptom(s)/sign(s) from more than one organ system or asthma, gastrointestinal, or cardiovascular are classified as grades 2 or 3. Respiratory failure or hypotension with or without loss of consciousness define grade 4 and death grade 5. The grade is determined by the clinician's clinical judgment.",
"     <br>",
"      <font class=\"bullet\">",
"       &bull;",
"      </font>",
"      This constellation of symptoms may rapidly progress to a more severe reaction.",
"      <br>",
"       &Delta; Symptoms occurring within the first minutes after the injection may be a sign of severe anaphylaxis. Mild symptoms may progress rapidly to severe anaphylaxis and death.",
"       <br>",
"        <font class=\"lozenge\">",
"         &loz;",
"        </font>",
"        If signs or symptoms are not included in the table or the differentiation between a SR and vasovagal (vasodepressor) reaction, which may occur with any medical intervention, is difficult, please include comments, as appropriate.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Cox C, Larenas-Linnemann D, Lockey RF, et al. Speaking the same language: The World Allergy Organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol 2010; 125:569. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37325=[""].join("\n");
var outline_f36_28_37325=null;
var title_f36_28_37326="Contents: Adult procedures";
var content_f36_28_37326=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Adult procedures",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Adult procedures",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Airway",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/14/28906\">",
"           Direct laryngoscopy and tracheal intubation in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/50/4905\">",
"           Emergent surgical cricothyrotomy (cricothyroidotomy)",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Anesthesia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/57/33689\">",
"           Infiltration of local anesthetics",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/51/34618\">",
"           Procedural sedation in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Cardiovascular",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/33/15894\">",
"           Arterial blood gases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/51/26424\">",
"           Arterial catheterization techniques for invasive monitoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/1/29\">",
"           Complications of central venous catheters and their prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/5/44119\">",
"           Emergency pericardiocentesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/32/44553\">",
"           Overview of central venous access",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/13/6361\">",
"           Peripheral venous access in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/14/3306\">",
"           Placement of jugular venous catheters",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/27/1466\">",
"           Placement of subclavian venous catheters",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/47/3833\">",
"           Principles of ultrasound-guided venous access",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/36/25159\">",
"           Technique of pericardiocentesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/61/21465\">",
"           Temporary cardiac pacing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/35/13877\">",
"           Venous blood gases and other alternatives to arterial blood gases",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Dermatology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/22/33124\">",
"           Closure of minor skin wounds with staples",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/7/18553\">",
"           Closure of skin wounds with sutures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/51/31543\">",
"           Dermatologic procedures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/20/40264\">",
"           Skin biopsy techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/32/41478\">",
"           Superficial wound repair with tissue adhesives",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/46/5865\">",
"           Technique of incision and drainage for skin abscess",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ear nose and throat",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/41/1690\">",
"           Approach to the adult with epistaxis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/47/24309\">",
"           Evaluation and repair of tongue lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/8/9351\">",
"           Subungual hematoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Minor emergency procedures",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/9/30872\">",
"           Assessment and management of scalp lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/22/33124\">",
"           Closure of minor skin wounds with staples",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/7/18553\">",
"           Closure of skin wounds with sutures",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/53/16216\">",
"           Digit dislocation reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/47/24309\">",
"           Evaluation and repair of tongue lacerations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/42/38564\">",
"           Fish-hook removal techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/47/13044\">",
"           Hair entrapment removal techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/25/30100\">",
"           Management of zipper injuries",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/51/32567\">",
"           Minor wound preparation and irrigation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/46/26340\">",
"           Reduction of temporomandibular joint (TMJ) dislocation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/49/8981\">",
"           Ring removal techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/8/9351\">",
"           Subungual hematoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/32/41478\">",
"           Superficial wound repair with tissue adhesives",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?5/46/5865\">",
"           Technique of incision and drainage for skin abscess",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Musculoskeletal",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/9/23703\">",
"           Digital nerve block",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/14/30951\">",
"           Intraarticular and soft tissue injections: What agent(s) to inject and how frequently?",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/57/28564\">",
"           Joint aspiration or injection in adults: Complications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/52/23368\">",
"           Joint aspiration or injection in adults: Technique and indications",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/31/28148\">",
"           Joint aspiration: The dry tap",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?37/9/38038\">",
"           Knee (tibiofemoral) dislocation and reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/46/26340\">",
"           Reduction of temporomandibular joint (TMJ) dislocation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/8/10378\">",
"           Shoulder dislocation and reduction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/54/15208\">",
"           Splinting of musculoskeletal injuries",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Neurology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/6/19561\">",
"           Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Obstetrics and gynecology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/11/2232\">",
"           Antepartum fetal heart rate assessment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/42/13992\">",
"           Approach to episiotomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/54/24420\">",
"           Culdocentesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/7/26742\">",
"           Mechanism of normal labor and delivery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/61/36824\">",
"           Ultrasound examination in obstetrics and gynecology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/63/28659\">",
"           Word catheter placement for treatment of Bartholin cysts and abscesses",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Ophthalmology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/28/44486\">",
"           Slit lamp examination",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pulmonary",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/33/15894\">",
"           Arterial blood gases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/23/12663\">",
"           Diagnostic thoracentesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/12/1226\">",
"           Placement and management of thoracostomy tubes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/35/13877\">",
"           Venous blood gases and other alternatives to arterial blood gases",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-917D24D510-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f36_28_37326=[""].join("\n");
var outline_f36_28_37326=null;
var title_f36_28_37327="Omphalitis shoelace";
var content_f36_28_37327=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50750&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50750&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Omphalitis shoelace",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 255px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Omphalitis with induration and erythema surrounding the umbilicus in a newborn Native American infant. The umbilicus was tied with a shoelace.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Martin I. Lorin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f36_28_37327=[""].join("\n");
var outline_f36_28_37327=null;
